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Abstract.
Human GLUTS has been heterologously expressed in Xenopus oocytes, 
allowing examination of its substrate selectivity and basic kinetic parameters. The 
Km for zero-Uans entry of D-fructose by GLUTS is 22.5 mM, but 2-deoxy-D- 
glucose is not transported by this isoform. Additionally, transport of fructose is 
not inhibited by the presence of either deoxyglucose or D-glucose. Analysis of the 
effects of pH on transport indicate that deoxyglucose is not transported across the 
pH range. Furthermore, the Km for transport of fructose remains constant under 
varying pH conditions.
The inhibitory effects of fused ring fructose analogues on the fructose 
transport of GLUTS have also been determined. Fructose transport by GLUTS- 
expressing oocytes is not inhibited by the fused pyranose ring analogues, 1,5- 
anhydromannitol and L-sorbose. However, the fused furanose ring analogue, 2,5- 
anhydromannitoi, does inhibit the transport of fructose by GLUTS in the same 
system.
GLUT2/GLUTS chimeras had been constructed previously. Expression of 
these mutants in Xenopus oocytes has allowed determination of their basic kinetic 
parameters, with a view to examine the structural basis for differential substrate 
selectivity between isoforms. Km values for the transport of alternative substrates, 
fructose and galactose, have been determined for these chimeras, and compared 
with parameters previously measured for deoxyglucose. All parameters were 
compared with Km values obtained for native GLUT2 and GLUTS in the same 
system. Results indicate that helix 7 participates in fructose recognition by GLUT2, 
and the equivalent helix in GLUTS is involved in high affinity deoxyglucose and 
galactose transport by this isoform.
A panel of rdneteen GLUTS mutants had been constructed previously, each 
incorporating substitution of an individual residue of hehx 8 with alanine. These 
have been expressed in the Xenopus oocyte system, allowing analysis of their basic
11
kinetic properties. The Km value for deoxyglucose entry was determined for each 
m utant and this compared to that of wild-type GLUTS. Only replacement of 
asparagine-S15 with alanine altered this transport parameter with respect to the 
wild type value, producing a 4-fold elevation of Km- Tins residue is polar and may 
be directly involved in the transport of glucose.
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CHAPTER 1.
Introduction.
1.1 General Background.
The ability of cells to selectively transport molecules and ions across 
their plasma membranes is an important feature of the essential link between 
m em brane physiology and cellular m etabolism . This link is clearly 
demonstrated by the mechanisms that have evolved in living cells to mediate 
the uptake of the most metabolically important biological molecule on earth- 
glucose.
In mammalian cells, these mechanisms fall into two general categories 
(reviewed in Carruthers, 1990). The first of these is a protein-mediated 
diffusion mechanism which involves the rapid diffusion of glucose down its 
concentration gradient via a protein carrier molecule. This transport event is 
driven only by the concentration gradient and can be bidirectional. This is 
termed facilitative diffusion. The second type of mechanism is termed active 
transport. This type of system couples the transport of glucose with an energy- 
producing reaction such as the hydrolysis of ATP or the co-transport of an ion. 
The expression of these active transport carriers is restricted to the apical 
membrane in cells of the absorptive epithelia in the small intestine and the 
reabsorptive epithelia of the kidney tubules. In all other tissues the uptake of 
glucose is achieved by facilitated diffusion, which is possible due to the 
maintenance of a relatively high physiological blood glucose concentration- 
approximately between 5-1 OmM.
Studies performed by Widdas in 1952, examining the saturable nature of 
sugar transport into erythrocytes, and by LeFevre in 1961, examining the 
competition between sugars for transport, showed that the erythrocyte system 
displayed modified Michaelis-Menton saturation kinetics, in which the carrier 
acted as the enzyme and D-glucose as the substrate on the outside of the cell 
membrane and the product on the inside (LeFevre, 1961, Widdas, 1952). In 
these studies, differences were noted in the kinetics of sugar uptake into
different tissue types which hinted at the prospect of the existence of tissue 
specific isoforms.
Evidence that the mechanism of glucose transport was at least partially 
protein-dependent came from studies by Jung (Jung, 1971), who showed that 
erythrocyte ghosts retain the capacity to transport glucose, whereas the protein- 
bereft pure phospholipid component of fractionated erythrocytes do not. 
Further studies also showed that glucose uptake into erythrocytes could be 
inhibited very efficiently by low concentrations of cytochalasin B or phloretin. 
These compounds had Ki values of 140nM and 200nM respectively (Bloch, 
1973, LeFevre & Marshall, 1959, Zoccoli et a l ,  1978). Much of the early kinetic 
data was generated using the erythrocyte system as these cells were easy to 
m anipulate and were available in large quantities. Several early studies, 
investigating the nature of the glucose binding site w ithin the carrier, 
demonstrated that the reversible binding of glucose to the carrier was mediated 
by hydrogen bonding (Barnett et a l ,  1973, Kahlenberg & Dolansky, 1972).
The purification of the erythrocyte transporter was achieved by two 
independent groups in the late 1970's. In 1977 Kasahara and Hinkle 
demonstrated that the protein they had purified could transport glucose when 
reconstituted into fractionated erythrocyte membranes, while in 1979, Baldwin 
et al showed that their purified protein could bind cytochalasin B (Baldwin et 
a l ,  1979, Kasahara & Hinkle, 1977). Both these studies revealed the carrier to be 
a heterologously glycosylated integral m em brane protein which, when 
analysed by SDS polyacrylamide gel electrophoresis, was found to migrate as a 
broad band of 55KDa in molecular mass. This could be reduced to a band of 
46KDa upon endoglycosidase H treatment.
Reconstitution of this purified protein into phospholipid vesicles 
demonstrated that it was the carrier system in its entirety, as the kinetics of 
transport were identical to those of the native protein (Wheeler, 1981). This
reconstituted protein could also bind cytochalasin B with a stoichiometry ratio 
of 1:1 (Baldwin et aL, 1981, Baldwin et ah, 1979).
This purification of the protein led to the production of antibodies 
(Sogin & H inkle, 1978), and its pa rtia l pro tein  sequencing. These 
advancements allowed the isolation and sequencing of the cDNA from the 
hum an hepatom a (HepG2) cell line in 1985 by Mueckler et al, and the 
subsequent cloning and sequencing of a further five functional isoforms of the 
carrier by various other groups (Mueckler, 1985).
The erythrocyte transporter, being the first to be cloned and sequenced, 
was later named GLUTl (Fukumoto et aL, 1989), and the other isoforms were 
named GLUTs 2-7 according to the chronology of the isolation of their cDNAs. 
Six isoforms to date, GLUTs 1, 2, 3, 4, 5, and 7, comprise the mammalian 
facilitative glucose transporter family.
1.2.1 Tissue-Specific Distribution of the Facilitative Glucose Transporters.
The observation that different tissues have varying needs for glucose 
throughout the progressive stages of development, and that these tissues 
display subtly different kinetics for the uptake of D-glucose first led researchers 
to propose that a family of transporters might exist. To date, seven such 
isoforms have been identified and named GLUTs 1-7. GLUTs 1-5 and GLUT7 
encode functional proteins, while GLUT6 is a pseudogene-like sequence.
1.2.2 GLUTl
GLUTl was the first transporter isoform to be cloned and remains the 
only one to be purified in a functional form. GLUTl is also referred to as the 
erythrocyte transporter due to its abundance in the erytluocyte membrane. It is 
also referred to as the brain-type or HepG2 transporter since the first clones
encoding it were isolated by screening rat brain tissue and the human 
hepatoma carcinoma (HepG2) cell line (Birnbaum et aL, 1986).
The cloning and sequencing of GLUTl revealed a protein of 492 amino 
acid residues. Since then, cDNAs from other species have been isolated, 
including mouse (Kaestner et aL, 1989), rabbit (Asano et aL, 1988), and pig 
(Weiler Guttler et aL, 1989). All have been found to be 492 residues in length, 
and display 97% sequence identity with human GLUTl.
The production of oligonucleotides (enabled by the isolation of the 
cDNA) allowed the screening of tissues for the presence of GLUTl mRNA. The 
relative GLUTl protein levels in these tissues could also be measured using 
antibodies generated against the purified protein. The highest levels of GLUTl 
were found in the membrane of erythrocytes where this transporter was found 
to constitute up to 7% of total membrane protein (Allard & Lienhard, 1985). 
High levels were also found in various blood-tissue barriers (Takata et aL,
1990) such as the blood-brain  and blood-nerve barriers, the placenta 
syncytiotrophoblast, and several blood-eye barriers. GLUTl was also found in 
virtually every other tissue, albeit at very low levels.
The physiological significance of such high levels of GLUTl in 
erythrocytes is unknown. At physiological temperature, the Km of GLUTl for 
the uptake of D-glucose is approximately 7mM (Lowe & Walmsley, 1986), 
which is close to physiological glucose concentrations. It is for this reason that 
GLUTl has been proposed to be responsible for the basal uptake of glucose into 
cells. However, at this rate of uptake the maximum transport capacity of the 
erythrocyte is 12,000 fold greater than the rate of cellular glucose utilisation.
One possible explanation for this is derived from the following 
observations: GLUTl is the transporter which is expressed in foetal tissues, 
including heart, liver and brown fat. In adults, these tissues have very low 
levels of GLUTl and the predom inant transporter is GLUT4 (Asano et aL, 
1988). Also, it has previously been noted that in most foetal animals the
erythrocytes have a very high capacity for D-glucose transport. In these 
animals, with the exception of primates, this capacity is lost soon after birth 
(Widdas, 1955). Therefore, it has been suggested that GLUTl may function in 
the foetus to mediate the transfer of D-glucose across the placenta into the 
intracellular space of the erythrocyte, and that this process still occurs to a 
lesser extent across the blood-tissue barriers in primates (Jacquez, 1984).
Another unusual observation is the elevation of GLUTl levels in 
transformed cells and indeed in all cultured cell lines. However, it has been 
noted that mitogens and growth factors can stimulate transcription of the 
GLUTl gene (Merrall et aL, 1993), as can a state of starvation (reviewed in 
Gould & Holman, 1993). Since cultured cells are subjected constantly to these 
conditions, it is thought that this mechanism may be responsible for elevated 
GLUTl levels in these cells.
1.2.3 GLUT2.
Due to the very low levels of GLUTl found in liver tissue, and because 
of the distinct glucose transport kinetics exhibited by this tissue, it was 
suspected that another transporter isoform was present in hepatocytes.
Using GLUTl cDNA oligonucleotides in low stringency hybridisation 
screening of hepatocyte DNA libraries, the GLUT2 cDNA was isolated 
(Fukumoto et aL, 1988). GLUT2 cDNAs have since been isolated from rat 
(Thorens, 1988), and m ouse (Suzue et aL, 1989).These cDNAs encode 
molecules which are 522, 523 and 524 amino acid residues long, respectively, 
and share 88% amino acid sequence identity with each other. Human GLUT2 
and hum an GLUTl share 55% sequence identity  and have virtually  
superimposable hydropathy plots. Most diversity between the two isoforms 
occurs in the extreme C-terminus and in the large loop that separates putative
transmembrane helices 1 and 2. In GLUT2 there is an additional 32 residues in 
this loop, which doubles its size with respect to the GLUTl loop.
The screening of tissues for GLUT2 protein revealed high levels of
GLUT2 in the (3-cells of the islets of Langerhans in the pancreas (Orci, 1989, |
;Thorens, 1988), in the transepithelial cells of the intestine and kidney tubules 
(Thorens, 1990), and in the hepatocytes of the liver. The molecular weight of 
the GLUT2 protein differs between tissues, being 53, 55, 57, and 61kDa in liver, ?
ir(3-cell, kidney, and intestine tissues respectively. This is thought to be the result 
of differences in the extent of glycosylation of GLUT2 in the various tissue 
types. Like GLUTl, the large extracellular loop of GLUT2 contains a single 
asparagine residue which is a potential site for N-linked glycosylation 
(Thorens, 1988),
The role of GLUT2 in the liver is important as it allows this organ to 
accumulate glucose for conversion to glycogen when blood glucose levels are 
high. Moreover, when blood glucose levels are low, glucose is produced by the 
liver's glucose yielding processes- glycogeneolysis and gluconeogenesis, and is 
released into the blood with identical kinetics to those of glucose uptake.
GLUT2 is a low affinity/high capacity "enzyme" both for D-glucose entry and |
exit (reviewed in Elliott & Craik, 1983), and it is present in the hepatocyte 
membrane in large quantities. It therefore allows the release and uptake of 
glucose to occur in a rapid and non saturable manner, thus enabling the liver 
to fulfil its important role in blood glucose homeostasis.
Interestingly, GLUT2 is found in the islets of Langerhans in the 
pancreas, but its expression is absolutely restricted to the (3-cells (Orci, 1989, 
Thorens, 1988). These are the cells which secrete insulin  in response to 
elevated blood glucose levels. Insulin secretion is achieved by transcription of 
the insulin gene which is in turn regulated by glucose uptake and metabolic 
processing in the (3-cell. It has therefore been suggested that GLUT2 plays an 
im portant role in this process. Since GLUT2 is a low affinity/high capacity
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enzyme, the uptake of glucose over the range of physiological concentrations 
(5-15mM) will be non-saturable, and furthermore, the rate will be directly 
proportional to the concentration of glucose in the blood. This has led to the 
speculation that GLUT2 allows glucokinase (which has a relatively low Km for 
glucose of 6mM) (Vischer et aL, 1987) to be the rate-limiting step in p-cell 
glucose metabolism. Some as yet unidentified downstream  product of this 
pathway may provide the signal that directly regulates the transcription of the 
insulin gene. Glucokinase may therefore act as the "blood glucose sensor" of 
the p-cell (reviewed in Gould & Holman, 1993).
GLUT2 seems to play an im portant role in glucose homeostasis 
wherever it is found. In the epithelia of the intestine and the kidney tubules, 
the high capacity transport property of GLUT2 ensures the efficient transfer of 
glucose dow n its concentration gradient into the bloodstream, the high 
concentration of glucose in the epithelial cells being achieved by the active 
transport of glucose from the lumen of these structures into the epithelial cells 
themselves, via active transport mechanisms.
1.2.4 GLUTS
The isolation of GLUT3 cDNA from hum an skeletal muscle DNA 
libraries was achieved using the same low stringency hybridisation techniques 
employed previously for the isolation of GLUT2 cDNA (Kayano et aL, 1988).
The GLUT3 protein was found to be 496 residues in length, displaying 
64% and 51% sequence identity with GLUTl and GLUT2 respectively (Kayano 
et aL, 1988).
Northern blot analysis of hum an tissues showed almost ubiquitous 
expression of GLUT3 mRNA with the highest levels found in neuronal and 
brain tissue, and in these tissues especially high levels were found in the 
cerebral areas (Kayano et aL, 1988). High levels of mRNA were also found in
the placenta and kidney (Kayano et aL, 1988). However, studies using an 
antibody raised against the carboxy-terminus of GLUTS showed that, while the 
protein is present in neuronal and brain tissues, it is present only in very low 
levels in heart, placenta and liver, and is almost undetectable in kidney (Gould 
et aL, 1992, Shepherd, 1992a).
Analysis of GLUTS protein distribution in other species, such as 
monkey, rabbit, rat and mouse (Maher et aL, 1992, Nagamatsu, 1992, Yano,
1991) have illustrated that the tissue distribution of GLUTS mRNA and 
protein is exclusively restricted to brain and neuronal tissue. GLUTS mRNA 
and protein are also expressed in cultured neuronal cell lines.
The apparent anomaly betw een rodent and hum an GLUTS mRNA 
tissue distribution may perhaps be due to contamination of the human tissues 
with neuronal tissue in the northern blot analysis. It is also possible however, 
that a post transcriptional regulation m echanism operates in hum an non 
neuronal tissues.
It has been suggested that the role of GLUTS in neuronal and brain 
tissue is a specific and important one: the brain is absolutely dependent upon 
glucose as its sole energy source since it is unable to derive energy from the 
hydrolysis of fatty acids. Furtherm ore, it has been found that glucose 
concentrations in the extracellular fluids of the brain are lower than those 
found in blood plasma (Lund-Anderson, 1979). The Km value for zero-trans  
entry (see section 1.4.2.2) of 2-deoxyglucose into X enopus  oocytes via GLUTS is 
~1.4mM (Colville et aL, 1993b), a value which is relatively low with respect to 
GLUTl which has a Km value of 7mM (Lowe & Walmsley, 1986). Therefore 
GLUTS has a greater efficiency for glucose transport under hypoglycaemic 
conditions. The co-expression of GLUTl and GLUTS in the brain tissue would 
therefore allow the high efficiency transport of glucose over the entire 
physiological range of blood glucose concentrations, with GLUTl working at its
highest capacity when blood glucose levels are high, and GLUTS transporting 
glucose more efficiently when blood glucose levels are low.
1.2.5 GLUTl
Studies involving the use of STS-Ll adipocytes showed that upon 
insulin stimulation the rate of glucose uptake increased between 12- and 15- 
fold. It was also noted however, that the increase in GLUTl at the plasma 
membrane was only around 4-fold. Therefore GLUTl could not be entirely 
responsible for this increase in transport ability in these cells. After feverish 
activity to clone the isoform responsible for this insulin stimulated transport, 
the cDNA for what is now referred to as GLUT4 was eventually isolated 
simultaneously by several groups. It was cloned from human (Fukumoto et 
aL, 1989, James et aL, 1989), rat (Birnbaum, 1989, Charron et al., 1989), and 
mouse (Kaestner et aL, 1989) cDNA libraries.
The cDNA for human GLUT4 was found to encode a protein of 509 
residues in length, which shared 65% sequence identity with GLUTl. Once 
again their hydropathy plots were superimposable (Fukumoto et aL, 1989, 
James et aL, 1989), with the exception of the amino-terminus of GLUT4 which 
was extended by an additional twelve amino acid residues with respect to 
GLUTl. Other more variable regions between these isoforms occur in the large 
extracellular loop which separates putative transmembrane regions 1 and 2; in 
the GLUT4 isoform this loop is longer.
Studies on rat adipocytes reported a 20- to SO-fold increase in D-glucose 
uptake upon insulin stimulation, while rat muscle cells exhibited a 7-fold 
increase (Ploug, 1987). The increase in glucose uptake by human adipocytes and 
human skeletal muscle cells in response to insulin was even lower: 2- to 4-fold 
(Pederson & Gliemann, 1981), and 2-fold (Dohm et aL, 1988). Kinetic data from 
these experiments has shown that the increase in transport capacity observed
10
in these tissues in response to insulin is brought about by a change in the 
Vmax/ and not (Holman et aL, 1990, May & Mikulecky, 1982, Simpson & 
Cushman, 1986, Taylor & Holman, 1981, Whitesell & Gliemann, 1979). 
Although there was, and still is, speculation that this increase in the V^ax of 
the transporter is achieved by intrinsic activation of the transporter protein, it 
is now largely established that this increase in transport capacity is achieved by 
recruitment of a large number of transporters to the plasma membrane from 
an intracellular pool, the exact nature and location of which is still unknown. 
This has been shown to occur in both fat (Cushman & Wardzala, 1980, Suzuki 
& Kono, 1980), and skeletal muscle (Hirshman et aL, 1990, Klip et aL, 1987).
Equilibrium exchange studies on GLUT4 have reported K^i values for 3-
O-methyl-D-glucose of l.SmM (Keller et aL, 1989), and 4.3mM (Nishim ura, 
1993). Therefore at low physiological glucose concentrations, GLUT4 is 
responsible for the majority of glucose uptake in hum an tissues. Upon insulin 
stimulation, the number of transporters increases at the plasma membrane 
and the result is an increase in the glucose transport capacity of the cell.
1.2.6 GLUTS
Using low stringency hybridisation to screen a hum an jejunal DNA 
library, Kayano et al isolated a cDNA with a GLUT-like sequence (Kayano et aL, 
1990). This cDNA was found to encode a protein of 501 amino acid residues in 
length and which is the most divergent of the GLUT sequences so far: there is 
only 42%, 40%, 39%, and 42% sequence identity between this isoform, referred 
to as GLUT5, and GLUTs 1-4 respectively.
Northern blot analysis of human tissues revealed that GLUTS mRNA is 
present at high levels in the epithelia of the small intestine and the kidney, in 
the testes and spermatozoa, and at lower levels in skeletal muscle and adipose
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tissue (Kayano et al., 1990). Immuno-blot and immunohistochemicai studies 
have shown that GLUTS protein is present in hum an muscle, testes and 
spermatozoa, the adipocyte plasma membrane, the small intestine, the kidney 
and heart (Burant et al., 1992, Shepherd, 1992b).
The presence of GLUTS in enterocytes was at first puzzling since there 
did not seem to be a need for an additional glucose transporter in this cell: the 
sodium linked glucose transporter SGLTl in the enterocyte is capable of high 
efficiency transport and accumulation of glucose against its concentration 
gradient. However, Burant et al expressed human GLUTS in X enopus  oocytes 
and demonstrated that this isoform is a fructose transporter, and has virtually 
no ability to transport glucose (Burant et aL, 1992).
It is thought that GLUTS is restricted to the brush border membrane of 
enterocytes, where it mediates the uptake of dietary fructose from the lumen of 
the gut, although some evidence exists to suggest that GLUTS may also be 
present on the basolateral membrane of human enterocytes (Davidson et aL, 
1992, Hundal et aL, 1992). Once inside the enterocyte, fructose is transported 
out of the cell by GLUT2, the isoform present on the basolateral membrane 
(Thorens, 1990).
Other cDNAs from species such as rat (Rand, 1993) and rabbit (Miyamoto 
et aL, 1994) have also been isolated, and studies on these homologues have 
provided conflicting evidence as to whether GLUTS, in these species, can 
transport glucose and bind cytochalasin B. These studies will be discussed in 
detail in Chapter 3.
1.2.7 GLUT6
A cDNA was isolated in 1990 which was found to have 70% sequence 
identity with GLUTS, and was named GLUT6 (Kayano et aL, 1990). However, 
further analysis of his isoform found multiple term ination codons in the
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cDNA sequence, and so this gene does not encode a functional protein (Kayano 
et aL, 1990). It has been suggested that the GLUT6 pseudogene-like sequence 
might have arisen from a gene duplication event involving the GLUT3 gene 
sequence, thus explaining the high degree of homology between these two 
sequences.
1.2.8 GLUT7
GLUT7 cDNA was isolated in 1992 from a rat DNA library (Waddell,
1992). This isoform was found to be 528 amino acid residues in length, and 
displayed 68% sequence identity with rat GLUT2. Rat GLUT2 and GLUT7 were 
found to be identical at three separate sequence locations, and there appeared 
to be very little base drift over much larger areas of the remaining sequence. 
Although these sequences do not coincide with the intron-exon boundaries of 
the GLUT2 gene, it is still possible that GLUT2 and GLUT7 mRNAs are I
generated by an unknown splicing m echanism (Waddell, 1992). One of the 
differences between these sequences is the presence of a six amino acid 
targeting motif (KKxKxx) at the C-terminus of the GLUT7 sequence, which is
%believed to be responsible for targeting this isoform to the endoplasmic 
reticulum .
GLUT7 was found to be present in the microsomal fraction of rat r
hepatocytes, and it was found to localise to the endoplasmic reticulum when 
expressed in COS-7 cells (Waddell, 1992).
The liver plays a crucial role in blood-glucose homeostasis. As '
previously described, it is responsible for the uptake and release of glucose 
from and into the blood, via the GLUT2 isoform which is present on the 
surface of hepatocytes. However, the term inal step in glycogeneolysis and 
gluconeogenesis is the dephosphorylation of glucose-6-phosphate by glucose-6- 
phosphatase, and this process occurs in the lum en of the hepatocyte
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endoplasmic reticulum. So glucose must traverse this membrane first before it 
can reach the cytosol for transport out of the hepatocyte via GLUT2. It has been 
suggested that GLUT7 mediates the transport of glucose out of the hepatocyte 
endoplasmic reticulum.
Waddell et al are to date, the only group to have successfully cloned this 
transporter cDNA. This, together with the fact that there are large stretches of 
sequence identical to that of GLUT2, and extremely low level of base drift over 
large areas of the remaining sequence, leaves doubt as to whether this cDNA 
may be a cloning artefact. Therefore the existence of GLUT7 awaits 
confirmation from other sources.
1-2.9 Homologous Transporters in Other Organisms.
In 1992 it was observed that glucose transporters shared homology with 
a num ber of bacterial transport proteins (Griffith et aL, 1992). Using the 
sequences of several known transporters: TetC protein (the tetracycline 
resistance protein of Gram-negative bacteria); TetL (the tetracycline resistance 
protein of Gram positive bacteria); AraE (a sugar transporter of E. coli); GLUT2; 
and CitA (the citrate transporter of Gram-negative bacteria), Griffith et al 
searched databases for proteins with homologous sequences. It was shown that 
a high level of homology existed between sequences from these proteins and a 
variety of other proteins from several different species. These included active 
and passive transporters of eukaryotic and prokaryotic organisms, sugar/H+ 
symporters from higher plants, green algae, protozoans, yeasts, cyanobacteria 
and eubacteria (reviewed in Griffith et aL, 1992, Henderson et a l ,  1992). 
Although these transporters differed in substrate specificity, the mechanism of 
transport and the presence of fairly highly conserved stretches of sequence 
within their cDNAs allowed the inclusion of these proteins into a transporter 
"superfamily". Also included in this group are the bacterial tetracycline and
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citrate transporters, and the fungal quinate transporters as well as the GLUTs. 
However some transporters, such as the mammalian sodium-linked glucose 
transporters and the bacterial ATP- and phosphoenol pyruvate-utilising active 
transporters, are, surprisingly, not included in this superfamily.
All members of the superfamily have similar hydropathy plots to those 
of the m am m alian glucose transporters, and, despite the differences in 
sequence length between the members of this group, they are all believed to 
have a structure which spans the membrane twelve times, with a large central 
cytoplasmic loop between helices 6 and 7 (Figure 1.2).
Transporters most closely related to GLUTl by sequence include AraE 
the H ^/ L-arabinose symporter of E.coli, XylE- the H+/D-xyIose symporter of 
E.coli, and GalP- the galactose transporter of E.coli. These share 23%, 27%, and 
25% sequence identity with GLUTl respectively. GalP and AraE also bind 
cytochalasin B. GalP shares the same sensitivity of GLUTl to the inhibitor 
forskolin (Martin et aL, 1994). Moreover, cytochalasin B photolabelled GalP can 
be proteolytically digested to yield labelled fragments similar in size to those 
produced by labelling and digestion of GLUTl (Cairns et aL, 1987).
It is not known if the lactose permease of E.coli is a member of the 
superfamily, as it appears to share very little sequence identity with GLUTl. 
However, it too, has twelve predicted transmembrane helices, and although 
the percentage of sequence identity with GLUTl is low, lac permease possesses 
many of the motifs which are highly conserved in this superfamily (Buchel e t 
aL, 1980).
1.3.1 Structure of the Mammalian Facilitative Glucose Transporters.
W hen the GLUTl prim ary sequence was subjected to hydropathy 
analysis (Mueckler, 1985), the pattern was found to contain twelve regions each 
approximately 21 residues in length. These were long enough to be possible
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hydrophobic or amphipathic membrane spanning a-helices. According to this 
structure, the N- and C-termini were predicted to lie on the same side of the 
membrane in addition to a large central loop which separated transmembrane 
regions 6 and 7. Another large loop between transmembrane segments 1 and 2 
was predicted to lie on the opposite side of the membrane from the central 
loop. Proteolytic digestion studies have shown that the N- and C-termini and 
the large central loop are cytoplasmically disposed, and the other large loop 
between transmembrane regions 1 and 2 is exofacial (Cairns et aL, 1987, 
Mueckler, 1985).
Following the isolation of the cDNAs for the other transporter isoforms, 
the same hydropathy analysis has been performed on these sequences and it 
has been show n that the traces are all virtually superim posable. The 
hydropathy plots of GLUTs 1, 2, 3, 4 and 5 are shown in Figure 1.1. The 
sequences that are most conserved between the isoforms lie w ithin the 
transmembrane regions and the least conserved areas least conserved lie in the 
N- and C-term inal regions and in the two large loops. Five of the 
transm em brane helices are predicted to be amphipathic: transm em brane 
regions 3, 5, 7, 8 and 11, and it has been suggested that these helices may form a 
hydrophilic pore across the lipid bilayer through which D-glucose might move 
during transport (Mueckler, 1985). The large intracellular loop between helices 
6 and 7 divides the structure into two "halves", a lthough w hether this 
division is relevant in the tertiary structure is not known. The other 
cytoplasmic loops are short, only eight residues long and, as a result, probably 
restrict movement of the transmembrane helices. The extracellular loops are 
less conserved in size and sequence than the cytoplasmic loops, probably 
allowing flexibility of the protein during transport. It has been suggested that 
constraints imposed by the short loops at the cytoplasmic side of the 
membrane may cause a bunching effect of the helices, so that the structure at
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the extracellular side of the membrane is more open and relaxed, possibly 
exposing the exofacial sugar binding site.
There are several conserved sequences within the transporter cDNA: 
there is a GRR(K) motif present between transmembrane regions 1 and 2, 
which is repeated again between transmembrane regions 7 and 8. ExxxxxxR is 
conserved between transm em brane regions 4 and 5, and repeated again 
between transmembrane regions 10 and 11. There is also a conserved PESPR 
sequence in the cytoplasmic loop between transmembrane helices 6 and 7, 
which is similar to the motif in the C-terminal cytoplasmic tail -PETKG. This 
repetition of conserved motifs may suggest the evolution of the transporter 
protein from an ancestral six transmembrane helix membrane protein by a 
gene duplication event (Baldwin & Henderson, 1989, M aiden et aL, 1987). 
Together with the fact that the cytoplasmic loops are so short and probably 
restrain the possible tertiary structure of the protein, this duplication suggests 
that the protein may well adopt a bilobular structure, with six helices in each 
domain (Hodgson et aL, 1992). This has been observed to occur with the E.coli 
lactose permease protein. This protein is also a transporter molecule with a 
membrane spanning structure that is proposed to be similar to the GLUTs. 
Low resolution electron microscopy studies on this protein have shown it to 
be arranged in the membrane in two discrete domains (Li & Tooth, 1987).
1.3.2 Topological Model of GLUTl.
The topological model of GLUTl shown in Figure 1.2 is largely based 
upon the results of hydropathy plot analyses on the amino acid sequence of the 
protein (Figure 1.1). This model was originally proposed by Mueckler et al 
(Mueckler, 1985). The "positive inside" rule of protein folding states that in 
mono- or polytopic membrane proteins, there is likely to be a prevalence of
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positively charged amino acids in the cytoplasmic domains of the protein. This 
model of the GLUTl transporter is consistent with the "positive inside" rule.
Several biochemical and biophysical studies have lent support to this 
model. Proteolytic digestion of GLUTl in erythrocyte membranes with trypsin 
yields several proteolytic fragments. Analysis of these fragments with peptide 
specific antisera shows that they correspond to the C-terminal region (residues 
451-492) and the large loop between putative transmembrane helices 6 and 7 
(residues 207-271) (Gairns et aL, 1987). The native transporter is known to be 
susceptible to proteolytic cleavage by trypsin only at the cytoplasmic surface, 
and so it was deduced that the C-terminus and the large loop between helices 6 
and 7 were cytoplasmically disposed.
The site of N-linked glycosylation has been shown to be residue Asn^s 
which lies in the loop between helices 1 and 2. This loop is predicted to be 
extracellular (Cairns et aL, 1987, Mueckler, 1985).
Studies on GLUTl in X en o p u s  oocytes have shown that Cys429 can be 
lab e lled  ex te rn a lly  by the im perm ean t sulphydryl reagen t bis- 
(maleimidomethyl)-ether-L-[35S] cysteine (May et aL, 1990, We liner et aL, 1992). 
This residue must therefore be extracellular and since it lies in the loop at the 
top of helix 12, that loop must also be extracellular. This is consistent with 
Muecklers' model.
Studies of GLUTl in intact erythrocytes have shown that residue Lys^oü 
which is predicted to lie in the exofacial loop between helices 7 and 8, can be 
la b e lle d  e x te rn a lly  by the  im p e rm e a n t b io tin y la tio n  reagent 
sulphosuccinimidyl-6-(biotinamido)-hexanoate (NHS-LC-biotin), and so this 
loop is also exofacial, as predicted (Preston & Baldwin, 1993).
Fourier Transform Infra-Red spectroscopy is a method whereby the a- 
helical, the p-sheet structure and the random  coil content of membrane 
proteins can be estimated when the proteins are in dilute aqueous media. This 
technique, together w ith circular dichroism studies, revealed that GLUTl
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contains a large proportion of a-helix, with a lesser p-sheet content (Chin et al, 
1986). These studies also measured the tilt angle of the helices from the plane 
of the membrane bilayer, and noted that this angle is perpendicular to the 
membrane, but is reduced upon the binding of D-glucose to the protein.
Further support for the topology of Muecklers' model was obtained in 
1994 when Hresko et al. published an elegant study which established the 
orientation of each of the soluble domains of the protein (Hresko et aL, 1994). 
These workers used a mutagenesis scanning technique in which they inserted 
an epitope into each of the soluble domains of an aglyco-GLUTl construct. 
This GLUTl construct had the Asn^s residue, the site of potential glycosylation, 
m utated to Thr^s a substitution which abolishes glycosylation. The epitope 
w hich was inserted  into the hydrophilic  dom ains of this construct 
corresponded to the glycosylation consensus sequence (Asn-x-Thr/Ser) of 
GLUT4. Since N-linked glycosylation occurs exclusively on the side of the 
membrane which is exposed to the lumen of the endoplasmic reticulum, only 
the epitope tagged loops that are exofacial can be glycosylated. Expression of 
these m utants in X en o p u s  oocytes showed quite convincingly that the 
Muecklers' model was correct; only those loops which were predicted to be 
exofacial were, in fact, glycosylated.
1.4.1 The Single Site Conformational Change Model.
It was shown in the 1970's that sugars with bulky C-4 groups (with 
respect to glucose), such as maltose and 4,6-0-ethylidene D-glucose, or sugars 
with bulky C-6 groups such as 6-O-propyl-D-glucose could inhibit the transport 
of D-glucose by erythrocytes. It was shown further, however, that these sugars 
could only effect inhibition of glucose entry when present extracellularly 
(Baker & W iddas, 1973, Barnett et aL, 1975). Sim ilarly, u-propyl-p-D-
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glucopyranoside could inhibit only glucose efflux when present inside the cell 
(Barnett et aL, 1975).
These studies eluded to the idea that there may be two glucose binding 
sites on the transporter, one exofacial and one endofacial, and that these are 
structurally different because influx and efflux of glucose are susceptible to 
inhibition by different sugar analogues.
More recent evidence for the separation of these binding sites has come 
from transporter-specific ligands that bind to only one site. Cytochalasin B is a 
compound that is thought to bind to the endofacial binding site, since it inhibits 
glucose efflux in a competitive manner (Cairns etaL, 1987). lAPS-Forskohn is also 
thought to interact with the endofacial site (Wadzinski et aL, 1987). ATB-BMPA, a 
bismannose derivative, is proposed to bind to the exofacial binding site, since it 
can inhibit sugar influx in a competitive manner (Clark & Holman, 1990). For 
further discussion of these ligands see section 1.6.
It is thought that the exofacial and the endofacial binding sites cannot be 
occupied simultaneously, and indeed, the formation of one is suspected to 
preclude formation of the other (reviewed Baldwin, 1993).
The single site alternating conformation model is represented by the 
diagram shown in Figure 1.3. What is not clear from the available evidence for this 
model is whether these binding sites, although conformationally different, are 
absolutely structurally separate.
Molecular modelling studies, based on the ability of sugar analogues to 
inhibit glucose influx and efflux, have produced a model describing how glucose 
sterically occupies each of these putative binding pockets.
This model is shown in Figure 1.4. Glucose is proposed to enter the 
exofacial binding pocket with its C-1 carbon atom going in first, and the C-4 last. 
When it leaves the endofacial pocket it is thought to leave C-1 first. It is thought 
that glucose efflux occurs by the direct reverse of this procedure, with glucose
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entering the endofacial binding pocket C-4 first and leaving the exofacial site, 
C-1 last (Barnett et aL, 1975).
1.4.2.1 Kinetics of Transport of D-Glucose by GLUTl.
Most of the work investigating the kinetics of transport by the glucose 
transporters has been perform ed on GLUTl. This is due to the functional 
purification of this isoform which is made possible by the ready availability of 
erythrocytes and their ease manipulation (Kasahara & Hinkle, 1977). However, 
it is thought that despite differences in sugar specificity, kinetic parameters, 
targeting patterns, ligand binding, hormonal regulation and tissue-specific 
distribution, the other isoforms of the GLUT family will share the same 
general mechanism as that of GLUTl.
In the following sections, a model is proposed which describes the 
general mechanism of transport. In these sections, and in subsequent chapters 
of this thesis, kinetic terms are used to describe the behaviour of the 
transporter within this model. These are listed and explained below. The terms 
cis and trans refer to the side of the membrane from which transport is 
measured and the opposite side, respectively.
1.4.2.2 Zero-Trans  Entry.
This term refers to the simplest type of assay to measure the transport 
activity of a carrier. In all of the flux experiments listed here, the movement of 
substrate is traced by the addition of small amounts of radioactive substrate. 
This is known as the radiolabel or tracer. The measurement of zero-trans  entry 
involves the pre-incubation of cells expressing the transporter in a substrate- 
free m edium for a suitable period of time that ensures that the concentration 
of substrate in the cytosol of the cell is as low as possible. The external sugar
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concentration is varied for each measurement. The initial transport rate of 
substrate into the cell should be linear since the cytosolic substrate 
concentration is zero. Only initial rates of sugar transport are measured, before 
trans ->cis transport starts to occur. Therefore, the kinetic parameter being 
measured is the substrate binding affinity at the exofacial binding site (Km 
outside) and the maximum velocity of substrate uptake under infinitely high 
substrate concentrations (Vmax entry).
1.4.2.3 Zero-Trans  Exit.
This term refers to the type of assay which measures the exit of substrate y
from cells at initial rates of transport. In this measurement, the cells are pre­
incubated in varying concentrations of substrate until equilibrium is reached, 
at which point the medium is rapidly aspirated off and replaced with another 
without substrate. Initial rates of substrate efflux are determined by measuring 
the amount of radioactive tracer that has been transported out of the cell. This 
assay measures the affinity of the endofacial substrate binding site (Km inside) 
and the Vmax for sugar exit.
1.4.2.4 Equilibrium Exchange.
In this type of assay the concentration of cytosolic substrate in the cell is 
equal to that of the surrounding medium. This is achieved by pre-incubation 
of cells in medium containing the substrate at various concentrations for a 
period of time that allows the substrate to equilibrate between the external 
m edium  and the cytosol. Uptake or efflux of tracer-labelled substrate is 
m easured at various substrate concentrations, but the concentration of 
substrate on the outside of the cell is always equal to that of the cytosol. In this 
way. Km and Vmax for substrate exchange (for entry or efflux) can be measured.
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1.4.3.1 Reaction Mechanism of the Single Site Model.
The simplest model which describes the transport cycling of GLUTl is 
known as the single site alternating conformer model. This was initially 
developed as a symmetric carrier model by Widdas (Widdas, 1952), but was 
later adjusted to the asymmetric model to account for the observed asymmetry 
of D-glucose transport by GLUTl (Geek, 1971). This model, shown in Figure 1.5 
as a King-Altman diagram, describes the re orientation of a single substrate 
binding site between two conformations: an outward-facing conform ation 
(T o ), and an inward facing conformation (Ti). This cycling can occur in the 
presence or the absence of substrate. The re-orientation of the loaded 
transporter (Tg) from the outward-facing conformation (T qs) to the inward 
facing conformation (T is) is responsible for the movement of substrate into the 
cell. This mechanism (in reverse) applies to efflux of substrate from the cell, 
the direction of the net transport flux being driven purely by the direction of 
the substrate concentration gradient.
In this model, it is important to note that the rate constants that describe 
the movement of the loaded transporter (kg, k_g) are both greater than those 
describing the movement of the empty transporter (k%, k_i). The dissociation 
constants of the substrate bound at the exofacial and the endofacial site are not 
necessarily equal. Furthermore, it has been shown by NMR studies, that the 
rates of association and dissociation of D-glucose at either binding site, are 
greater than those of the re orientation of loaded or unloaded transporter 
(Wang, 1986). In short, the slowest step in the cycle is the re-orientation of the 
unloaded transporter. It is also important that the rate of re-orientation of the 
loaded carrier is faster than the reorientation of the empty carrier, and that 
movement of the loaded carrier from the outward facing to the inward facing
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conformation is faster than the reverse of this step. This is im portant in 
explaining the phenomenon of frans-acceleration (section 1.4.3.3).
1.4.3.2 Measurement of Steady State Rate Constants.
Evidence in support of this model has come from the measurement of 
steady-state and pre-steady state GLUTl kinetics. The steady state kinetics have 
been determ ined by m easuring the zero-trans  entry, zero-trans  exit and 
equilibrium  exchange constants of GLUTl in erythrocytes over a range of 
temperatures (Lowe & Walmsley, 1986).
The kinetics of GLUTl are temperature dependent, displaying lower Km 
and Vmax values at lower temperatures. However, the transporter always 
displays simple, hyperbolic Michaelis-Menton kinetics (i.e. simple Michaelis- 
Menton kinetics, but "modified" to account for the fact that the "enzyme" is a 
transporter, and the substrate is a transported sugar, which is not structurally 
modified by the action of the enzyme). It has been demonstrated that the 
temperature dependence of the zero-trans  Michaelis constants observed at low 
tem peratures is not due to a change in the affinities of the exofacial and 
endofacial binding sites, but as a result of differences in the rate constants for 
transporter re orientation. Therefore, at 0°C for exam ple, there is an 
asymmetric distribution of outw ard facing and inw ard facing transporters 
which is a direct result of the inequality of re orientation rate constants (ki, k_i, 
and kg, k_g). Thus, in the absence of glucose, only 6% of the transporter 
population is predicted to be in an outward-facing conformation (To). At 
physiological tem perature, the proportion of outward-facing transporters 
increases to 40%, as a direct change in the rate constants (ki, k_i) that govern re­
orientation of the transporter from the inward-facing to the outward-facing 
conformation.
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It has been suggested that the temperature dependence of GLUTl is the 
consequence of the large endothermie enthalpy and positive entropy changes 
associated with the re orientation of the transporter from an inward-facing 
conformation to an outward-facing conformation (Walmsley, 1987).
1.4.3.3 Measurement of Pre-Steady State Rate Constants.
Pre-steady state values have been obtained using purified G L U T l  
reconstituted into leaky vesicles (Appleman & Lienhard, 1989). Unidirectional 
conversions from one conformational state to another (half turnovers) can be 
observed by monitoring changes in protein fluorescence upon the addition of 
specific inhib itors w hich orientate the transporters into a particu lar 
conformation. This is possible since each conformation displays a slightly 
different pattern of intrinsic fluorescence at 336nm. Such studies have utilised 
site specific ligands such as 4,6-O-ethylidene-D-glucose, an external ligand, and 
phenyl-p-D-glucoside, an internal ligand. By adding saturating concentrations 
of 4,6-O-ethylidene-D-glucose at 10<X3, the population of transporter molecules 
is pulled rapidly into the outward facing conformation (T o ), and trapped in 
this state. At lO^C it is possible to measure the time taken for the transporters 
to achieve this conformation (i.e. Ti-> T o). The rate constants for this event, k_ 
2 and k_i, are determined by performing the above in the presence and absence 
of glucose respectively. In this way it is possible to m easure single half 
turnovers of the transporter. The To(±s) > Ti(±s) step can be measured by the 
addition of the internal ligand phenyl-(3-D-glucoside, and the rate constants kg 
and k i can be measured by performing the above in either the presence or the 
absence of glucose respectively.
The values obtained for rate constants using this technique are shown 
in  Figure 1.5 legend. Importantly, the relative rates of each step are in the order 
of k2 > k_2 > ki >k_i -the slowest step being the re orientation of empty carrier.
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The dissociation constants of the substrate at the exofacial binding site and the 
endofacial binding site (Kgo and Kgj respectively), have been calculated by the 
application of these rate constants to the observed kinetic models. It has been 
calculated that at 37X2 the value of Kgo is -lOmM, and Kgi is 23mM (Lowe & 
Walmsley, 1986). Therefore, the rate of dissociation of substrate at the exofacial 
site is greater than this event at the endofacial site.
Taken together, these values explain the phenom enon of traris- 
acceleration. It has been shown that the presence of substrate on the trans- 
(opposite) side of the membrane actually stimulates transport of tracer into the 
cell. This is thought to occur by the following mechanism: under zero-trans  
conditions, the initial flux of D-glucose is uni directional, and is limited by the 
slowest step in the cycle, re orientation of the empty carrier. However, as the 
substrate accumulates on the trans side of the membrane, and the state of 
equilibrium  exchange approaches, the overall rate of transport increases 
because the empty carrier re-orientation step is bypassed. Instead, the carrier
re orientates itself in an occupied state and this is a faster event. This
4'mechanism in effect, increases the number of unoccupied transporters in the 
outw ard facing conformation (To), and therefore increases transport rate. 
However, it should be noted that it is the flux of tracer that can be shown to 
increase. The net flux of substrate across the membrane remains constant, as 
the transport of every molecule of substrate into the cell is followed by the 
efflux of another. This is the mechanism by which trans-acceleration occurs, 
the phenomenon exhibited by GLUTl, and many other transport proteins, it 
has been suggested that GLUT2 and GLUT4 do not display this behaviour 
(Gould & Holman, 1993). However, it is difficult to measure this property of a 
transport protein unless it can be purified and reconstituted into phospholipid 
vesicles, where the transport kinetics are easier to measure, and equilibrium of 
substrate with the water space of the vesicle is slower. This has not been
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possible for the other isoforms as they have not been purified to a functional 
form. GLUTS and GLUTS have not been investigated for this property.
1.4.3.4 Multiple-Site Models.
Carruthers has shown that inconsistencies exist between the kinetic data 
from GLUTl studies and the predicted values obtained using integrated rate 
equations applied to the one site alternating conformation model (Carruthers, 
1990). He has proposed several a lternative m odels to explain these 
discrepancies, each of which is based upon the assumption that the transporter 
possesses two glucose binding sites which are present on opposite sides of the 
membrane sim ultaneously (Carruthers, 1991). Evidence for such a two site 
carrier comes from studies of erythrocyte glucose transporters where it has 
been demonstrated that the transporter molecules can bind cytochalasin B and 
then bind exofacial ligands, such as maltose, 4,6-O-ethylidene-D-glucose, or 
phloretin simultaneously (Helgerson & Carruthers, 1987). Also, it has been 
shown that the effects of each of these compounds on the inhibition of D- 
glucose transport by each of the other compounds, suggests that in addition to 
the two sites existing simultaneously, the binding of one ligand exhibits 
negative cooperativity on the binding of the second ligand (Carruthers & 
Helgerson, 1991).
However, as discussed by Baldwin (Baldwin, 1993), most of the kinetic 
data does agree with the one site asymmetric model, if allowances are made for 
the different measurement techniques, and for the fact that sugars may not 
display "ideal" behaviour.
Also, fluorescence, proteolytic digestion, chemical inactivation and most 
ligand binding studies all support the single site alternating conformation 
model. These are discussed below. However, Carruthers has also suggested an 
explanation for the discrepant data, which can incorporate the one site model.
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This involves oligomerisation of GLUTl transporter molecules, and it is 
discussed in section 1.10.
1.5.1 Conformational Change in GLUTl Detected by Changes in Intrinsic
Fluorescence.
The wavelength of fluorescence emissions from tryptophan residues 
w ithin proteins is dependent upon the polarity  of the surround ing  
environment, that is, whether the residue is in a hydrophilic or a hydrophobic 
environment. This property of tryptophan can therefore be exploited in the 
investigation of transmembrane proteins.
GLUTl has six tryptophan residues throughout its sequence (Mueckler,
1985). Examination of the intrinsic tryptophan fluorescence of GLUTl has 
shown that these residues are distributed in both hydrophobic and hydrophilic 
environments. These experiments also indicate that there is a difference in 
intrinsic fluorescence of exofacially and endofacially orientated transporters, as 
demonstrated with the use of site-specific ligands. It has been shown that at 
specific wavelengths, the tryptophan fluorescence of exofacially-orientated 
transporter is 20% less than the endofacial conformation (Krupka, 1972, Pawagi 
& Deber, 1990).
Intrinsic fluorescence of membrane proteins can be quenched by the
:
addition of small hydrophilic molecules such as potassium  iodide, and 
measurements of quenching efficiency can be used to assess the position and 
accessibility of fluorescent groups. Such measurements of GLUTl have shown 
that not all of the emissions can be quenched by the addition of potassium 
iodide. This result indicates that most of the tryptophan residues are located 
within the membrane bilayer and are therefore inaccessible to the potassium 
iodide, whilst those responsible for that part of the signal that can be quenched.
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are present in a more hydrophilic and accessible environm ent (Pawagi & 
Deber, 1990).
It was show n that in the presence of glucose the quenching of 
fluorescence is reduced. This result indicates that the binding and transport of 
D-glucose causes the movement of one or more tryptophan residues from a 
hydrophilic environment to a hydrophobic environm ent (Chin et al., 1992, 
Pawagi & Deber, 1990). This reduction in quenching is not observed when the 
transporter binds cytochalasin B or maltose. Therefore, this probably represents 
a transition state in the transport process which involves the movement of the 
vulnerable tryptophan into the membrane bilayer, where it is shielded from 
quenching. These results are consistent with the idea of large segments of the 
protein moving to induce a large conformational change associated with 
transport catalysis.
These observations are also consistent with data from circular dichroism 
spectroscopy studies. It has been shown that the binding of D-glucose results in 
a 10% increase in the a-helical content of the GLUTl protein. The addition of 
cytochalasin B can reverse this effect. The binding of maltose, however, leads 
to a 10% reduction in the a-helical content (Pawagi & Debber, 1987, Pawagi & 
Deber, 1990). Taken together, these studies support the suggestion that maltose 
stabilises the transporter in an outward-facing conformation, while D-glucose 
induces a change to the inward-facing conformation.
The movement of tryptophan(s) from a solvent accessible environment 
into the lipid bilayer is likely to occur via the movem ent of one of the 
transmembrane helices. Pawagi and Debber have predicted that the segment of 
GLUTl most likely to be able to exist as a hydrophilic loop or as an a-helix, is 
that comprised of residues 378-398. This sequence lies w ithin helix 10. The 
presence of several proline and glycine residues is thought to contribute to the 
flexibility of this segment (Pawagi & Deber, 1990).
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Tryptophan residues Trp^88 and Trp'^f^ pg within or close to this predicted 
dynamic segment. They also lie in the proximity to the cytochalasin B binding site, 
and exhibit a fluorescence excitation wavelength similar to that required for 
cytochalasin B photoactivation (Holman & Midgley, 1985). These residues have 
therefore been implicated in the glucose transport mechanism. Substitution of 
both Trp888 and Trp412 in GLUTl has been shown to result in a drastic loss of 
transport activity, and perturbation of the endofacial binding site as indicated by a 
loss of cytochalasin B binding and photolabelling (Inukai et ah, 1994) (section 
6.2.3).
1.5.2 Changes in Proteolytic Susceptibility: Support for the Alternating
Conformation Model.
Proteolytic digestion of GLUTl by trypsin occurs at the cytoplasmic face, 
and produces two large membrane embedded protein fragments, and two soluble 
peptides which correspond to the C-terminus (amino acid residues 457-492) and 
the large cytoplasmic loop between helices 6 and 7 (residues 213-269) (Cairns et al., 
1987, Gibbs et al., 1988). The rate of proteolytic digestion is reduced in the presence 
of ligands that reversibly bind to the exofacial binding site such as maltose, 4,6-0- 
ethylidene-D-glucose and phloretin (Gibbs et ah, 1988, King et at., 1991). Also, it 
has been shown that photoaffinity labelling of GLUTl by the impermeant 
bismannose compound ATB-BMPA almost completely protect the protein from 
cleavage by thermolysin (Clark & Holman, 1990).
These effects suggest that, when the glucose transporter becomes stabilised 
in an outward facing conformation by the action of ligand binding to the exofacial 
site, the associated conformational change in the protein has resulted in
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a relocation of the proteolytic cleavage points on the cytoplasmic loop and tail so 
that they are now inaccessible to enzyme attack.
Conversely, the reversible binding of ligands to the endofacial binding site 
causes an increase in the rate of proteolysis. Presumably this is because the 
opening of the endofacial site to accept the endofacial ligands results m exposure 
of the cleavage points at the cytoplasmic face and thus increases their 
susceptibility to proteolytic attack. The presence of intracellular glucose also 
increases the rate of digestion by the same mechanism.
In following this line of argument it might be expected that the presence of 
cytochalasin B on the endofacial side of the membrane would greatly increase the 
rate of digestion, but this does not occur with tryptic digestion (Gibbs et al., 1988, 
King et al., 1991). It is possible that, because cytochalasin B is a large, bulky 
molecule, steric hindrance may block accessibility of the proteases to the cleavage 
points. However, digestion with thermolysin occurs when cytochalasin B is bound 
to the transporter, but not when ATB-BMPA is bound (Holman et al, 1986). The 
binding of cytochalasin B presumably exposes the thermolysin cleavage points, 
while the binding of ATB-BMPA puUs them toward the membrane bilayer into a 
protected position.
It has been shown that if GLUTl is subjected to tryptic digestion first and 
then exposed to cytochalasin B, then the remaining membrane embedded protein 
fragments can still bind the ligand (Cairns et al., 1987), and therefore the C- 
terminal tail and the large cytoplasmic loop probably not involved in the 
formation of the cytochalasin B binding site.
However, the exofacial ligand ATB-BMPA, cannot bind to the protein after 
it has been subjected to proteolytic digestion (Clark & Holman, 1990). It would 
seem that at least part of the cytoplasmic C-terminal tail is important in the 
form ation of the outw ard  facing conformation. This has been further 
demonstrated by the construction of a GLUTl mutant which has the last 37 amino 
acid residues deleted from its cytoplasmic C-terminal tail (Oka, 1990). This mutant
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can still bind cytochalasin B, and therefore its endofacial binding site must still be 
intact, but it cannot transport deoxyglucose, and furthermore it cannot bind the 
exofacial hgand ATB-BMPA. This mutant, it would seem, is locked in an inward- 
facing conformation. Deletion of the last 12 amino acid residues by comparison, 
produced a functional protein -so it appears that residues 455-480 are important 
for the ability of the molecule to undergo conformational change (section 6.2.7).
1.5.3 Chemical Inactivation of GLUTl: Support for the Alternating
Conformation Model.
The chemical inactivation of GLUTl and the patterns of ligand protection 
almost mirror those described for ligand protection from proteolytic digestion of 
the protein.
Early studies investigating GLUTl in intact erythrocytes showed that the 
rate of irreversible chemical inactivation by the amino group-modifying reagent
l-fluoro-2,4-dinitrobenzene can either be increased by the presence of 
extracellular glucose, or decreased by the presence of intracellular glucose 
(Edwards, 1973).
The inactivation of GLUTl by n-propyl-fi-D-glucopyranoside, a molecule 
which is known to bind to the endofacial binding site, is accelerated by the 
presence of intracellular glucose (Barnett et ah, 1973). Also, protection from 
inactivation by this molecule can be afforded by the binding of exofacial ligands 
such as maltose, 4,6-O-ethylidene-D-glucose, phloretin, and 6-O-alkyl galactose 
(Baker & Widdas, 1973, Barnett et ah, 1975, Krupka, 1971).
Similarly, modification of the exofacial cysteine residue (Cys^^^) by the 
im p erm ean t sulphydryl g ro u p -m o d ify in g  agen t p -ch lo rom ercu ri- 
benzenesulphonate (pCMBS), leads to inactivation of the transporter (May et
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al., 1990, Wellner et al., 1991), and this rate of modification can be increased by 
the presence of exofacial ligands such as maltose and phloretin.
This effect is presum ably due to the transient stabilisation of the 
transporter in an outw ard facing conformation, brought about by exofacial 
ligand binding, resulting in the exposition of Cys^29 to the modifying agent. 
This likely occurs because Cys^29 is not directly adjacent to the exofacial binding 
site although its accessibility is linked to the unfolding of the exofacial binding 
site, thereby allowing the modifying agent to attack the Cys^29 residue without 
steric hindrance from the various exofacially bound ligands.
The rate of inactivation can also be decreased in the presence of 
cytochalasin B, which stabilises the transporter in an inw ard facing 
conformation (Krupka, 1971, May, 1988, May, 1989).
These studies suggest that when the transporter is in an outward facing 
conformation (i.e. when exofacial ligands are bound), Cys^29 jg in an exposed 
and probably hydrophilic environment. When the transporter adopts an 
inward facing conformation (i.e. when endofacial ligands are bound), some 
movement may occur in helix 10 which results in Cys429 being buried in the 
membrane bilayer. Alternatively, movement may occur in the other loops 
which results in the protection of Cys429  ^ but the steric constraints imposed by 
the short length of the exofacial loops makes this unlikely.
1.6 Photoaffinity Labelling of GLUTl by Ligands that Bind to a Specific
Conformational Shape.
Cytochalasin B, a fungal metabolite, has been shown to bind GLUTl in a 
D-glucose inhibitable manner, w ith a ratio of binding of one molecule of 
cytochalasin B per GLUTl polypeptide chain (Baldwin & Lienhard, 1989). 
Cytochalasin B can also be photoactivated by ultraviolet light, and can 
photolabel GLUTl (Shanahan, 1982).
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As discussed previously, the binding of cytochalasin B to the endofacial 
binding site increases the susceptibility of GLUTl to proteolytic digestion by 
thermolysin (Karim et ah, 1987).
Later studies in which PH] cytochalasin B was used to bind to and label 
the transporter, then treated with proteolytic enzymes to release the labelled 
fragment, suggested that the site of labelling was contained within amino acid 
residues 389-412. These residues lie in the loop connecting helices 10 and 11, 
and within helix 11 itself (Holman & Rees, 1987).
This entire sequence is thought to also contain the endofacial glucose 
binding site, and it is often assumed that the endofacial binding sites for 
glucose and for cytochalasin B are one and the same. The rationale behind this 
thought is based upon the fact that glucose and cytochalasin B can 
competitively inhibit each other's binding to the endofacial site. Also, the 
binding moiety of cytochalasin B has an arrangement of oxygen atoms that is 
superimposable with that of glucose, and is therefore proposed to interact with 
the endofacial binding site, via the formation of hydrogen bonds, in the same 
manner as glucose.
Forskolin is also proposed to have this same arrangem ent of oxygen 
atoms, and has also been demonstrated to specifically label glucose transporters 
(Sergeant & Kim, 1985, Shanahan et ah, 1987). Binding of forskolin is D-glucose 
and cytochalasin B inhibitable. This compound may therefore interact with the 
endofacial glucose binding site, however, the sidedness of forskolin binding 
has not been confirmed by kinetic transport studies.
Studies of the related bacterial transporters (section 1.2.9) suggest that the 
cytochalasin B binding site and the forskolin binding site may not be 
analogous. The E.coli galactose/H+ sym porter GalP and the arabinose/H + 
symporter AraE can both bind cytochalasin B whilst the xylose/H+ symporter 
XylE can not. Forskolin, if the binding site was shared with cytochalasin B, 
should show the same pattern of binding between these transporters- but does
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not. Forskolin can bind to GalP only, it cannot bind to either AraE or XylE 
(Henderson et al., 1992). However, this may be due to differences in the 
binding pockets of these transporters regarding how easily they can accept large 
bulky molecules such as forskolin and cytochalasin B.
lAPS forskolin is a lipophilic 7-substituted derivative of forskolin 
which, unlike the original compound, does not activate adenylate cyclase 
(Joost et al., 1988). When GLUTl is labelled with [3H]-IAPS forskolin and then 
proteolytically cleaved, a labelled fragment is produced which corresponds to 
amino acid residues 369-389. These residues lie within helix 10 (Wadzinski et 
al., 1990). The site of labelling in GLUT4 with lAPS forskolin has been assigned 
to helix 9 (Hellwig et al., 1992). This sequence is not identical to that labelled by 
cytochalasin B but it does lie in very close proximity to it. It is also possible that 
this sequence is important in the structural formation of the cytochalasin B 
binding site pocket, even though the residues are not directly labelled by this 
molecule.
Site directed mutagenesis studies have investigated the importance of 
tryptophan residues Trp^^s and Trp^i2 in the glucose transport mechanism. 
The importance of these tryptophans is implicated by their proximity to the 
region of cytochalasin B binding (i.e. residues 265-456), and because they have 
a fluorescence excitation w avelength  sim ilar to th a t requ ired  for 
photoactivation of cytochalasin B (Holman & Rees, 1987) (Inukai et a l, 1994). 
The results of these studies have suggested a model for the labelling of GLUTl 
in which cytochalasin B can photolabel either Trp^ ®® or Trp^^2 also section
6.2.3 for further discussion.
ATB-BMPA is a hydrophilic, impermeant ligand which was specifically 
designed to in teract w ith  the exofacial glucose b ind ing  site and be 
photoreactive (Holman & Midgley, 1985, Midgley et ah, 1985). Binding of this 
compound is D-glucose inhibitable, and also can be displaced by 4,6-O- 
ethylidene-D-glucose or cytochalasin B. Proteolytic studies of photolabelled
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GLUTl have suggested that the sequence that contains the ATB-BMPA binding 
site is within amino acid residues 301-330 (Davies et al., 1991). These residues 
lie within helix 8. Site directed mutagenesis studies have shown that the 
binding of ATB-BMPA to GLUTl can be abolished by the substitution of the 
glutamine residue Gln282 in helix 7 by leucine. Cytochalasin B binding in this 
mutant was comparable to wild type, which suggests that the exofacial and 
endofacial binding site are structurally separate (Hashiramoto et al., 1992). The 
site of binding and the site of photolabelling need not be identical, therefore, 
ATB-BMPA probably binds to Gln2S2 in helix 7, but photolabels another site in 
helix 8.
1.7 The Contribution of Molecular Biology to the Understanding of the
Transport Mechanism of GLUTl.
Site directed mutagenesis has proved to be a valuable tool in the study 
of the facilitative glucose transporters. It has been shown that it is possible to 
disrupt either the exofacial or the endofacial binding site by the substitution of 
key amino acid residues, w ithout causing perturbation of the other. The 
substitution of Gln2S2 in helix 7 of GLUTl with leucine for example, causes 
perturbation of the exofacial binding site, w ithout causing any detectable 
structural disruption of the endofacial binding site (Hashiramoto et al., 1992). 
The substitution of Tyr293 in GLUTl, on the other hand, results in disruption 
of the endofacial binding site, without affecting exofacial ligand binding (Mori 
et al., 1994). These studies further demonstrate that the exofacial and endofacial 
binding sites are structurally distinct and separate. Gln^^z and Tyr293 of GLUTl 
are thought to be essential in the ability of the transporter to undergo the 
conformational change associated with transport. The substitution of these 
residues is thought to lock the transporter in an inward facing or an outward 
facing conformation, respectively. Therefore, the substitutions do not exactly
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disrupt the structure of the respective binding sites, rather, they prevent their 
formation (see section 6.2.2).
The C-terminal cytoplasmic tail has also been shown to be important in 
the conformational change mechanism. Deletion of the last 37 amino acid 
residues from the C-terminal tail of GLUTl results in a molecule which is 
locked in an inward-facing conformation (Oka, 1990). The endofacial binding 
site in this molecule remains intact, but the transporter cannot achieve the 
conformational change necessary to expose the exofacial binding site. This 
study will be discussed later, section 6.2.7. Transport activity in all of these 
conformationally locked mutants is abolished.
1.8 The Role of the C-terminal "H a lf  of the Transporter in Formation of
the Exofacial and Endofacial Binding Sites.
Site-directed mutagenesis has identified several key amino acid residues 
which are involved in the exofacial and endofacial binding sites of the 
transporter (Chapter 6). However, it is interesting to note that all but one of the 
residues found to be important in ligand binding and conformational change, 
are located within the C-terminal "half" of the transporter (i.e. from the start of 
the amino terminus to the start of helix 7). The only residue outwith the C- 
terminal domain, whose substitution has been shown to have any effect on 
ligand binding, is Gln^^i (helix 5). Substitution of this residue with aspartate 
reduces the transport activity of the molecule, which is caused by a decrease in 
the catalytic turnover of the protein. The ability of this molecule to bind the 
exofacial ligand 4,6-O-ethylidene-D-glucose is also reduced. This may indicate 
that Gln^^i is involved in the exofacial binding site, however, this is unlikely 
since the affinity of the exofacial binding site for D-glucose was unaffected, and 
the decrease in transport activity exhibited by the mutant was associated with a 
decrease in catalytic turnover. The reduced affinity for 4,6-0-ethylidene-D-
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glucose is probably due to a more general structural disruption rather than a 
specific effect from loss of this residue. Since most of the amino acid 
substitutions found to affect ligand binding are located in the C-terminal half of 
the protein, it is likely that the residues directly involved in formation of the 
glucose binding sites are located here also. Evidence from ligand binding and 
proteolytic digestion studies have also suggested that the sites of ligand binding 
are located within this half of the protein.
The length of the cytoplasmic C-term inal tail is crucial in the 
conformational change mechanism (Muraoka, 1995). The cytoplasmic C-terminal 
tail of GLUTl stretches from the end of the twelfth helix to the carboxy terminus, 
and is 42 amino acid residues in length. Of these a minimum structure of 18 
residues is essential for conformational change. However, the C-terminal tail has 
also been im plicated by several studies as being partly  responsible in 
determining isoform-specific kinetics (Katagiri et ah, 1992, Buchs, 1995, Due, 
1995). This aspect of transporter function is further discussed in Chapter 5.
The lack of information on the role of the N-terminal "half" of the 
transporter has prom pted one group to investigate this. Cope et al have 
produced a study in which cDNAs encoding the N-terminal and C-terminal 
"halves" of GLUTl are expressed either separately or together in Sf9 (Spodptera 
frugiperida clone 9) insect cells (Cope et ah, 1994). It has been shown that, when 
expressed alone, the C-terminal half is not capable of binding either the exofacial 
ligand ATB-BMPA, or the endofacial ligand cytochalasin B. Identical results are 
obtained when the N-terminal domain is expressed in isolation. However, if
1
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both constructs are expressed together in the same cell, ligand binding is 
restored.
These results suggest that although the endofacial and exofacial binding 
sites have been mapped to regions in the C-terminal half of the protein, this 
domain is not sufficient to form these binding pockets. It has been suggested
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therefore, that the N-terminal half of the protein may be necessary to provide a
packing surface against which the helices of the C-terminal half of the protein
can correctly arrange themselves, forming a stable structure to expose either 
the endofacial or the exofacial binding site.
1.9 Molecular Model of the Tertiary Structure of GLUTl.
Several studies have demonstrated that the protein undergoes a large 
conformational change, and that this change is too large to be mediated by the 
localised movement of amino acid side chains alone. It has been suggested that 
helix 10 is a highly mobile region. The conserved sequence within this helix 
(Phe328„Xrp388) is thought to be a pivotal point of flexibility (Pawagi & Deber, 
1990). Movement may occur around this point which allows the helices to 
orientate themselves to expose, alternatively, the endofacial and exofacial 
binding sites.
When the transporter is in the inw ard facing conformation, it is 
believed that helices 11 and 12 pack against the exofacial binding site which is 
composed of sequences which lie w ithin helices 7, 8, and 9. When the 
transporter is in an outward facing conformation it is thought that helices 11 
and 12 pack against the endofacial binding site which is composed of sequences 
in the base of helix 10.
M olecular m odelling studies (Osguthorpe & Holm an, unpublished 
work) also suggest that the base of helix 12 and the C-terminal tail will pack 
against the base of helix 10 (which contains the endofacial binding site), and 
block this site when the transporter is in the outward facing conformation. 
This model would explain why the C-terminally truncated mutant is locked in 
an inward facing conformation, and why the length of the tail is critical in 
determining the ability of the molecule to form the exofacial binding site: 
presumably the cytoplasmic tail is necessary to pack against the endofacial
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binding site and block it. Therefore, in the C-terminally deleted mutant, the 
tail is not long enough to block the endofacial binding site, and so the 
endofacial binding site stays permanently exposed.
The tertiary structure of the glucose transporter, despite the extensive 
mutagenesis studies, remains largely a matter of speculation. Recently, Zeng e t 
al have proposed two models describing the helical packing of the protein 
(Zeng et al., 1996). These models are computer generated, making use of recent 
advances in protein structure prediction algorithms. A diagram  of these is 
shown in Figure 1.9. In generating these models, the authors of this study 
propose that they have taken into account the physical dimensions and water 
accessibility of the channel, the length of the loops between the helices, the 
macrodipole orientation in the four helix bundle motif and the helix packing 
energy. In each of these models, it is predicted that five helices, either helices 3 
,4, 7, 8 and 11, (model 1) or 2, 5, 11, 8 and 7 (model 2) bundle together to line the 
channel, w ith the rem aining helices packing around the outside of the 
channel. Each of these models has a high level of compatibility with the 
available m utagenesis data. However, in the absence of crystallographic 
evidence, details of the tertiary structure of the protein cannot be determined 
with any degree of certainty.
1.10 Oligomerisation of GLUTl.
It has been shown by Carruthers that GLUTl protein, recovered from 
erythrocytes by cholate solubilisation of membranes and purified by the 
app lication  of size exclusion chrom atography and sucrose gradient 
ultracentrifugation, can be reconstituted into proteoliposomes which then 
display transport activity and D-glucose inhibitable cytochalasin B binding 
(Hebert & Carruthers, 1991). Furtherm ore, it has been show n through 
measurement of the sizes of these particles, that, under different reducing
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conditions, GLUTl exists in complexes of either dim ers or tetram ers. 
H ydrodynam ic stud ies of cholate so lubilised  GLUTl, the use of 
conformationally-specific antibodies, and chemical cross-linking studies of 
membrane resident GLUTl have suggested that native GLUTl exists in the 
tetram eric form (Hebert & Carruthers, 1992). In this tetram eric state, the 
GLUTl complex binds one molecule of cytochalasin B per two molecules of 
GLUTl, and presents at least two binding sites to D-glucose. When this 
complex is reduced to the dim eric form, cytochalasin B binds with a 
stoicheometry of one molecule per one GLUTl molecule and the dim er 
presents a single population of binding sites for glucose. Carruthers’ model for 
interaction of monomeric subunits is shown in Figure 1.7. In the dimer, the 
monomeric subunits can isomerise between the exofacial and endofacial 
binding sites independently of each other. Cytochalasin B binds to the 
endofacial conformation thus giving rise to the observation that, in the 
dimeric form, GLUTl binds cytochalasin B with a stoicheometry of 1:1 (Hebert 
& Carruthers, 1992). In the tetrameric state however, Carruthers has proposed 
that the conformationally active parts of each monomer are constrained by the 
interaction of the subunits. This results in the coupled isomérisation between 
the exofacial and endofacial conformations in the two dimers which comprise 
the tetramer, so that each dimer presents an exofacial binding site and an 
endofacial binding site simultaneously. The binding sites are arranged in an 
antiparallel manner (Figure 1.7). Thus, when one subunit isomerises from the 
inward to the outward facing conformation, this induces the isomérisation of 
the adjacent subunit in the opposite direction. Carruthers proposes that the 
GLUTl tetramer is 2-8-fold catalytically more active than the dimer. This 
model has been shown to fit most of the kinetic data on substrate binding 
(Hebert & Carruthers, 1992). Presumably, the physiological advantage of this 
system is that the slowest step in the transport cycle- the re orientation of 
empty carrier, is made faster by the coupled isomérisation of the adjacent
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subunit, thereby increasing the rate of catalytic turnover. This model may also
explain the differences observed in the kinetics of purified reconstituted 
GLUTl and the kinetics of GLUTl in intact erythrocytes, where it has been
shown that the catalytic turnover (Kcat) of the reconstituted protein is 20-fold 
lower than that of native transporter in erythrocytes (Connolly et aL, 1985, 
Hebert & Carruthers, 1992, Wheeler, 1981).
The tetrameric structure is proposed to be stabilised by the presence of a 
single intramolecular disulphide bridge between Cys847 and Cys^^i (Zottola et 
al., 1995). However, a recent publication describes a GLUTl cysteineless-mutant 
which is reported to retain wild type kinetics (Due et ah, 1995a). This m utant 
must therefore be capable of accelerated exchange, so the role of the putative 
disulphide bridge in facilitating accelerated exchange is not clear.
There is some evidence in support of this model from the expression of 
glucose transporters in heterologous cell types. Pessino et al produced a study 
in which two GLUTl/GLUT4 chimeric glucose transporters were each shown 
to co-immunoprecipitate with native GLUTl from CHO cells (Pessino, 1991). 
The chimeric transporters were composed of GLUTl sequence with either the 
C-terminal 29 residues, or the C-terminal 294 residues substituted with GLUT4 
sequence. The antibody used in the immunoprécipitation was raised against a 
GLUT4 C-terminal peptide. This suggests that the sequence important in the 
interaction of the subunits is present in the first 199 residues of GLUTl. No co- 
immunoprecipitation of native GLUT4 and native GLUTl was detected in 3T3- 
L1 cells using this antibody, suggesting that GLUTl can form homodimers but 
not heterodimers in vivo.
It has been shown that GLUT2 and GLUT3 can be heterologously 
expressed in oocytes, where they display differing kinetic profiles (Burant & 
Bell, 1992a, Colville et ah, 1993b). These transporters can be expressed 
sim ultaneously in this system, and the resulting kinetic pattern  can be 
separated into two components attributable to each of the isoforms. This
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indicates that, at least in this system, heterodimers are not formed (Burant &
Bell, 1992a).
1.11 Aims of This Study.
The purpose of this study is initially to characterise the basic kinetic 
parameters of fructose transport by human GLUTS when expressed in the 
X e n o p u s  oocyte system. Little is known about this isoform, and previous 
studies which have measured the kinetics of transport and substrate specificity 
have thrown up conflicting results. It has previously been demonstrated that 
GLUT2, the only other glucose transporter isoform capable of fructose 
transport, accepts fructose in the furanose ring form. Since it is not known 
how fructose is bound by GLUTS, or which ring form is preferred, it is 
intended to determine this by using fructose analogues which are locked in 
either the furanose or pyranose ring forms, in inhibition studies. It is also 
intended to examine the effects of pH on the function of GLUTS, since this
:isoform is expressed in tissues of the mammalian body which are exposed to a 
wide range of pH values.
The structural basis of fructose recognition in GLUT2, and indeed the 
basis for substrate selectivity and isoform specific kinetics of both GLUT2 and 
GLUT3 will be investigated by the characterisation of a series of GLUT2/ GLUT3 
chimeric transporters. These will be expressed in the X en o p u s  oocyte system, 
which will allow the m easurement of the kinetics of transport of fructose, 
deGlc and galactose.
In an effort to further investigate the structural basis of substrate binding 
in isoforms other than GLUTl, GLUT3 has been chosen as a template for site 
directed mutagenesis. A series of mutants have been constructed where each 
amino acid residue in helix 8 of GLUT3 is individually replaced with alanine.
It is intended to express these mutant constructs in the Xenopiis  oocyte system.
J
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and to measure the Km value for the transport of deoxyglucose. It is hoped that 
this characterisation might identify residues involved in substrate binding in 
GLUT3.
The GLUT2/GLUT3 chimeric constructs used in this work have been 
made by Dr Margaret Arbuckle, and the GLUT3 helix 8 point mutants have 
been made by Dr Michael J. Seatter. Additionally, some of the characterisation 
of these mutants was performed by the above, and it is noted in this thesis 
where it is included.
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Figure 1.1
Hydropathy Plots of GLUTs 1, 2,3 and 5.
This diagram shows the hydropathy plots of GLUTs 1, 2, 3, and 5. The plots 
are virtually superimposable, and this is thought to reflect a similar membrane 
topology and a common mechanism of action. The topological model of GLUTl 
shown in Figure 1.2 is largely based on this analysis.
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Figure 1.1-Hydropathy Plots of GLUTs 1,2,3 & 5.
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Figure 1.2
Topological Model of the Mammalian Facilitative Glucose Transporters,
This model is based on the results of hydropathy analysis of GLUTl 
(Mueckler, 1985), and has been confirmed by glycosylation scanning mutagenesis. 
Since the hydropathy plots of GLUTl and GLUTs 2, 3, 4, and 5 are virtually 
superimposable, so it is assumed that this model is applicable to all the isoforms 
in the glucose transporter family. The diagram  shows the twelve predicted 
transmembrane helices as boxes, numbered 1-12. The amino- and carboxy-termini 
(labelled NH 2 and COOH respectively) are on the cytoplasmic face of the 
membrane. The N- and C-terminal "halves" of the structure are separated by the 
large central cytoplasmic loop between helices 6 and 7. The other large loop is 
exofacial, and connects helices 1 and 2. This loop contains a site for N-linked 
glycosylation. This site is labelled "CHO" in the diagram. Invariant residues are 
shown by their single letter abbreviations, and filled circles represent invariant 
po lar re s id u e s  w h ich  are  p re d ic te d  to be m em b ran e  located.
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Figure 1.2
Topological Model of the Mammalian Facilitative Glucose Transporters
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Figure 1.3
Diagram Describing the Single Site Alternating Conformation Model of GLUTl.
This diagram describes the conformational changes in GLUTl (and in the 
other isoforms), which are associated with the transport of D-glucose. The 
diagram shows the binding of glucose to the outward-facing transporter, the 
conformational change which closes the exofacial binding site, opens the 
endofacial binding site, and which results in the transport of glucose to the other 
side of the membrane, the dissociation of glucose from the endofacial binding site, 
and the re-orientation of the carrier to the outward-facing conformation. This 
diagram is purely schematic, and does not attempt to represent the actual changes 
in the transporter structure.
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Figure 1.3
Diagram of the Single Site Alternating Conformation Model of GLUTl.
Exterior Cytoplasm
Figure 1.4
Interaction of p-D-glucose at the Exofacial Binding Site of GLUTl.
This diagram of the hydrogen bonding interactions of p-D-glucose with the 
exofacial binding site of GLUTl, is based on a model proposed by Barnett et al. 
Hydrogen bonds form between the transporter and the sugar hydroxyls of carbons 
C-1, C-3 and C-4. The oxygen of the sugar is also involved. Possible hydrophobic 
interactions between the transporter and the sugar at the C-6 position have also 
been suggested (Barnett et aL, 1973). Hydrogen bonds are represented by dotted 
lines, and the C-6 hydrophobic interactions are illustrated as a dashed area.
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Figure 1.4
Interaction of p-D-Glucose at the Exofacial Binding Site of GLUTl.
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Figure 1.5
King-Altman Representation of the Transport Cycle of GLUTl.
This figure shows a King-Altman diagram of the alternating conformation 
model of GLUTl. To represents the transporte r in the outw ard-facing  
conformation, in the absence of substrate. TqS represents the transporter in the 
outward-facing conformation, in the presence of substrate. Ti, and TiS represent 
the transporter in the inw ard-facing conformation, in the absence and the 
presence of substrate, respectively. Kso and Ksi represent the dissociation 
constants of substrate (i.e. D-glucose), at the exofacial and endofacial binding sites, 
respectively. The rate constant for the re orientation of the unloaded transporter 
from the outward-facing conformation to the inward-facing conform ation is 
denoted as k%. Re orientation of the empty carrier from the inward-facing 
conformation to the outward-facing conformation is denoted as k_i. The rate 
constants for the movement of loaded transporter from the outward-facing 
conformation to the inward-facing conformation and back again, are denoted as 
k2, and k_2, respectively. The values of these constants, measured for GLUTl at 0°C 
are shown below (Lowe & Walmsley, 1986).
Rate Constant Value at 0°C (s"i)
ki 12.1 ±0.98
-^1 0.726 + 0.498
k? 1113 ±498
ko 90 ±3.47
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Figure 1.5
King-Altman Representation of the Transport Cycle of GLUTl.
To
ToS ^
k
A . Ti
à Ki à
Kso Ksi
f
TiS
54
Figure 1.6
Structures of Cytochalasin B and ATB-BMPA.
This diagram shows the structures of cytochalasin B and ATB-BMPA. These 
compounds interact competitively w ith glucose at the endofacial and exofacial 
binding sites, respectively. They are also thought to bind to and photolabel the 
transporter, specifically at these sites.
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Figure 1.6
Structures of Cytochalasin B and ATB-BMPA.
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Figure 1.7
Diagram Showing the Proposed Model of GLUTl Oligomerisation.
This diagram shows a representation of the two oligomeric structures that 
GLUTl can exist in, as described in the model proposed by Carruthers. GLUTl can 
exist as a dimer or a tetramer. Each of the two molecules of GLUTl that exist in 
the dimer can isomerise independently of the other. Hence in this situation, both 
transporters can be outw ard-facing or inw ard-facing at the same time. 
Alternatively, one may be outward-facing whilst the other is inward-facing. In the 
tetrameric form however, the isomérisation of each of the subunits is linked to 
the others. The tetramer is effectively composed of two dimers of GLUTl, but the 
subunits of these dimers are linked, so that isomérisation of one subunit results 
in the isomérisation of the adjacent subunit. Therefore, in the tetramer, two of the 
GLUTl subunits will be outward-facing, and two will be inward-facing. Glucose 
binding to any of these subunits will induce conformational change in that 
subunit, and also in the adjacent subunits. The result of this is that every re­
orientation of a GLUTl subunit from the outward-facing conformation to the 
inward-facing conformation is accompanied by the linked movement of another 
subunit into the outward-facing conformation. The diagram indicates that from 
the evidence put forward by Carruthers, tetrameric GLUTl can be converted to 
dimeric GLUTl under reducing conditions (Herbert and Carruthers, 1992).
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Figure 1.7
Diagram Showing the Proposed Model of GLUTl Oligomerisation.
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Figure 1.8
Diagram Showing Regions of Importance in the Transporter Structure.
This diagram shows regions of the transporter which have been shown to 
be involved in form ation of the exofacial and endofacial binding sites, as 
dem onstrated by studies using conformational-specific ligands ATB-BMPA, 
Forskolin, and cytochalasin B. Also shown in this diagram are regions important 
in the ability of the molecule to undergo conformational change.
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Figure 1.8
Diagram Showing Regions of Importance in the Transporter Structure.
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Figure 1.9
Speculative Models of the Helical Packing in the Tertiary Structure of GLUTl.
This diagram shows a representation of two speculative helical packing
models for GLUTl, proposed by Zeng et ah Both of these computer generated
models take into account various physical constraints on the possible tertiary
structure. Macrodipoles arranged in antiparallel orientations within four-helix
bundles are proposed to provide electrostatic stability. In both models in this
diagram, the four-helix bundle arrangements are indicated by red dotted lines.
The helices proposed to line the membrane spanning channel are show n in
yellow, and the surrounding helices, in green. In model 2 helix 6 is distant to helix
7, and this distance is possible because of the long cytoplasmic loop between these
helices. This model therefore, not only suggests a role for the large cytoplasmic
loop, but also accounts for the bilobular structure which has been observed
experimentally for other transport proteins, such as the lac permease of E.coli. 
(Zeng et, al ,  1996).
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Figure 1.9
Speculative Models of the Helical Packing in the Tertiary Structure of GLUTl.
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CHAPTER 2.
Materials and Methods.
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2.1 Materials.
A dult female Xenopus  laevis  were obtained from  either Blades 
Biologicals, Edenbridge, Kent, UK, or directly from South Africa, (African 
Xenopus  Facility, PO Box 118, Noordhoek, Republic of South Africa). "Frog 
Brittle" was also obtained from Blades Biologicals.
Tricaine Methane Sulphonate, MS222 was supplied by Thompson & 
Joseph Ltd., Norwich, UK.
Chromic sterile catgut® was supplied by Ethicon Ltd., London, UK.
2-deoxy-D-glucose, 3- D-galactose, p-D-fructose, L-arabinose, D-mannose, 
phloretin, kanamycin, ampicillin, tetracycline, dithiothreitol, cytochalasin B, 1,5- 
anhydro-D-m annitol and 2,5-anhydro-D-mannitol were supplied by Sigma 
Chemical Company, Poole, Dorset, UK, and L-sorbose was supplied by Pfanstiehi 
Laboratories Inc., Waukegan, IL, USA.
A m m onium  form ate, and chloroform  (Analytical Reagent) were 
supplied by BDH, Poole, UK.
Bacto®-tryptone, Bacto®-agar and Bacto®-yeast extract were supplied by 
Difco, East Molesey, Surrey, UK.
Tris was supplied by Boehringer Mannheim Cmbh., Lewes, East Sussex,
UK.
Agarose (electrophoresis grade), DNA ligase and 5x ligase buffer were 
supplied by Cibco BRL, Paisley, UK.
Lambda ladder (BsfE 11 digested) and ribonuclease A were supplied by 
New England Biolabs, Hitchen, Herts, UK.
Sequencing grade urea. Tris, EDTA, de-ionised formamide, TEMED and 
Mixed Bed Resin were obtained from International Biotechnologies Inc. Ltd. 
(IBl), Cambridge, UK.
National Diagnostics Sequagel-6^'^ 6% sequencing gel solution and 
SequageP^ Complete Buffer Reagent were obtained from BS&S, Edinburgh, UK.
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Ultima~flo AF scintillant was obtained from Canberra Packard Ltd., 
Pangbourne, Berks., UK.
Taq DyeDeoxy™ Terminator Cycle Sequencing kits and sequencing-grade 
phenol/ch loroform /H 2O (68:18:14) was obtained from Applied Biosystems Inc. 
(ABI), Warrington, Cheshire, UK.
Elutip-D DNA purification columns (Schleicher & Schuell) were obtained 
from Anderman Ltd, London, UK.
Permacel™ tape was obtained from Genetic Research Instrum ents, 
Dunmow, Essex, UK.
Alconox™ detergent was supplied by Aldrich Chemical Company Ltd., 
Gillingham, Dorset, UK.
'Native' Pfu DNA polymerase and 'Native' Pfu polymerase lOx buffer 
were obtained from Stratagene, Cambridge, UK.
Vent DNA polymerase was supplied by New England Biolabs Inc., 
Beverly, MA.
All restriction enzym es and corresponding lOx buffers, Taq DNA 
polymerase w ith supplied lOx buffer and MgCl2, calf intestinal alkaline 
phosphatase and lOx buffer, polynucleotide kinase and polynucleotide kinase 
lOx buffer, rNTPs, dNTPs, nuclease-free H^O, 5x transcription buffer, 
dithiothreitol (DTT), RNasin, RNA ladder (360-9,490 bases) and SP6 RNA 
polymerase were supplied by Promega, Southampton, UK.
[2,6-^H]2-deoxy-D-glucose, [U-^4c]D-fructose and [U-^H]D-galactose were 
supplied by DuPont NEN, Stevenage, Herts, UK.
"Sculptor™ in vitro mutagenesis system- RPN 1526" kits and P^P]dATP 
(5000 C i/mmole; 10 m Ci/m l) were supplied by Amersham International pic., 
Aylesbury, Bucks, UK.
Dialysis tubing (Visking size 1-8/32") was supplied  by Medicell 
International Ltd, London, UK.
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Sterile Acrodisc® 0.2 n m  filters were supplied by Gelman Sciences Ltd., 
Northam pton, UK.
Sodium  diguanosine triphosphate, GpppG (5' Cap) was supplied by 
Pharmacia, Milton Keynes, UK.
All oligonucleotides (Tables 5.1 and 5.2) were synthesised by Dr. V. Math, 
Department of Biochemistry, University of Glasgow.
Unless indicated otherwise, all remaining chemicals were supplied by 
Fisons, Loughbourgh, UK.
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2.2 In Vitro Transcription of mRNA from Plasmid cDNA.
All work w ith mRNA was performed with sterile equipm ent whilst 
wearing gloves. Ribonucleases which can degrade mRNA can be found on the 
skin and elsewhere, and as these are very stable enzymes, this precaution was 
taken to avoid potential degradation of the mRNA. All reagents were thawed 
on ice. A nucleotide stock (2.5 mM rATF, 2.5 mM rCTP, 2.5 mM rUTP and 0.5 
mM rGTP) was diluted from stock 100 mM ribonucleotides. The following 
reagents were added to a sterile microfuge tube in the order shown, at room 
temperature:-
75 jLii ribonuclease-free H2O 
40 ]id 5x transcription buffer 
20 r1 100 mM dithiothreitol (DTT)
5 jitl RNasin (a synthetic inhibitor of ribonuclease)
40 r1 nucleotide mix (see above)
10 r1 GpppG (5' Cap) (25 u n its /100 jiil).
10 pi linearised plasmid cDNA (- 1 /i-g/ml)
1.5 pi SP6 polymerase (25 units)
This gave a total volume of 200 pi (before enzyme addition). The tube was 
placed in a 3 7 ^  water bath for a 1 hour incubation, after which a further 1.0 1^ 
of SP6 polymerase was added, mixed and incubated at 37°C for 30 min. At this 
point the reaction was centrifuged in a microfuge to collect the condensate and 
then 1 volume of phenol/chloroform [1:1 (v/v)] added. This was vortexed for 1 
min and centrifuged in a microfuge for a further 1 min. The upper aqueous 
phase, which contained both mRNA and cDNA, was carefully collected into a 
clean tube. 100 pi of chloroform /isoam yl-alcohol (24:1) was added to the 
solution, before vortexing, centrifuging, and again collecting the aqueous phase. 
This procedure was repeated, before finally adding 0.3 volum es of 5 M 
potassium acetate and 2.5 volumes of ice-cold absolute ethanol to precipitate the
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nucleic acid. The reaction was mixed and placed at -20X^ for approximately 2 
hours, or at -80°C for 20minutes, then centrifuged in a microfuge for 30 min. 
The pellet was washed with 1 ml 70% ethanol and centrifuged as above (the 70% 
ethanol was made up using ribonuclease-free water). All traces of ethanol were 
removed from the pellet by drying under vacuum. The pellet was resuspended 
in 35 pi of ribonuclease-free H2O. 5 pi of this was mixed with 3 pi of 5x DNA gel 
loading buffer (Table 2.1) and loaded into a 1% agarose gel overlaid with Ix TAB 
running buffer (Table 2.1). 5 jul of 100 pg/m l BstE II-cut lambda ladder DNA was 
loaded into an adjacent well and the current adjusted to 50 mA so that 
negatively charged nucleic acids m igrated tow ard the positive electrode. 
Electrophoresis was carried out until the dye-front was half to two thirds across 
the gel, then 20 pi of 10 m g/m l ethidium bromide added per litre of running 
buffer. The bands were visualised by viewing the gel under ultra-violet light. A 
typical photograph of mRNA on a 1% agarose gel is shown in Figure 2.2.
2.3 Using X enopus  Oocytes.
2.3.1 Handling X enopus,
Adult female Xenopus laevis (average length 15 cm) were kept in aquaria 
at a constant temperature of 16-18®C on a 12 hour day/ night cycle. The animals 
were housed 2-4 per tank, in distilled water in a quiet environment. They were 
fed once weekly with raw chopped sheep heart and the aquaria cleaned the 
following day. Alternatively they were fed Blades Biologicals "Frog Brittle". Each 
animal was kept for at least one month before operating to allow acclimatisation 
to its new environment. Oocytes were generally satisfactory after this initial 
period, however during the summer poor oocytes were frequently encountered, 
coincident with seasonal variability of the female cycle in these animals.
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2.3.2 Anaesthesia.
The anaesthetic was prepared by dissolving 0.75 g Tricaine M ethane 
Sulphonate (MS222) in 500 ml distilled water. 25 ml of 0.5 M sodium bicarbonate 
was added to ensure that the pH of the anaesthetic approached neutrality and 
hence was acceptable for the animal. The animal to be operated on was placed in 
the tank with the anaesthetic and supervised to ensure that it did not drown. 
Typically, animals were unconscious after 5-10 min. The animal was placed on 
its back and observed. If it did not move, it was judged to be unconscious.
2.3.4 Surgery.
Home Office Project and Individual Animal H andling Licenses were 
required for work on Xenopus. The surgery was generally performed by Dr 
Micheal Seatter, and occasionally by Dr Fiona Thomson and Dr. Gwyn Gould 
The animal was placed on its back and, using a sharp scalpel, a centimetre-long 
incision was made in the dermis and then another one directly underneath in 
the abdom inal wall. A small clump of oocytes was removed using fine 
watchmaker’s forceps and small scissors. These were placed into a petri-dish 
containing Barths buffer (Table 2.1). Oocytes were determined to be healthy if 
they fulfilled several important criteria. Oocytes had to be approximately 1 mm 
in diameter; required well-defined animal (dark) and vegetal (light) poles, with 
a sharp distinction at the boundary; required no discoloured patches; and had to 
exhibit a certain robustness when manipulated. These were defined as stage V 
and VI oocytes. If the oocytes were judged to be healthy, enough were removed 
from the toad as required for injection and non-injected controls. The animal 
was then sewn up using chromic sterile catgut, w ith a single stitch in the 
abdominal wall and two stitches in the dermis. The animal was then placed on 
its front in a recovery tank containing 2-3 mm of distilled water until it fully
»
69
regained consciousness, when it was returned to its own holding tank. A 
m inim um  period of no less than three months was allowed to pass before 
operating on the same animal: after this second operation the animal was 
sacraficed.
2.3,4 Oocyte Isolation and Injection.
Oocytes were rem oved from  ad u lt fem ale X en o p u s  laevis  and 
indiv idually  dissected. This involved rem oving the oocytes from the 
connective tissue and blood vessels which provide the oocytes with nutrients 
and remove toxic wastes. Oocytes were placed into a petri-dish, immersed in 
Barths buffer (Table 2.1), to maintain the environment as close to in vivo  
conditions as possible. Using a binocular microscope and fine watchmakers 
forceps, stage V and VI oocytes were removed from their connective tissue and 
then transferred to a container with fresh Barths buffer. Damaged oocytes were 
immediately discarded to minimise the exposure of healthy oocytes to proteases. 
Generally, 2-3 times as many oocytes were isolated than actually required since a 
percentage of the population would be expected to die before they were assayed. 
Oocytes were selected as required for injection with 50 nl of in vitro transcribed 
mRNA encoding GLUT2, GLUT3, GLUT5 or a mutant transporter, or to act as 
non-injected "control" oocytes.
The injection apparatus consisted of a 10 pi micro-injector (Drummond 
Scientific Co.); six inch long capillary tubes; a micro-manipulator (Narishige, 
Japan); a needle-puller (World Precision Instruments); a binocular microscope 
with separate light source; a petri-dish with a SpectraMesh grid (Fischer); and 
paraffin oil. Gloves were worn at all times to prevent contamination of the 
mRNA by ribonuclease present on fingertips. A capillary tube was placed in the 
needle-puller and by a combination of heating and pulling produced needles 
with a bore size of about 2 jum. The tip of one was broken off near the end with
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fine forceps and, using a syringe and 25 gauge needle, filled with paraffin oil. 
This was attached to the micropipette (set at about 1.5 ^1) and secured in the 
micro-manipulator. GLUT mRNA was placed into a 1.5 ml microfuge tube and 
pulsed for 30 sec in a microfuge to remove any debris or insoluble material. 
About 7 jul of mRNA was taken from the supernatant and placed onto a sterile 
microfuge tube lid. The micropipette was lowered so that the end of the needle
was submerged in the droplet, and the mRNA taken up slowly into the needle. 
Oocytes were placed on a grid in a petri-dish with Barths buffer and orientated so 
that the pale vegetal pole was uppermost. They were injected with a precise 
volume of mRNA (50 nl) and then removed to a separate container. The 
oocytes were incubated in Barths buffer for 48-72 hours prior to assay,
■ i :transferring to fresh buffer every 12 hours. Non-injected oocytes were treated in 
an identical fashion. After this period, oocytes were assayed for the ability to 
transport the sugars appropriate for the experiment.
2.4 Sugar Transport in X en o p u s  oocytes.
Groups of between 6 and 10 oocytes were incubated in 0.45 ml Barths 
buffer (Table 2.1) at room temperature in 13.5 ml centrifuge tubes. Transport 
(zero-trans entry) was initiated by the addition of 50 p\ of [2,6-^H]2-deoxy-D- 
glucose, [3H]D-galactose, or [U-H CjD-fructose to give a specified final sugar 
concentration with an activity of -1 juCi/ml. After a designated time, usually 15 
or 30 min, the transport of sugar into the oocytes was quenched by rapid 
aspiration of the media and three washes with 5 ml ice-cold 150 mM phosphate 
buffered saline, pH 7.4, (IxPBS, Table 2.1) containing 0.1 mM phloretin (a potent 
transport inhibitor). The oocytes were dispensed individually into scintillation 
vials using a pipetteman and a tip which had the end cut off, and then 1ml of 
1% sodium dodecyl sulphate (SDS) added. The vials were covered with Cling 
Film and left overnight at room temperature to solubilise the oocytes, before the
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■addition of 4 ml scintillation fluid and subsequent measurement of radioactive 
uptake by a scintillation counter. For each group of GLUT-injected oocytes 
assayed at a particular sugar concentration, a group of non-injected oocytes were 
assayed under identical conditions. This control gave a value for radioactive 
sugar transport by native oocyte glucose transporters plus background radiation 
levels. Hence, the rate of uptake in GLUT-injected oocytes less the rate of 
transport in control (non-injected) oocytes gave a value corresponding to 
specific transport by heterologous transporters. Transport with a variety of sugar 
concentrations was measured for each assay so that Lineweaver-Burk plots 
could be constructed, and Km and K^  values determined. For assays involving 
the inhibition of radioactive sugar uptake by another sugar, the oocytes were 
exposed to the inhibitor in 0.45 ml Barths buffer at least 15 min prior to addition 
of labelled sugar.
2.5 General Techniques for the M anipulation of DNA.
2.5.1 Plasmid Construction.
The hum an glucose transporter constructs used for the preparation of 
mRNA have been described previously (Kayano et ah, 1990). Human GLUTs 2, 3 
and 5 were in pSP64T (Kreig & Melton, 1984) and named pHTL217, pSPGT3, and 
pHGLUT5 respectively. These constructs contain the protein coding region of 
the cDNA flanked by 89 bp of 5'- and 141 bp of 3 -untranslated sequence from the 
Xenopus p-globin gene (Kayano et ah, 1990) (Figure 2.1). The plasmid contains a 
SP6 RNA polymerase promoter at the 5' end of the transporter sequence and a 
sequence encoding ampicillin resistance.
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2.5.2 Linearisation of Plasmid cDNA.
pHTL217, pSPGTS, pHGLUT5 or any of the chimeric or point mutation 
constructs, were specifically restricted once at the 3' end of the cDNA, 
downstream  of the coding sequence. This had the effect of linearising the 
plasmid, so that the efficiency of subsequent mRNA synthesis reactions were 
increased by ensuring that the SP6 RNA polymerase used did not continue 
synthesis of mRNA after transcription of the transporter. The choice of 
restriction enzyme depended on the particular plasmid and transporter. GLUTS 
and the helix 8 point mutation constructs were linearised using Xba 1, GLUT2 
and the chimeric constructs by Sal I, and GLUTS by H in d llL  10 pg  of plasmid 
cDNA was digested in a total volume of 20 ^1 overnight at 37X2 (section 2.5.4). 1 
pi of this reaction was loaded onto a 1% agarose gel and electrophoresed to 
confirm linearisation (section 2.5.3). From this point onwards, all work was 
done using sterile microfuge tubes whilst wearing gloves. lOOjul of ribonuclease- 
free H 2O was added to the tube, the solution extracted with 1 volume of 
phenol/chloroform  (1:1), then twice with chloroform/isoamyl-alcohol (24:1). 
The cDNA was precipitated by the addition of 0.3 volumes of 5 M potassium 
acetate and 2.5 volumes of absolute ethanol, and incubation at -20°C for at least 1 
hour. The tube was centrifuged in a microfuge for 30 m in at 4°C, the pellet 
resuspended in 1 ml 70% ethanol, centrifuged again in a microfuge for 30 min, 
and the pellet finally resuspended in 10 jul of ribonuclease-free H2O. This was 
ready to be used in a mRNA synthesis reaction (section 2.2).
2.5.3 Agarose Gel Electrophoresis of DNA.
Various gel volumes, combs and agarose concentrations were used. The 
gel volume was governed by the number of samples, the volume of the samples 
and to a lesser extent the required degree of separation of the DNA bands. The
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choice of comb depended only on the volume of the samples. The concentration 
of agarose used varied depending on the molecular weight of the DNA band to 
be visualised- high agarose concentrations aided the separation of low 
molecular weight bands, and lower agarose concentrations give better separation 
with higher molecular weight bands. Typical concentrations used were 1.0% and 
1.6% (w/v).
Example:- for a 100 ml 1.0% Agarose Gel.
An appropriate gel base was selected and the ends secured with tape to 
prevent gel leakage. 1.0 g of agarose was weighed out and distilled water added 
to a total volume of 100 ml. This was heated in a microwave oven until the 
solution just boiled and left to cool until hand hot. 2 ml of 50xTAE buffer (Table
2.1) was added to the gel solution and mixed. The contents were poured onto the 
gel base, the comb inserted and the gel left to set for about 20 min. The tape was 
then removed and the entire gel and its base placed into the electrophoresis tank 
so that the wells were nearest to the negative electrode. About 1 litre of IxTAE 
buffer (Table 2.1) was added to the chamber so that the entire gel was submerged, 
and then the comb was removed. To each sample, 1/4 volume of 5x DNA gel- 
loading buffer (Table 2.1) was added and mixed. The samples were loaded into 
the wells by pipetting directly above them- the glycerol in the sample buffer 
ensured that the samples were more dense than the buffer and therefore the 
samples sank into the wells. 10 pi of loading buffer containing 25 ;/g/m l BstE 11- 
cut lambda ladder DNA was loaded into an adjacent well. The electrodes were 
connected so that the negative electrode was closest to the sample wells. The 
samples were electrophoresed at 50-100 mA using an LKB 2197 power supply 
until the dye front had migrated two thirds of the way along the gel towards the 
positive electrode, then 50 pi of 10 m g/ ml ethidium bromide was added per litre 
of running buffer, and left at room temperature for 30- 45 min. The DNA was
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1v isua lised  by u ltra -v io le t lig h t using  an U ltrav io le t P roducts Inc. 
transillum inator, and the size of any DNA band checked by its relative 
m igration to the lam bda ladder. The gel was then photographed using a 
Mitsubishi video copy processor.
2.5.4 Restriction Digestion of DNA.
Restriction digestion of DNA was performed by the addition of restriction 
enzymes to DNA in the appropriate buffer, optimising salt concentration and 
pH for individual enzymes. Generally, from 0.5-10 pg of DNA was digested per 
reaction. The total reaction volume was 10 pi per 1 pg  DNA and the quantity of 
enzyme added equal to 1 unit per 1 pg  DNA. The reaction was carried out by the 
addition of 1 volume of lOx buffer to 9 volumes diluted DNA solution, before 
the addition of enzyme. This was incubated for 3 hours at 37 (or otherwise 
depending on the particular enzyme). For digestions w ith more than one 
enzyme, the reaction was carried out as usual with the first enzyme (the one 
which utilises lower salt concentrations), and then salt added to the reaction to 
optimise conditions for the second digestion which was subsequently carried 
out. Alternatively, if both enzymes utilised approximately the same optimum 
reaction conditions, both digests could be carried out sim ultaneously. The 
reactions were then added to 1/4 volume of 5x DNA gel loading buffer and the 
solution loaded onto an appropriate agarose gel. This was electrophoresed, 
stained w ith ethidium  bromide and DNA bands visualised as described above 
(section 2.5.3). Any bands of interest were excised from the gel with a scalpel and 
purified as described (sections 2.6.4, 2.6.6).
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2.5.5 Déphosphorylation of Double-Stranded DNA using Calf Intestinal 
Phosphatase.
Plasmid DNA was digested with the appropriate restriction enzyme for 
3hrs and then treated with RNase A for 15 min at 37^C (section 2.5.4). The mix 
was then made up to a volume of 100 p\ with dephosphorylation buffer (1 mM 
ZnCl2> 1 mM MgCl2, 10 mM Tris-HCl pH 8.8) and 10 units of Calf Intestinal 
Phosphatase (CIP) was added (lOX am ount recom ended by Promega, the 
supplier). After incubation at 37X2 for 2hrs, plasmid cDNA was isolated from the 
enzyme reagents by phenol extraction and precipitation (section 2.5.2), and DNA 
was resuspended in 20 pi of H 2O.
2.5.6 Ligation of Double-Stranded DNA.
cDNA fragm ents were ligated to plasm id DNA by the following 
procedure. In order to increase the efficiency of ligation, the reaction was 
performed with a high GLUT cDNA: plasmid DNA molar ratio, (between 3:1 
and 10:1). 100 ng of plasmid DNA which had been CIP-treated was added to 
GLUT cDNA at the appropriate molar ratio , and the mix incubated at 60®C for 5 
min. After pulsing the sam ples briefly in a microfuge, an aliquot of 5x 
concentrated ligation buffer and 3 units of T4 DNA ligase were added, and the 
samples then incubated overnight at 16X2. Competent bacteria were then 
transformed with 5- 10 jul of the ligation reaction as described (section 2.5.7).
2.5.7 Preparation and Transformation of Competent E. coli DH5a cells.
A colony was picked from a freshly grown plate of DH5a cells, and used to 
innoculate 3 mis of 2xYT medium in a universal container (Table 2.1). After an 
overnight incubation at 37*^ C in a shaking incubator, 200^1 of the resulting
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culture was removed and used to innoculate 50 mis of 2xYT medium which was 
contained in a 500 ml culture flask (-this ensured good aeriation of the growing 
culture). This culture was placed in at 37°C in a shaking incubator for 2 hrs, or 
until an O.D. of 0.2 was reached.
The cells were then harvested by transferring the 50 ml culture to a sterile 
plastic 50 ml Falcon tube, and spinning at 3K for 10 mins in a Beckman benchtop 
centrifuge. After carefully discarding the supernatant, the cell pellet was gently 
resuspended in 2 mis of TSB buffer (Table 2.1). This cell suspension was 
incubated on ice for 10 mins, after which 200 i^l aliquots were removed and 
transferred to sterile 1.5 ml eppendorf tubes. At this point the cells were 
competent for transformation by the following method.
Plasmid DNA was then added to the 200 fxl aliquots of cells -typically 1 
and 7 \xl depending upon the concentration of the DNA. The cells and the DNA 
were mixed together by gently flicking the eppendorf tube, then transferred back 
to ice and incubated for at least 5 mins and no longer than 30 mins. 800 \xl of 
TSB+glucose (Table 2.1) was then added to each of the 200 |il transformation 
reactions, gently mixed by flicking, and transferred to a shaking incubator at 37"C 
for at least 1 hr (-this allows expression of the ampicillin resistance gene on the 
pSPGT plasmid). The cells were collected by microfuging the eppendorf tubes for 
30 secs, removing 800 jrl of the supernatant, and gently resuspending the cell 
pellet in the remaining 200 volume. This 200 \il volume was then removed 
and plated out onto 2xYT agar plates which had am picillin added at a 
concentration of 50 ^igmpl (Table 2.1). The plates were allowed to dry, then were 
placed upside-down in a 37°C incubator and left overnight.
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2.5.8 Preparation of Small Amounts of Plasmid DNA from Transformed E.coli
DH5a cells.
Any colony of interest was picked from the agar plate by stabbing with a 
sterile pipette tip, and used to innoculate a universal container containing 3 mis 
of 2xYT culture medium. This was grown up overnight at 37°C in a shaking 
incubator, after which 1.5 mis of culture was removed and placed in a sterile 
microfuge tube. The tube was microfuged for 30 secs to pellet the cells, the 
supernatant removed, and the pellet resuspended in 100 1^ of STET buffer (Table
2.1). 20 p.1 of a 10 m g/m l lysozyme solution was added and mixed thoroughly by 
vortexing before being placed in a boiling water bath for 50 secs. Once removed, 
the tube was microfuged immediately for 10 mins, and the resulting lysis pellet 
removed with a sterile cocktail stick. At this point in the procedure the DNA 
could be precipitated from the solution by the addition of 60 jiil of isopropanol 
followed by a 5 min incubation at -20°C, and the DNA pelleted by spimiing for 
10 mins in a microfuge. Removal of the isopropanol and air drying of the 
eppendorf tube for 15 mins w ould yield a DNA pellet which could be 
resuspended in an appropriate volume of sterile water-typically 20 d^. This 
method of extraction was used if the purity of the DNA was not important, 
alternatively, if cleaner DNA was required, the sample could be purified by a 
phenol/chloroform extraction procedure followed by ethanol precipitation. This 
w as the m ethod m ost frequen tly  used. One phenol extraction, two 
phenol/chloroform  (1:1 v /v ) extractions, and two chloroform/ isoamylalcohol 
(24:1 v /v ) washes of the supernatants were performed, retaining each time the 
upper aqueous phase. After the final wash, 0.3 volumes of 3 M sodium acetate 
and 2.5 volumes of 100% ethanol were added to precipitate the DNA. This was 
incubated at -20°C for at least an hour before pelleting the DNA by 
centrifugation for 30 min in a microfuge. The ethanol was removed, the pellet 
washed with 70% ethanol and centrifuged for a further 30 min, before drying
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under vacuum. The pellet was resuspended in 20 1^ of sterile water. 1 jiil of this 
was added to 1 ml of sterile water and the absorbance measured at 260 nm. The 
concentration was determined from the calculation below.
2.5.9 Calculation to Determine the Plasmid DNA Concentration and Purity.
absorbance value of 1.0 at 260 nm = 50 fxg/ml of dsDNA. 
absorbance value of "y" at 260 nm = "y" x 50 |xg/ ml of dsDNA.
absorbance at 260 mn = " Z " 
absorbance at 280 nm
DNA has a lower protein concentration and has a higher purity when the 
value of " Z " is nearer to 2.0.
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2.6 Recombinant Polymerase Chain Reaction.
2.6.1 Primary Polymerase Chain Reactions using Taif DNA Polymerase.
2.6.1a Synthesis of Oligonucleotides.
Oligonucleotides (60-61'mers) with sequence composed in part of GLUT2 
and part GLUTS from various helical regions in the C-terminal half of the 
transporter protein were synthesised (Dr. V. Math, Department of Biochemistry, 
University of Glasgow). Pairs of oligonucleotides were constructed: one 
sequence representing the sense strand and another the complementary 
sequence, both of which had GLUT2 or GLUTS binding sequences and GLUTS or 
GLUT2 "tails". These will be referred to subsequently as internal primers. 
Additionally, two oligonucleotides (37’mers) were constructed which had 
positive polarity and sequence complementary to the antisense strands of the 
untranslated region at the 5' ends of GLUT2 and GLUT3. Likewise, antisense 
oligonucleotides (37'mers) were synthesised which bound to the positive 
strands of cDNA at the untranslated region at the 3’ ends of GLUT2 and GLUT3 
(Figure 5.3). Both these oligonucleotides incorporated a Sal I restriction site at 
their 5' ends (Table 5.1) and are subsequently referred to as external primers.
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2.6.1b Primary PCR: Reaction Conditions.
1.6 jiig "internal" primer.
1.6 jLig "external" primer.
10 ng template dsDNA
2 Jill nucleotide mix (20 mM dATP, 20 mM dCTP, 20 mM dTTP,
20 mM dCTP)
10 jid lOx Taq polymerase reaction buffer.
6jri 25 mM MgCl2
2.0 units Taq polymerase
sterile water to give a final volume of 100 jitl
Reactions were carried out in 0.5 ml microfuge tubes, adding the Taq 
polymerase last. Upon completion of the thermal cycling (see below), 20 jtil of 5x 
DNA gel loading buffer was added to each reaction and mixed, before loading 
the entire reaction mixture onto a 1.5% agarose gel. Following electrophoresis, 
cDNA bands were excised, electro-eluted (section 2.6.4), purified and ethanol 
precipitated (section 2.6.6), combining the contents of 3-6 reactions, and finally 
resuspending each pellet into 40 jiil of sterile water. 5 jttl of this was then 
electrophoresed on another 1.5% agarose gel to determ ine the recovery of 
purified primary product.
2.6.1c Thermal Cycling.
The tubes were placed in a Techne PHC-3 Thermal Cycler with a heated 
lid. The following procedure was programmed into the machine:-
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Initial Extension 95°C 3 min
Cycling- (30 cycles total, with a l^ C /sec  ramp rate.) 
Separation 95°C 1 min
Reannealing X°C 1 min
Extension 72^C 2 min
Final Extension 
Soak
72°C
4°C
10 min 
Hold
"X" = 0-5°C below the melting temperature of the oligonucleotide having the 
lower melting temperature.
2.6.1d Secondary PCR: Reaction Conditions.
0.8 ng  "external-sense" primer
0.8 ng "external-antisense" prim er
1-2 //I template (5' primary product)-approx lOOng
1-2 fil template (3' primary product)-approx lOOng
2 jid nucleotide mix (20 mM dATP, 20 mM dCTP, 20 mM dTTP,
20 mM dCFP)
10 /il lOx Taq polymerase reaction buffer
4 jxl 25 mM MgCl2
2.0 units Taq polymerase
sterile water to give a final volume of 100 /il
Secondary reactions were carried out in a similar way to primary reactions 
except that there were two primary product templates instead of one. The 3' end 
of the 5' primary product (encoding the N-terminal portion of the protein) and
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the 5' end of the 3' primary product (encoding the C-terminal portion of the 
protein) were single-stranded, complementary and overlapped (Figure 5.2). The 
first few cycles of the chain reaction involved the association of the two primary 
products as well as the polymerisation. The reactions were treated exactly in the 
same way as the primary reactions, except that the final pellet was resuspended 
in 10 /il of sterile water.
2.6.2 Polymerase Chain Reaction using Pfu DNA Polymerase.
2.6.2a Primary PCR: Reaction Conditions.
0.8 /ig "internal" primer.
0.8 /ig "external" primer.
100 ng template dsDNA
1 /d nucleotide mix (20 mM dATP, 20 mM dCTP, 20 mM dTTP,
20 mM dCTP)
10 /il lOx Pfii DNA polymerase reaction buffer
2.5 units Pfu  DNA polymerase
sterile water to give a final volume of 100 //I
Oligonucleotides used were identical to those used with reactions 
involving Taq DNA polymerase. Reactions were carried out in 0.5 ml 
microfuge tubes, adding the Pfu  polymerase to the reactions after the initial 10 
min amiealing step. This is referred to as "Hot Start PCR". Upon completion of 
the thermal cycling (section 2.6.2c), 20 /il of 5x DNA gel loading buffer was added 
to each reaction and mixed, before loading the entire reaction mixture onto a 
1.5% agarose gel. Following electrophoresis, DNA bands were excised, electro­
eluted (section 2.6.4), purified and ethanol precipitated (section 2.6.6), combining 
the contents of 3-6 reactions and finally resuspending each pellet into 40 /il of
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sterile water. 5 /il of this was then electrophoresed on another 1.5% agarose gel 
to determine the recovery of purified primary product.
2.6.2b Secondary PCR: Reaction Conditions.
0.8 /ig "external- sense" primer
0.8 /ig "external- antisense" primer
1-2 /il template (5’ primary product)-approx 200ng
1-2 /il template (3* primary product)-approx 200ng
1 /il nucleotide mix (20 mM dATP, 20 mM dGTP, 20 mM dTTP,
20 mM dCTP)
10 /il lOx Pfu  DNA polymerase reaction buffer
2.5 units Pfu  DNA polymerase
sterile water to give a final volume of 100 /il
Secondary reactions were carried out in a similar way to primary reactions 
except that there were two primary product templates instead of one. The 3' end 
of the 5' primary product (encoding the N-terminal portion of GLUT3) and the 
5' end of the 3' primary product (encoding the C-terminal portion of CLUT3) 
were single-stranded, complementary and overlapped (Figure 5.2). The first few 
cycles of the chain reaction involved the association of the two primary products 
as well as the polymerisation between the two external primers, but uses the 
same reaction protocol as that used for the generation of primary products with 
Pfu polymerase. The reactions were treated exactly in the same way as the 
primary reactions, except that the final pellet was resuspended in 10 /il of sterile 
water.
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2.6.2c Thermal Cycling.
The tubes were placed in a Techne PHC-3 Thermal Cycler with a heated 
lid. The following procedure was programmed into the machine:-
Initial Extension 95*^ 0 10 min
Addition o f Pfu D N A  polymerase.
Cycling- (3 cycles total, with a 1°C/sec ramp rate.)
Separation 95°C 1 min
Reannealing 37°C 5 min
Extension 72°C 5 min
Cycling- (27 cycles total, with a 1°C/sec ramp rate.)
Separation 95°C 1 min
Reannealing 56°C 2 min
Extension 72°C 5 min
Final Extension 
Soak
72°C
4°C
10 min 
Hold
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2.6.3 Polymerase Chain Reactions using Vent DNA Polymerase.
2.6.3a Primary PCR: Reaction Conditions.
0.8 ng "internal" primer.
0.8 n s  "external" primer.
5-50 ng template dsDNA (optimised for each reaction)
2 jul nucleotide mix (20 mM dATP, 20 mM dGTP, 20 mM dTTP,
20 mM dCTP)
10 /d lOx Vent DNA polymerase reaction buffer
2-5 \û MgS04 (25 mM stock) (optimised for each reaction)
2.5 units Vent DNA polymerase
sterile water to give a final volume of 100 /d
Oligonucleotides used were identical to those used w ith reactions 
involving Taq and Pfu DNA polymerase. Reactions were carried out in 0.5 ml 
microfuge tubes, adding the Vent polymerase to the reactions after the initial 10 
min annealing step. This is referred to as "Hot Start PCR" (section 5.3.2). Upon 
completion of the thermal cycling (section 2.6.3.c), 20 /d of 5x DNA gel loading 
buffer was added to each reaction and mixed, before loading the entire reaction 
mixture onto a 1.5% agarose gel. Following electrophoresis, DNA bands were 
excised, electro-eluted (section 2.6.4), purified and ethanol precipitated (section 
2.6.6), combing the contents of 3-6 reactions and finally resuspending each pellet 
into 40 /it of sterile water. 5 jul of this was then electrophoresed on another 1.5% 
agarose gel to determine the recovery of purified primary product.
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2.6.3b Secondary PCR: Reaction Conditions.
0.8 ng  "external- sense" primer
0.8 n s  "external- antisense" primer
1-2 /d template (5' primary product)-approx 100 ng
1-2 jLil template (3' primary product)-approx 100 ng
2 jtd nucleotide mix (20 mM dATP, 20 mM dGTP, 20 mM dTTP,
20 mM dCTP)
10 jiil lOx Vent DNA polymerase reaction buffer
2-5 /il MgS0 4  (25mM stock) (optimised for each reaction)
2.5 units Vent DNA polymerase
sterile water to give a final volume of 100 /il
Secondary reactions were carried out in a similar way to primary reactions 
except that there were two primary product templates instead of one.
87
2.6.3c Thermal Cycling.
The tubes were placed in a Techne PHC-3 Thermal Cycler with a heated 
lid. The following procedure was programmed into the machine:-
Initial Extension 95°C 10 min
Addition o f  Vent D N A  polymerase.
Cycling- (27 cycles total, with a l°C /sec ramp rate.)
Separation 95°C 1 min
Reannealing 56°C 2 min
Extension 72°C Y min
Final Extension 72°C 10 min
Soak 4°C Hold
"Y" = time in minutes calculated for each fragment on the basis of 1 min per 
Kbp DNA.
2.6.4 Elution of DNA from Gel Fragments by Electrophoresis.
The gel fragment containing the DNA band of interest was put into 
dialysis tubing (section 2.6.5) which had been clipped shut at one end. Then 1 ml 
of TAE buffer was added to the tubing and the other end secured, ensuring that 
no air bubbles rem ained w ithin. This tubing was then placed into an 
electrophoresis tank containing 1 litre of TAE buffer. The tubing was laid at an 
angle perpendicular to the direction of current and the voltage increased to 150 
V for 2 hours. Next, the voltage polarity was reversed so that the current flowed 
in the opposite direction for 30 sec to ensure that the cDNA was removed from 
the membrane and was present in solution. The solution was removed from
the tubing with a sterile pasteur pipette and placed into a 5 ml "bijou" tube. 
Then a further 1 ml of TAE buffer was added to the tubing and pumped up and 
down vigorously to remove any residual cDNA, before adding this to the same 
bijou tube.
2.6.5 Preparation of Dialysis Tubing.
D ialysis tubing (Visking size 1-8/32") was cut into lengths of 
approximately 6 cm. 10 g of this was placed in a beaker with 500 ml of 2% 
sodium hydrogen carbonate, 10 mM EDTA and boiled for 10 min. The solution 
was then poured away and the tubing washed twice in distilled water. The 
tubing was stored at 4°C in 50% ethanol, 50% water, 1 mM EDTA. When 
required, the tubing was washed by boiling briefly in distilled water.
2.6.6 Purification of DNA using Elutip-D Affinity Columns. 
Components:-
High salt solution (see below)
Low salt solution (see below)
Sterile 10 ml syringes 
Sterile 1 ml syringes 
Sterile Acrodisc® 0.2 p m  filters 
Elutip-D columns
Low salt solution 
0.2 M NaCl 
20 mM Tris, pH 7.4 
1 mM EDTA
High salt solution 
1 M NaCl
20 mM Tris, pH 7.4 
1 mM EDTA
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This procedure could be used to purify both PCR fragments or plasmid 
DNA. A 10 ml syringe was loaded with 2 ml of high salt solution, the Elutip-D 
column attached to the syringe and the solution passed through the column to 
remove any DNA which might be present. A second syringe was loaded with 5 
ml low salt solution and this was passed down the column to remove all traces 
of high salt solution. The DNA sample in TAE buffer was taken up into the 
same syringe. A 0.2 jum filter was attached between this syringe and the column 
and the DNA passed through the column at a flow rate no faster than 1 m l/m in . 
The column was then washed with 3 ml of low salt solution, again using the 
same syringe and filter. Finally the DNA was eluted from the column in 0.4 ml 
of high salt solution into a sterile microfuge tube. 1.2 ml of ethanol was added to 
the tube, mixed and incubated at -20°C for 1 hour. The precipitated DNA was 
collected by centrifugation in a microfuge tube for 30 min, washed with 70% 
ethanol, centrifuged again for another 30 min, the pellet dried and resuspended 
in a suitable volume of sterile water, generally 20 /d.
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2.7 Ta^DyeDeoxy^ Terminator Cycle Sequencing Protocol.
This protocol was used with the Applied Biosystems Taq DyeDeoxy™ 
Terminator Cycle Sequencing Kit, in conjunction with the Applied Biosystems 
Model 373A Automated Sequencer.
2.7.1a Kit Reagents.
100 nl GDyeDeoxy™ Terminator
100 n\ ADyeDeoxy™ Terminator
100 /d TDyeDeoxy™ Terminator
100 /il GDyeDeoxy™ Terminator
100 /d dNTP mix- (750 /iM dGTP, 150 y U  dATP, 150 /iM dTTP,
150 /iM dCTP)
400 units AmpliTaq® DNA Polymerase, 8 units / /it
400 /d 5x Terminator Ammonium Cycle Sequencing (TACS) Buffer-
(400 mM Tris-HCl, 10 mM MgClz, 100 mM (NH4)2S0 4  pH 9.0)
6 /ig pGEM®-3Zf(+) double-stranded DNA Control Template,
0.2 /ig/jul
50 fÂ -21M13 Forward Primer, 0.8 pmoles//il
2.7.1b Other Reagents.
Distilled water
De ionised formamide
Phenol/ H 2O/ Chloroform (68:18:14, v / v / v )
Alconox™ detergent 
Ethanol
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A / Gel Reagents- Sequagel-6™ 6% Sequencing Gel Solution 
SequageR^ Complete Buffer Reagent 
B/ Gel Reagents- 40% Acrylamide stock solution (19:1 Acrylamide: 
Bisacrylamide)
Other Reagents- lOxTBE Buffer (8.2 g EDTA, 107.8 g Tris, 55.0 g Boric acid 
per litre )
10% Ammonium persulphate
50 mM EDTA
TEMED
Urea
dH 20
Mixed Bed Resin
2.7.2 Preparation of Templates.
Plasmid dsDNA was prepared from colonies as described previously 
(section 2.5.8). The quantities of tem plate and sequencing oligonucleotide 
primers used per reaction were 2 jwg dsDNA template and 3.2 pinoles of primer. 
The primers used are listed in Table 5.2,
In either case the combined volume of template and primer did not 
exceed 10.5 y l  since 9.5 /d of reaction premix was added to bring the final 
volume to 20 /rl. The total volume was adjusted to 20 /d by the addition of 
sterile water. A reaction premix sufficient for 20 reactions consisted of:-
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Reagents
5x TACS Buffer 80 /d
dNTP mix 20 nl
DyeDeoxy™ A Terminator 20 ni
DyeDeoxy^^ T Terminator 20 jul
DyeDeoxy^^ G Terminator 20 ni
DyeDeoxy^^ C Terminator 20 nl
AmpliTaq® DNA Polymerase 10 /d
The reagents were mixed in a 0.5 ml microfuge tube- 
Reaction Premix 9.5 //I
* Template DNA 5.0 /d
Primer 4.0 /d
dHzO 1.5 (d
Final volume 20 jul
* ssDNA solution concentration -  0.2 m g/m l 
dsDNA solution concentration = 0.4 m g/m l
* * Primer concentration with ssDNA template = 0.4 pmoles/ /d
Primer concentration with dsDNA template = 0.8 pm oles//d
2.7.3 Thermal Cycling.
The tubes were placed in a Techne PHC-3 Thermal Cycler with a heated 
lid. The following procedure was programmed into the machine:-
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Initial Extension 96°C 3 min
Cycling
Separation 96°C 30 sec
Reannealing 50°C 15 sec
Extension 60°C 4 min
(30 cycles total, with a l°C /sec ramp rate.) 
Soak 4°C Hold
2.7.4 Acrylamide Gel Preparation.
The gel needed at least 2 hours polymerisation time before pre-running 
so the gel was prepared whilst the reactions underwent thermal cycling.
2.7.5a Preparing the Gel Plates.
The plates, spacers and comb were washed w ith Alconox and dH20. 
Only the plates were then wiped with absolute ethanol. The plates were aligned 
with the spacers between them along the outside of the longer edges. The plates 
were clamped in that position and FermaceR'^ tape applied along the short 
bottom edges of the plates and the lower ends of both longer edges so that the 
corners were covered and a seal was formed. The plates were balanced on a rest 
so that open top was raised and the angle between the plane of the plates and 
that of the desktop surface was 30-45°.
2.7.5b Casting the Gel.
This involved using Gel Reagents A. 80 ml of Sequagel-6 6% 
Sequencing Gel Solution was mixed with 20 ml of SequageR“ Complete Buffer
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Reagent and 0.8 ml of 10% ammonium persulphate solution was added while 
stirring. The gel was immediately poured between the glass plates up to the top 
edge of the notched plate, with the aid of a 60 ml syringe. All air bubbles were 
removed by tapping the plates or with the aid of a Promega "Bubble Hook". The 
plates were lowered so that they were lying flat on the bench and the gel casting 
comb carefully inserted. The comb was secured by clamping the top of the gel 
with two binder clamps. It was left to polymerise completely- this took at least 2 
hours.
2.7.6 Setting Up for a Run.
All the clamps and tape were removed from the gel plates and the casting 
comb carefully taken out. Excess acrylamide was cleaned off the plates which 
were then washed with Alconox^'^, distilled water and ethanol making sure that 
the plates were especially clean in the region where the laser read (about a third 
of the way from the bottom of the plates). A 24-well-shark's tooth comb was 
carefully placed on the gel surface so that it indented the gel but did not 
puncture it. The 373A DNA Sequencer and the Macintosh Ilci computer were 
switched on. The gel was placed onto the lower buffer chamber and the beam- 
stop rack locked. The "Start Pre-run" button on the 373A keypad was pressed 
followed by "Plate Check". "Scan" and "Map" on the Macintosh Menu were 
opened. If the baselines were flat, then there was judged to be no dirt on the 
plates- if they were not then the plates were cleaned again. Next, "Abort Run" 
was pressed and the upper buffer chamber and the alignm ent brace were 
secured. 1.5 litres of IxTBE buffer, pH 8.3 was prepared and about half added to 
the upper buffer chamber and the remainder poured into the bottom chamber. 
The wells were rinsed with a syringe fitted with a 18-gauge needle containing Ix 
TBE buffer. The electrode leads were attached and "Start Pre-run" and then "Pre­
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run Gel" selected. Pre-running took at least 5 ruin but longer if required. "Abort 
Run" was pressed to stop.
2.7.7 Sample Extraction and Precipitation.
After the cycling (section 2.7.3) was complete, 80 jt/1 of sterile water was 
added to each reaction mixture. 100 /tl of phenol/w ater/chloroform  (68:18:14, 
v / v /v )  was added to each tube and vortexed for at least 1 min, and then 
centrifuged for 2 min in a microfuge. The upper aqueous phase was retained, 
discarding the lower organic phase. This process was repeated. The extracted 
aqueous phase was transferred to a fresh microfuge tube and precipitated by the 
addition of 15 /il of 2 M sodium acetate and 300 //I of absolute ethanol (stored at 
-20°C). Tubes were vortexed to mix the contents and then placed at -20°C for 30 
m in  to ensure complete precipitation. The tubes were centrifuged in a 
microfuge for 15 min to pellet the cDNA, the pellets washed in 70% ethanol, 
and dried by centrifugation under vacuum.
2.7.8 Preparing and Loading the Samples.
4 /il of de ionised form am ide/10 mM EDTA was added to each of the 
samples and mixed well. This was heated at 90°C for 2 min, and placed onto ice 
immediately. The wells of the gel (section 2.7.5b) were flushed out with IxTBE 
and 4 /il of each odd-numbered sample added to its corresponding well in the 
gel. The door was closed and "Start Run" pressed. This was left for 10 min. 
"Interrupt Run" was pressed and all the wells flushed out again. The even- 
numbered samples were loaded and the sequencer restarted. "Collect" on the 
Controller panel on the Macintosh display was clicked and the details of the 
samples filled out on a "New Sample Sheet".
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2.7.9 Analysis of Samples,
The samples were electrophoresed at a constant temperature of 40°C for 
12 hours, passing through the "read window" area of the gel where laser light 
was periodically passed along this area of the gel. The resulting fluorescence 
emitted by the DyeDeoxy™ Term inator dyes over a period of time were 
measured by the 373A sequencer and incorporated by the ABl Data Collection 
Program on the Macintosh Ilci computer. After the data was collected, it was 
analysed by the ABI Data Analysis Program. Sequences were determined by use 
of this program. When different sequences were generated by the use of various 
sequencing prim ers (Table 5.2) w ith the same tem plate cDNA, these were 
compared using the Cenejocky II (Biosoft) program.
97
Table of Buffers.
Buffer Constituents
SOxTris-acetate (TAE) buffer 242 g Tris base; 57.1 ml glacial acetic acid, 
100 ml 0.5 M EDTA, pH 8.0
lOxTris-borate (TBE) buffer 108 g Tris base; 55.0 g Boric acid; 
40 ml 0.5 M EDTA, pH 8.0
TE buffer (pH 8.0) 10 mM Tris.Cl, pH 8.0, 1 mM EDTA, pH 8.0
STET buffer 8% w / V sucrose;
0.5% w /v  TritonX-100; 50mM EDTA 
(pH8); lOmM Tris, pH8.
lOxPhosphate Buffered Saline 
(PBS)
80 g NaCl; 2 g KCl; 14.4 g NaiHPO^; 
2.4gKH2P04,pH 7.4
TSB (Transformation and 
Storage Buffer).
L-Broth +10%w /v  PEC (Mol Wt 3350), 
5% w /v  DMSO, lOmM MgCl2  ^
lOmM MgSO^.
TSB + Glucose As TSB + 20mM glucose.
5x DNA gel-loading buffer 0.25% w /v  bromophenol blue; 
30% w /v  glycerol in water
Barths buffer 88 mM NaCl; 1 mM KCl; 2.4 mM 
NaHCOs; 0.82 mM MgSOé; 0.41 mM 
CaCl2; 0.33 mM Ca(N0 3 )2;
5 mM HEPES-NaOH, pH 7.6.
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Table 2. 2 Bacterial Media and Agar.
Type Constituents (per litre)
Luria-Bertani medium (LB) 10 g Tryptone (Bactotryptone); 
5 g Yeast extract; 10 g NaCl
2xYT medium 16 g Tryptone; 10 g Yeast extract; 
5 g NaCl
LB plates 10 g Tryptone; 5 g Yeast extract; 
10 g NaCl, 15 g Agar
2xYT plates 16 g Tryptone; 10 g Yeast extract; 
5 g NaCl, 15 g Agar
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Figure 2.1
Diagrammatic Representation of pSP64T Vector.
GLUT2 cDNA was ligated to Bglll DNA linkers and cloned into the 
untranslated regions of the X en o p u s  p-globin gene, which had previously been 
cloned into the m ultiple cloning site of pSP64 (Kreig & Melton, 1984). GLUTS 
cDNA was cloned into pSP64T as a Bgl It/ B a m H  1 fragment into the untranslated 
regions of the Xenopus  p-globin gene, and GLUTS was force cloned into the Bgl II 
site in the (3-globin gene. The 5' untranslated region (UTR) is 89 bp long and the S' 
untranslated region is 141 bp long. These function to stabilise the in vitro  
synthesised mRNA in Xenopus  oocytes. The GLUT cDNA and its flanking 
sequences are located 3' of the SP6 polymerase promoter.
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Figure 2.1
Diagram of GLUT cDNAs in pSP64T Vector.
SP6 prom oter
5' Xenopus UTR
gDNA  sequencepGLUT
Ampicillin
Resistance
3' Xenopus UTR
H indni. Sail, XbalT
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Figure 2.2
This shows a photograph of 2 pil samples of in vitro synthesised mRNA 
which have been electrophoresed on a 1% denaturing agarose gel and stained with 
ethidium bromide. Lane 1 shows DNA markers (not applicable to RNA sizes), lanes 
2, 3 and 4 show samples of GLUT2/ GLUTS chimeric mRNA.
The size of all mRNA bands are approximately 1,700 bases.
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Figure 2.2
1% Agarose Gel Showing in vitro Transcribed mRNA.
Lane 1
DNA 
Template 
mRNA
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Figure 2.3
Diagram Showing Cloning of Chimeric PCR Products into the pSP64T Vector 
Backbone.
The pSP64T vector backbone was obtained by restricting pSPGT4 with Sal I. 
This released a fragment which corresponded to the coding region of GLUT4, a 
200bp fragment corresponding to the 3' untranslated region of the Xen o p u s  p- 
globin gene, and a 3Kb fragment which corresponded to the rem ainder of the 
pSP64T vector. This was alkaline phosphatase treated, and ligated to Sal I restricted 
PCR products as described. The ampicillin resistance gene was used to screen 
against background colonies arising from untransfected cells.
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Figure 2.3
Cloning of Chimeric PCR Products into the pSP64T Vector Backbone.
SP6 prom oter
5' Xenopus UTR
cDNA
sequence
Ampicillin
Resistance
3' Xenopus UTR
Hindlll. Sail. Xbed7
SP6 prom oter
5' Xenopus UTR
Chim eiic 
cDNA sequenceAm picillin 1 
Resistance \
Hindlll. Sail. XbalT
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CHAPTER 3.
Studies of the GLUTS Isoform
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3.1.1 Introduction.
The cDNA of hum an GLUTS, isolated from a hum an jejunal DNA 
library, encodes a protein of 501 amino acid residues in length. With the 
exception of GLUT7, GLUTS is the least well characterised isoform of the GLUT 
family. It is also the most divergent, displaying only between 39% and 42% 
amino acid sequence identity with GLUTs 1, 2, 3 and 4. Northern blot analyses 
have shown that human GLUTS mRNA is present at high levels in the small 
intestine, the kidney, testis and spermatozoa, and at lower levels in muscle 
tissue and in the plasm a membrane of adipocytes (Kayano et al., 1990). 
W estern blot analysis and immunohistochemicai studies have shown that 
human GLUTS protein is present in the small intestine, testis kidney, heart, 
brain and in the plasma membrane of adipocytes (Burant et al ,  1992, Shepherd, 
1992b).
Burant et al have expressed hum an GLUTS in Xenopus  oocytes and 
shown that this isoform is a high capacity fructose transporter, which displays 
virtually no ability to transport glucose (Burant et al., 1992). This surprising 
property of GLUTS explains its presence in the epithelia of the small intestine 
(Davidson et ah, 1992) It has been shown that human GLUTS is localised to the 
brush border membrane (BBM) of jejunal epithelial cells, where it is thought 
to mediate the uptake of dietary fructose from the gut lumen, in a facilitative 
m anner.
It had been suspected prior to the isolation and characterisation of 
GLUTS that there might be a fructose carrier in the gut which was independent 
of the sodium / glucose co-transporter SGLTl, since individuals with genetic 
mutations in this carrier were still capable of fructose metabolism (Wright et 
a l ,  1991).
GLUT2 is also found in enterocytes (Thorens, 1990). This isoform is also 
capable of fructose transport, as has been demonstrated by its expression in
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oocytes (Gould et ah, 1991). GLUT2 however, is restricted to the basolateral 
membrane (BLM), where it is thought to mediate the efflux of glucose and 
fructose from these cells into the blood (Thorens, 1990). A diagram of this 
movement of sugars across the epithelium is shown in Figure 3.1. A recent 
study has shown that GLUTS may also be present on the basolateral membrane 
of human enterocytes (Hundal et al., 1992). There is no evidence to suggest that 
GLUTS is found on the basolateral membrane of rat or rabbit enterocytes.
The role of GLUTS in human spermatocytes may be in mediating the 
uptake of fructose whilst the sperm  is still in the seminal fluid. It has been 
reported that hum an spermatocytes use fructose when in the seminal fluid, 
and that there is a shift in the metabolic requirements from fructose to glucose 
w hen the spermatocytes enters the female reproductive tract (Peterson & 
Freund, 1975). It has also been suggested that the utilisation of fructose may be 
associated with the mechanisms which prevent acrosomal breakdown of the 
plasma membrane of the spermatocyte, while it is in the seminal fluid. This is 
thought to prevent prem ature activation of the spermatocyte, although it is 
not understood how this happens (Rogers & Perreault, 1990).
The role of GLUTS in brain and kidney is unclear: these organs receive 
very little fructose as the prim ary site for fructose metabolism is the liver. 
Furthermore, in humans, GLUTS is apparently absent from the liver. As far as 
it is understood, fructose transport into and out of this organ is mediated solely 
by GLUT2 (Thorens, 1990).
Northern blot analysis of tissues for rat GLUTS mRNA has shown that 
the transcript can be found in intestine, kidney and brain tissue (Rand, 1993). It 
has been shown that rat spermatocytes utilise fructose as a metabolic energy 
source (Hussain, 1989), and so the absence of GLUTS mRNA in testicular tissue 
is surprising. Similar experiments on rabbit tissues have shown that GLUTS 
mRNA is found at high levels in the intestine and kidney (Miyamoto et ai .
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1994). It is not yet clear if these results are indicating a species difference in 
tissue specific GLUTS distribution.
Recently, the presence of human GLUTS has been detected in insulin 
responsive tissues (Hundal et ah, 1992, Shepherd, 1992b), and although it has 
been demonstrated that fructose is transported into adipose cells (Halperin & 
Cheema-Dhadli, 1982), and muscle (Ahlborg & Bjorkman, 1990), the role of 
fructose metabolism in these tissues is unclear. Also, human GLUTS has also 
been detected in the cerebral microganglia (Maher et ah, 1994). The ambient 
fructose levels are low in these cells however, and so this may indicate that 
human GLUTS facilitates the transport of another, as yet undefined substrate 
(Maher et ah, 1994).
3.1.2 Substrate Selectivity of GLUTS.
Studies utilising the X en o p u s  oocyte expression system have yielded 
conflicting evidence on the preferred substrate of GLUTS. As previously 
described, human GLUTS exhibits high efficiency fructose uptake and displays 
alm ost no ability to transport D-glucose, when expressed in oocytes. 
Additionally, the transport of D-fructose is insensitive to inhibition by D- 
glucose and cytochalasin B (Burant & Bell, 1992a). However, Shepherd et al 
have shown that cytochalasin B can photolabel a protein from small intestine 
m em brane fractions which is im m unoprecipitated by a GLUTS antibody 
(Shepherd, 1992b). Cytochalasin B has been shown to competitively inhibit 
glucose efflux from erythrocytes, and therefore is proposed to interact with the 
endofacial glucose binding site of GLUTl (section 1.6). The site of 
cytochalasin B photolabelling is not necessarily the same as the binding site, 
and so it is possible that cytochalasin B can photolabel GLUTS but does not 
bind to the endofacial fructose binding site. Therefore, the endofacial fructose 
binding site in GLUTS may not be analogous to the endofacial glucose binding
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site in the other isoforms. Table 3.1 describes differences in reported properties 
of hum an GLUTS, and GLUTS from other species, when expressed in different 
expression systems.
Studies of GLUTS from rat and rabbit highlight ambiguity regarding the 
substrate selectivity of this isoform. It has been shown that rat GLUTS, when 
expressed in X e n o p u s  oocytes, is capable of glucose transport in addition to 
fructose transport (Rand, 1993). Similar results have been reported for sugar 
uptake in oocytes expressing rabbit GLUTS (Miyamoto et al., 1994). Miyamoto 
et al reported that fructose uptake by rabbit GLUTS in Xenopus  oocytes could be 
inhibited by D-glucose and by D-galactose (Table 3.1).
However, when the properties of either rat or rabbit GLUTS are studied 
in brush border membrane vesicles, the results conflict w ith those derived 
from studies using the oocyte system. The fructose transport kinetics of rabbit 
GLUTS in BBM vesicles are similar to those of GLUTS expressed in oocytes. In 
BBM vesicles however, fructose uptake via GLUTS cannot be inhibited by D- 
glucose or by D-galactose. Furthermore, oocytes injected with total jejunal 
rabbit GLUTS mRNA also displayed fructose uptake which was insensitive to 
inhibition by D-glucose and D-galactose (Miyamoto et ah, 1994). Recently it has 
been shown that rat GLUTS in BBM vesicles displayed fructose transport 
which was not inhibited by D-glucose or phloretin (Corpe et al., 1996).
This has led to speculation of the involvem ent of another protein 
which may be associated with the regulation of GLUTS substrate specificity. It 
has been suggested that such a protein (which is presumably absent in oocytes) 
might associate with GLUTS in such a way that the glucose binding site is 
either modified or in some way made inaccessible (Miyamoto et al., 1994). As 
yet, there is no evidence in the literature to support this speculation.
The cDNA from rat GLUTS has recently been transfected into CHO cells 
(Inukai et al ,  1995). In this expression system, rat GLUTS mediates the efficient 
uptake of fructose and displays no glucose transport activity at all.
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Furtherm ore, in this study GLUTS could not be photolabelled  w ith 
cytochalasin B.
In addition to the conflicting results on the apparent species-specific 
ability of GLUTS to transport glucose and bind cytochalasin B, there is also 
some disagreement in the literature regarding the K^i for fructose zero-trans  
entry into BBM vesicles. (For a description of kinetic terms, see section 1.4.2.1) 
This kinetic parameter has been calculated to be 18mM in rabbit (Schultz & 
Strecker, 1970), 4mM in guinea pig (Mavrias & Mayer, 1973), 17mM in hamster 
(Honneger & Semenza, 1973), and llOmM in rat (Crouzoulon & Korieh, 1991, 
Sigrist-Nelson & Hopfer, 1974) experiments. Other studies with rat GLUTS, 
expressed in CHO cells, have shown the Km to be lO-lSmM (Inukai et al., 1995). 
The discrepancies between these studies may be due to the procedures used to 
obtain BBM vesicles. It is difficult to obtain pure BBM vesicles without any 
contamination from the basolateral membrane. Therefore, it is possible that 
the high Km values measured, especially in the rat experiments, may be due to 
a GLUT2 contamination from basolateral membrane fractions, since GLUT2 
has a high Km for fructose transport (Colville et ah, 1993b).
3.1.3 GLUT2, GLUTS, and SGLTl in the Small Intestine.
The tissue specific distribution of GLUTS in hum an, rat and rabbit 
differs slightly as described above. However, in all of these species GLUTS is 
present in the brush border membrane of small intestine and kidney epithelial 
cells. SGLTl, the sodium /glucose co-transporter is also expressed on the BBM 
of these cells. It is widely accepted that these transporters act in concert to 
facilitate the uptake of dietary sugars from the lumen of the small intestine 
into enterocytes. Transport from the enterocytes into adjacent cells occurs 
across the basolateral m em brane via GLUT2. In hum an, rat and rabbit 
epithelial cells the expression of GLUT2 is exclusively restricted to the
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basolateral membrane. It is thought that GLUT2 mediates the efflux of both 
glucose and fructose from enterocytes (Figure 3.1), although in humans GLUTS 
may also be expressed on the BLM (Hundal et ah, 1992).
In the hum an sm all intestine GLUTS is expressed in both the 
duodenum and the jejunum (proximal and distal gut) . Recently, a study of the 
sod ium /g lucose  co-transporter, SGLTl, has shown that the transport 
properties of this carrier change as the pH of the gut changes (Hirayama et ah, 
1994). When the carrier is present in the proximal end of the small intestine 
where the pH is low, it uses H+ in the co-transport of glucose. In this situation 
SGLTl acts as a low affin ity /high capacity transporter. When the carrier is 
present in the distal end of the gut where the pH is higher, a Na+ ion can be 
used instead of a proton. In this situation SGLTl acts as a high affinity/low 
capacity transporter. This situation makes physiological sense: in the distal end 
of the gut, the concentration of glucose will be low, and therefore a carrier with 
a high catalytic turnover is not necessary. However, a carrier which does have 
a high affinity for its substrate is an advantage, SGLTl in this situation is able 
to scavenge the remaining glucose from the gut lumen, thus increasing the 
overall efficiency of glucose uptake.
Since GLUTS is also expressed throughout the small intestine and is 
therefore subject to a range of pHs, it is possible that the properties of GLUTS 
may change in response to pH changes.
Additionally, hum an GLUTS is expressed in spermatozoa where it is 
thought to be responsible for the uptake of fructose by the spermatocyte prior 
to ejaculation. Once the spermatocyte enters the female reproductive tract, 
where the pH of its environment changes, the metabolic substrate becomes 
glucose (Peterson & Freund, 1975). Therefore, one of the aims of this study is to 
examine whether pH can affect the substrate preference of GLUTS when 
expressed in oocytes.
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3.1.4 Structural Requirements of Fructose Binding to GLUTS.
The transfection of rat GLUTS cDNA into GHO cells enabled Inukai et al 
to measure and compare the parameters of fructose and glucose transport by 
this isoform to those of rabbit GLUTl, which had also been transfected into this 
cell line (Inukai et ah, 1995). Subsequently, Inukai et al produced a panel of rat 
GLUTS/rabbit GLUTl chimeric transporter constructs which were expressed in 
the CHO cell line. The rationale of this was to define the domains of the 
transporter structure which are necessary for fructose transport by GLUTS, and 
glucose transport by GLUTl. This approach is analogous to that chosen by this 
laboratory to study fructose transport by GLUT2 (Chapter 4). The results of this 
study suggested that the presence of two regions of GLUTS were mandatory for 
fructose transport: the entire N-terminal half of the protein up to the sixth 
helix, and the C-terminal cytoplasmic tail. In contrast, the middle intracellular 
loop and the C-terminal half of the protein, from helix 7 through to helix 11, 
were necessary for glucose transport. Furthermore, replacing either the N- 
terminal half of GLUTl or the C-terminal cytoplasmic tail of GLUTl with the 
corresponding sequence of GLUTS, produced no marked effects on glucose 
transport activity. From this it was suggested that the structural requirements 
for fructose transport are more stringent than those for glucose transport 
among the glucose transporter family. However, it could be the case that the 
sequences important in GLUTS are more widely distributed throughout the 
protein, rather than clustered in restricted regions.
This situation differs from that of fructose transport by GLUT2, where it 
has been shown that helix 7 is essential for fructose transport activity in this 
isoform  (Chapter 4). A dditionally , the conclusion that the C-terminal 
cytoplasmic tail is not involved in glucose transport by GLUTl is also 
contentious (sections 4.1.2 and 6.2.7). It is possible that the C-terminal tail of
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GLUTS has the necessary sequences to complement the essential sequences in 
the G-terminal half of GLUTl.
3.1.5 Studies of Other Fructose Transporters.
It has been reported  that the hexose transporter of the parasite 
Trypanosoma brucei  transports D-glucose and D-fructose with equal efficiency 
(Fiy et a l ,  1993). Furthermore it has been shown that this transporter accepts D- 
glucose in the pyranose ring form, and D-fructose in the furanose ring form. In 
aqueous solutions D-fructose exists predominantly (-70%) in the pyranose ring 
form (Fry et al., 1993), and so it is rather surprising that this transporter has 
evolved to transport both glucopyranose and fructofuranose with equal 
efficiency. It was also shown in this study that the trypanosome transporter 
accommodates glucopyranose and fructofuranose by binding to hydrogen 
bonds directed at the C-3, C-4 positions and ring oxygen positions, although the 
oxygen can be substituted by nitrogen without any great effect. Hydrogen 
bonding at the C-2 position is less important.
The substrate binding requirements of GLUT2 have been investigated 
(Colville et al., 1993a). GLUT2 can transport both fructose and glucose but does 
so with unequal efficiency. D-glucose is a competitive inhibitor of D-fructose 
transport by GLUT2, and vice versa, therefore these substrates probably share 
the same exofacial binding site, or at least the regions involved in the exofacial 
binding sites overlap. It has been shown that GLUT2, like the trypanosome 
transporter, also binds the pyranose ring form of D-glucose and the furanose 
ring form of D-fructose (Colville et ah, 1993a). Hydrogen bonding at carbon 
positions C-1, C3, and C-4 have been shown to be important in the binding of 
D-glucose to the exofacial binding site of GLUT2, whereas, it has been shown 
these interactions occur with the C-3 and C-4 positions but not with the C-2 
position of D-fructose. (Colville et al., 1993a)
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It is not known whether GLUTS binds fructose in the pyranose or the 
furanose ring form. In the GLUTl/GLUTS chimeric study discussed above, it 
was suggested that the regions essential for fructose transport in GLUTS differ 
from those necessary in transport of glucose by GLUTl. The regions of GLUTS 
involved in fructose transport also differ from the regions of GLUT2 involved 
in fructose transport (Chapter 4). Therefore, given that fructose exists 
predominantly in the pyranose form in aqueous solutions, and that GLUTS is 
a high efficiency fructose transporter, it is possible that this isoform may 
transport fructose in the pyranose ring form. Additionally, since the transport 
of fructose by hum an GLUTS is not inhibited by cytochalasin B, and the 
transport of fructose by GLUT2 is, then this may suggest that the endofacial 
fructose binding site of GLUTS may not be analogous to the endofacial fructose 
binding site in GLUT2.
It w ould  therefore be instructive to investigate the structural 
requirements for fructose binding to GLUTS. To determine which ring form is 
accepted by GLUTS it is proposed to make use of fructose analogues which are 
locked in either fused pyranose or furanose ring forms (Figure 3.2).
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3.2 Aims of This Study.
1. To establish a Km value for the transport of D-fructose by human
GLUTS when expressed in X en o p u s  oocytes.
2. To assess the substrate selectivity of human GLUTS in oocytes.
3. To test the kinetics and substrate selectivity of GLUTS over a range
of temperatures and pH values.
4. To determine the preferred fructo- ring form of GLUTS.
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3.3 Results.
3.3.1 Measurement of the Value for the Transport of D-Fructose by
Hum an GLUTS in X e n o p u s  Oocytes.
The Km value for the transport of D-fructose by GLUTS was determined 
by measuring the rate of uptake of trace radiolabelled sugar over a range of 
external sugar concentrations into oocytes which had been injected with 
GLUTS mRNA at least 48 hrs prior to the assay. Lineweaver-Burk plots were 
constructed, and Km values for zero-trans  uptake were determined from the 
equation of the line. This calculation is as follows:
Equation of a straight line : y = mx + c.
Therefore, when y = 0,
X = - c/ m
The point at which the line cuts the x axis = 1/-Km- 
When y=0,
X = [l/-Km]
then K m = -l/[- c/m]
Figure 3.3 shows a Lineweaver-Burk plot of D-fructose transport by 
GLUTS. The data used to construct this graph was taken from a typical 
experim ent. The Km value for this transport event was found to be 
22.S±10mM. This figure is the m ean of at least three independen t 
determ inations, in which different batches of cRNA and different oocyte 
populations were used.
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3.3.2 Determining the Substrate Selectivity of Human GLUTS in X en o p u s  
Oocytes.
The transport rate of GLUTS injected oocytes was determ ined for the 
uptake of 0.1 mM D-fructose and 0.1 mM deGlc. Also, the effects of the addition 
of 100 mM L-glucose, D-glucose or D-fructose on these transport rates were 
examined. The results are shown in Figure 3.4.
3.3.3 The Effects of pH on the Substrate Selectivity of Human GLUTS in 
X e n o p u s  Oocytes.
To investigate the effects of pH on the substrate specificity of GLUTS, the 
uptake of 0.1 mM D-fructose or O.lmM deGlc by GLUTS injected oocytes was 
measured over a range of pH values. The results are shown in Figure 3.S. The 
uptake of D-fructose was unaffected by reducing the pH from 7.5 to 4.5. Also, 
the lack of glucose transport displayed by the GLUTS isoform in oocytes 
remained unchanged at lower pH.
3.3.4 The Effects of pH on the Km for Fructose Transport by GLUTS in 
Xenopus  Oocytes at pH 4.5.
The Km for fructose transport by hum an GLUTS at pH 4.5 was 
determined by measuring the rate of uptake of trace radiolabelled fructose, 
over a range of external sugar concentrations as described. A typical 
Line weaver Burk plot is shown in Figure 3.7.
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3.3.5 Analysis of the Preferred Fructo- Ring Form Accepted by Human 
GLUTS.
To establish w hether GLUTS accepts fructose in the furanose (S- 
membered) or the pyranose (6-membered) ring form, the uptake of D-fructose 
by GLUTS injected oocytes was measured in the presence and absence of 
various fructose analogues. The effects of inhibition of fructose uptake by the 
fructose analogues l,S-Anhydromannitol, 2,S-Anliydromannitol and L-sorbose 
were measured. The results of this study are shown in Figure 3.8.
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Figure 3.1.
Diagram Showing the Uptake and Efflux of Dietary Sugars Across an Intestinal 
Epithelial Cell.
The uptake of dietary D-glucose across the enterocytes of the small intestine 
occurs via the sodium-glucose co-transporter SGLTl. This transporter utilises the 
energy gained from the transport of a Na+ ion down its concentration gradient, to 
transport one glucose molecule into the cell against its concentration gradient. 
The gradient of Na+ ions in the cell is maintained by the sodium/potassium  
exchange pump. The uptake of dietary fructose occurs via facilitative transport by 
GLUTS. These transporters are present on the brush border membrane of these 
cells which is exposed to the lumen of the small intestine. The efflux of both 
sugars from these cells across the basolateral membrane is mediated by GLUT2.
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Figure 3.1
Diagram Showing the Uptake and Efflux of Dietary Sugars Across an Intestinal 
Epithelial Cell.
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Figure 3.2
Structures of Pyranose and Furanose Forms of p-D-Fructose, and Fused-Ring 
Fructose Analogues.
This diagram shows a comparison of pyranose and furanose forms of 
fructose, and the structures of fused-ring fructose analogues. Compound I is p-D- 
fructofuranose (5-m em bered ring form  of D-fructose), C om pound II is 
fructopyranose (6-membered ring form of D-fructose), Compound III is 2,5 
anhydromannitol (fused 5-membered ring fructose analogue). Compound IV is
1,5 anhydro-D -m annitol (fused 6-m em bered ring fructose analogue), and 
Compound V is a-L-sorbopyranose (L-sorbose -6-membered ring analogue).
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Figure 3.2
Structures of Pyranose and Furanose Forms of p-D-Fructose^ and Fused-Ring 
Fructose Analogues.
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Figure 3,3
Lineweaver-Burk Plot of Fructose Uptake by Human GLUTS-Injected Oocytes.
Each point is the mean of the transport rate determined from groups of at 
least 10 oocytes (section 2.4). Rate of transport was determined by exposure of the 
oocytes to radiolabeled fructose for 60 m ins and the counts per m inute 
determined as described (section 2.4). For each experiment endogenous oocyte 
transport was measured by a parallel incubation of uninjected "control" oocytes in 
trace radiolabeled fructose. The values obtained for the control oocytes at each 
concentration were subtracted from the values obtained from  the chimera- 
injected oocytes to obtain the heterologous transport rate. Transport rates in 
control oocytes were typically 10% of the injected oocytes. Error bars are excluded 
for clarity, but the range of error was typically 10%. The data shown here is 
representative of at least four separate experiments.
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Figure 3.3
Lineweaver-Burk Plot of Fructose Uptake by Human GLUTS-Injected Oocytes.
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Figure 3.4
Graphs showing the Uptake of O.lmM DeGlc by GLUT2-Injected, GLUTS-Injected 
and Control Oocytes.
This graph shows the uptake of O.lmM pH]2-deoxy-D-glucose into X enopus  
oocytes injected with either GLUT2 or GLUTS mRNA. Uptake was measured over 
a 30 min time period. The rate of uptake into non-injected^ control oocytes is also 
shown to illustrate the low level of deGlc transport into GLUTS-injected oocytes. 
Each column represents the transport rate into at least 10 oocytes i  SEM. This 
graph is representative of at least three experiments. Transport rate varies with 
each oocyte batch due to differing levels of protein expression, however, this 
graph is typical in that deGlc uptake by GLUTS is consistently lower or equal to 
level of uptake by non-injected oocytes.
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Figure 3.4
Graphs showing the Uptake of O.lmM DeGlc by GLUT2-Injected, GLUTS
Injected and Control Oocytes,
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Figure 3.5
Graph Showing the Inhibition of Uptake of O.lmM Fructose by lOOmM D-Glucose, 
L-Glucose or D-Fructose.
This graph shows the uptake of O.lmM D-fructose by GLUT5-injected 
oocytes, and the inhibition of this uptake by D-fructose, D-glucose and L-glucose, 
when added at a concentration of lOOmM. Rates of uptake into non-injected 
oocytes are subtracted from rates of uptake into GLUT5-injected oocytes. Each 
column represents the uptake of fructose into at least 10 oocytes ±  SEM from a 
representative experiment (if n > 3). Uptake in this experiment was measured 
over a 60 min time period. Oocytes were exposed to competing sugar 10 mins 
prior to the addition of trace radiolabelled fructose.
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Figure3.5
Graph Showing the Inhibition of Uptake of O.lmM Fructose by lOOmM D- 
Glucose, L-Glucose or D-Fructose.
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Figure 3.6
Graph Showing the Effects of pH on the Transport Activity of GLUT5-Injected 
Oocytes.
This graph shows the rate of uptake of O.lmM D-fructose by GLUTS injected 
oocytes, when incubated in transport medium of different pH values. The rate of 
uptake into non-injected oocytes is subtracted from the rate of uptake into non­
injected oocytes. Each column represents the transport rate of at least 10 oocytes + 
SEM, from a representative experiment (if n >3). Uptake was measured over a 60 
min time period.
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Figure 3.6
Graph Showing the Effects of pH on the Transport Activity of GLUT5-Injected 
Oocytes.
pH
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Figure 3.7
Lineweaver-Burk Plot of Fructose Transport by GLUTS-Injected Oocytes at 
pH 4.5.
Transport rates of D-fructose into GLUT5-injected oocytes were measured 
exactly as described, with the exception that the transport medium in the assay 
was adjusted to pH 4.5. This plot was constructed as described in section 3.3.1. Note 
that this experiment was only performed once, however, the Km value obtained 
was, within the limits of experimental error, identical to the Km value obtained 
for GLUT5-injected oocytes at pH 7.5 in the same experiment, on the same batch of 
oocytes.
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Figure 3.7
Lineweaver-Burk Plot of Fructose Transport by GLUTS-Injected Oocytes at 
pLI 4.5.
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Figure 3.8
Graph Showing the Inhibition of Fructose Transport by GLUTS-Injected Oocytes, 
by Fused-Ring Fructose Analogues.
This graph shows the uptake of O.lmM D-fructose by GLUTS-injected 
oocytes, and the inhibition of this uptake by fused-ring analogues. L-sorbose and 
1,5 anhydromannitol are fused pyranose ring forms, while 2,5 anhydrom annitol 
is a fused furanose ring structure. These com pounds were added  at a 
concentration of 50 mM. Rates of uptake into non-injected oocytes have been 
subtracted from rates of uptake into GLUT5-injected oocytes. Each colum n 
represents the uptake of fructose into at least 15 oocytes + SEM from  a 
representative experiment (if n > 3). Uptake in this experiment was measured 
over a 60 min time period. Oocytes were exposed to competing analogue 10 mins 
prior to the addition of trace radiolabelled fructose.
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Figure 3.8
Graph Showing the Inhibition of Fructose Transport by GLUTS-injected
Oocytes, by Fused-Ring Fructose Analogues.
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3.5 Conclusions.
3.5.1 Kinetics and Substrate Selectivity of Human GLUTS in Xenopus
Oocytes.
The Km value for fructose transport was measured as 22.5-1 OmM. This 
value is similar, although slightly higher to that reported by Burant et al 
(Durant et al., 1992).
The substrate preference of hum an GLUT5 in the oocyte system was 
investigated. It was found that GLUTS could not transport deGlc, and the 
presence of 50 mM or 150 mM D-glucose or L-glucose did  not inhibit the 
transport of D-fructose. This is also in agreement with data from Burant et aL
3.5.2 The Effect of pH on Substrate Selectivity of Human GLUTS in
X e n o p u s  Oocytes.
The effects of pH  on the transport of D-fructose and deGlc were 
measured. It was found that a decrease in pH from 7.5 to 4.5 had no effect on 
the fructose transport activity of GLUT5. The Km for fructose uptake at pH 4.5 
was determined. There was no change in this value when measured at this pH 
compared to the Km at pH 7.5. Also, there was no increase in the transporter's 
ability to transport deGlc. The substrate specificity of GLUTS is therefore, 
unchanged throughout this pH range. It was not possible to measure the effect 
of lowering the pH  below 4.5 as this would have deleterious effects on the 
oocyte membrane (Dr. Amir Ahmed, personal communication). Therefore, in 
this respect, this experiment does not completely replicate the conditions in 
the small intestine, especially the proximal end of the small intestine where 
the pH will be lower than 4.5. Nevertheless, if a decrease in pH did induce a 
change in either affinity of GLÜT5 for fructose or glucose, it would be expected
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that at pH 4.5, such an effect would be detectable. It is perhaps interesting in 
itself, that such a large decrease in pH does not affect the transporters activity.
3.5,3 Analysis of the Preferred Fructo- Ring Form Accepted by Human
GLUT5.
The ability  of fused ring  fructose analogues L-sorbose, 1,5 
anhydrom annitol, and 2,5 anhydrom annitol to inhibit the uptake of D- 
fructose has been studied. 1,5 anhydromannitol is a fused ring pyran- analogue 
of fructose, and 2,5 anhydrom annitol is fused in the fur an- ring form. L- 
sorbose exists mainly in the pyranose ring form. The structures of these 
compounds are shown in Figure 3.2. Figure 3.8 shows the inhibitory effects of 
these analogues on the transport of 0.1 mM D-fructose. As can be seen from 
this graph, the presence of 50 mM L-sorbose or 50 mM 1,5 anhydromannitol 
does not inhibit D-fructose transport at all. These analogues are in the fused 
pyran- ring form. Therefore, this indicates that there is no competition of these 
analogues for the binding site of D-fructose. The furan- fused ring analogue 
however, does compete with D-fructose for the exofacial binding site of 
GLUT5. This is demonstrated by the (-65%) inhibition of fructose transport by 
50 mM 2,5 anhydromannitol. The results of these experiments indicate that 
GLUT5 transports D-fructose in the furanose ring form.
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3.6 Summary.
The kinetics of transport and substrate specificity of GLUT5 have been 
poorly studied, and previous work on this isoform from different species and 
in different expression systems has yielded widely conflicting results (see table 
3.1). The kinetic parameters and substrate specificity of hum an GLUTS have 
been reported in only one previous study (Burant et aL, 1992). Therefore, we 
have measured a Km value for the uptake of D-fructose by hum an GLUTS in 
the X en o p u s  oocyte system, and found this value to be 22.5+10 mM. This value 
is similar to that reported by Burant et al. We have also tested the substrate 
specificity of human GLUTS in the oocyte system, specifically to determine if 
this isoform can transport deGlc or if the transport of D-fructose is D-glucose 
inhibitable. Our results support those of Burant et al in that we have detected 
no glucose transport activity in this isoform, and D-fructose transport was not 
inhibited by lOOmM D-glucose.
The intestinal Na+-glucose cotransporter, SGLTl, has been shown to 
vary its affinity for substrate according to the pH of the intestine. Since GLUTS 
is expressed in a variety of pH environments, both throughout the gut and 
elsewhere in human tissues, we investigated the effects of varying pH of the 
transport medium of GLUT5-injected oocytes. This was found to have no effect 
on the transport activity or affinity of human GLUTS for fructose, as measured 
by Km- Furthermore, no deGlc transport activity was observed regardless of pH.
It has been shown previously for GLUT2, that fructose is transported in 
the furanose form, and glucose in the pyranose form (Colville et aL, 1993a). It 
has also been shown that the fructose transporter of the parasite Trypanosoma  
bruceii, can transport fructose in the furanose and the pyranose ring-form (Fry 
et aL, 1993). Previous studies, utilising the chimeric transporter approach, have 
investigated the structural requirem ents of GLUTl and GLUT5 for the 
transport of both D-glucose and D-fructose. This work has shown that the
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regions of GLUTl required for glucose transport differ greatly from the regions 
of GLUTS required for fructose transport. On the basis of these observations, 
we proposed that the substrate binding sites of these isoforms may not be 
analogous. Therefore, we have investigated the ring-form  of fructose 
transported by human GLUTS. Preliminary studies have shown that fructose is 
transported in the furanose ring form, as demonstrated by the inhibition of 
fructose transport by the fused-furanose ring analogue, 2,5 anhydromannitol. 
Therefore, this situation may be analogous to the transport of fructose by 
GLUT2. Further inhib ition  studies w ith  hydroxyl-substitu ted  fructose 
analogues with GLUT2 and GLUTS will provide more information on the 
structural requirements of fructose binding to these isoforms.
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CHAPTER 4.
Kinetic Characterisation of
GLUT2/GLUT3 Chimeric Transporters.
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4.1.1 Introduction.
The mechanism by which GLUTl undergoes conformational change 
during transport catalysis has been well studied (Chapter 1, sections 1.4-1.7). 
Much of the work on GLUTl has also focused on m apping the exofacial and 
endofacial glucose binding sites. These sites have been shown to be structurally 
separate, and are located in different regions of the protein. ATB-BMPA, the 
exofacial ligand photolabels GLUTl in the region of helices 7 and 8 (Davies et 
aL, 1991), whereas cytochalasin B, the endofacial ligand, photolabels a region 
between helices 10 and 11 (Holman & Rees, 1987). The structural separation of 
the sites has further been proposed on the basis of kinetic studies and inhibitor 
selectivity.
From ligand binding and proteolytic digestion studies, it has been 
shown that the C-terminal half of GLUTl contains sufficient sequence 
inform ation to bind cytochalasin B and ATB-BMPA. However, studies 
utilising the baculovirus system to express "half" GLUTl molecules have 
suggested that the binding of these ligands can only occur if the C-terminal half 
of GLUTl is co-expressed with an independent construct encoding the N- 
terminal half (Cope et aL, 1994). Therefore, it is proposed that while the six 
helices of the C-terminal half of GLUTl are probably directly involved in 
formation of the glucose binding sites, the N-terminal half is necessary for 
correct structural packing of the C-terminal helices (section 1.8).
The importance of the C-terminal half of GLUTl in substrate binding 
has also been implicated by site directed mutagenesis studies. An account of 
the details of this work is given in Chapter 6. According to Muecklers 
topological model of GLUTl (Figure 1.2), helices 3, 5, 7, 8 and 11 are moderately 
amphipathic, and therefore able to form a channel through which glucose 
could pass during transport. Within each of these helices there are several 
polar residues which would be able to participate in hydrogen bonding with
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the sugar molecule. Site directed mutagenesis has identified several residues 
important in exofacial and endofacial sugar binding, and in conformational 
flexibility. However, all but one of these residues reside in the C-terminal half 
of the molecule. In Figure 1.9, two putative models are described for the 
arrangement of helices which form the transmembrane channel (section 1.9). 
These models are speculative, however, it is interesting to note that they both 
include the C-terminal helices 7, 8, and 11 in the formation of the transporter 
channel.
4.1.2 Previous Studies of Regions Involved in Substrate Selectivity.
The topology of GLUTl has been well characterised (section 1.3.2), and 
m any stud ies have been conducted which suppo rt the a lternating  
conformation model. The exofacial and the endofacial sugar binding sites of 
GLUTl have been mapped to defined regions (sectionl.6), and the kinetics of 
sugar transport exhaustively measured (section 1.4.2.1).
The hydropathy plots of each of the isoforms in the glucose transport 
family are virtually superimposable (Figure 1.1). Therefore, although the bulk 
of the work has focused on GLUTl, it is thought that the topology and 
transport mechanism of the other isoforms are similar, if not identical to those 
of GLUTl.
However, there is very little published work which investigates the 
substrate binding sites of the other isoforms, each of which has a distinct 
substrate selectivity (Table 4.1). There are obviously differences in the way each 
isoform binds and transports substrate. Such differences determ ine for 
example, why only GLUT2 and GLUTS can recognise and transport fructose, or 
why GLUT3 can bind and transport D-galactose with such high affinity. 
(Fructose "recognition" is used here to mean that these transporter iso forms 
possess the sequence information which facilitates fructose binding.) Previous
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work on GLUTl has also largely ignored another area of interest; what 
structural features of the protein determine the isoform-specific kinetics.
There are few studies in the literature which attempt to answer these 
questions, and those which have, have produced conflicting results. Inukai et 
al have performed a study which examines the structural basis of the substrate 
specificity of GLUTS and GLUTl (Inukai et ah, 1995). This study involved the 
expression of chimeric GLUTl / GLUTS constructs in CHO cells. The results 
from this study suggested that two large regions of the GLUTS protein were 
essential for the ability of these chimeric molecules to transport fructose. These 
regions were the entire N-terminal "half" of the protein- from the N-terminus 
up to the end of the sixth helix, and the C-terminal cytoplasmic tail- from the 
end of helix 12 to the carboxy-terminus. (From here on, the cytoplasmic C- 
terminal tail may be referred to as the "C-tail".) For the ability of the chimeras 
to transport glucose, the middle cytoplasmic loop (between helices 6 and 7), 
and the C-terminal "half" of the protein (from helix 7 to the end of helix 11) 
were essential. Moreover, the ability to transport glucose was not affected by 
replacing the N-terminal half of GLUTl, or the C-tail of GLUTl with the 
corresponding regions of GLUTS. This study however, only examined the 
substrate preference of the chimeric molecules, and did not examine the effects 
of the replacement of specific regions on the kinetics of sugar transport.
The C-terminal cytoplasmic tail of each of the isoforms is variable in size 
and sequence. This observation suggested to Katagiri et al that this region of 
the transporter may play a role in determ ining specific kinetics of each 
isoform. Therefore, Katagiri et al have constructed a chimeric molecule in 
which the last 42 amino acids of the cytoplasmic tail of GLUTl are replaced 
with those of GLUT2 (Katagiri et al., 1992). This construct has been expressed in 
CHO cells, and the Km for deGlc shown to be 3-fold higher than that of wild- 
type GLUTl. From this, it has been inferred that in this chimera, the C-
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terminal tail of GLUT2 confers "GLUT2 -like" kinetic properties on the GLUTl 
molecule.
There are, however, some problems with this study: CHO cells, the 
expression system this group have chosen to use, express endogenous GLUTl, 
and so the accurate m easurem ent of kinetics in this system is difficult. 
Therefore, although the Km of this chimera has increased to 3-fold that of the 
GLUTl wild type, it is difficult to know if this value is representative of a 
GLUT2 Km value, when m easured in this system. Additionally, accurate 
estimation of the num ber of transporters at the cell surface is necessary to 
relate m easured Vmax to turnover number. Such estimations are difficult at 
best, and the subcellular fractionation procedure employed by Katagiri may not 
be ideal in this regard.
However, Due et al have also produced a study which suggests that the 
last 29 amino acid residues of the C-terminal tail are im portant in determining 
the affinity of GLUTl (Due et al., 1995b). It was shown that replacement of the 
last 29 residues of the GLUTl C-terminal tail, with those of GLUT4, has the 
effect of reducing the Vmax of the transporter. Also, if the last 29 or 73 amino 
acid residues of GLUT4 are replaced with those of GLUTl, the Vmax increases 
to almost half of that of GLUTl, and the affinity for substrate decreases by half, 
this study was perform ed in X enopus  oocytes, and again, in this system 
accurate determ ination of the number of transporters at the cell surface is 
difficult (section 4.6.3). Determining the parameter of Vmax therefore, may not 
be accurate.
It has been shown that swapping the C-terminal tail of m urine GLUTl 
with that of m urine GLUT4 results in abolition of the GLUTl property of 
accelerated exchange (sections 1.4.2.1-1.4.3.4). However, replacing the GLUT4 
tail with GLUTl does not confer the property of accelerated exchange onto the 
GLUT4 molecule (Dauterive et aL, 1996). This study was also performed in 
X en o p u s  oocytes. Therefore, in addition  to the problem s of accurately
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m easuring V^ax/ there are difficulties inherent in measuring the property of 
accelerated exchange outwith a cell-free system (section 1.4.3.3).
Further evidence for the involvement of the C-terminal tail in isoform- 
specific kinetics, comes from a study by Buchs et al (Buchs et al., 1995). In this 
study, replacement of the last 30 residues of the carboxy-terminus of GLUT4 
with those of GLUT2, results in a transporter which displays an affinity for 3-0- 
methyl glucose which is intermediate between GLUT4 and GLUT2. Moreover, 
replacement of the entire C-terminal half of GLUT4 (from the start of the large 
middle loop) with corresponding sequence of GLUT2 results in a transporter 
which displays transport kinetics highly similar to GLUT2.
On the basis of the studies discussed above, it may not be possible to 
assume that the regions of the transporter structure that confer isoform specific 
substrate selectivity are the same as those involved in isoform specific 
transport kinetics. Additionally, the extent of the involvement of the C- 
terminal tail and other regions in the substrate selectivity and kinetics of 
GLUTl is not clear. It may be that the importance of these regions vary 
between isoforms.
The purpose of this chapter is to determine the structural basis of 
substrate selectivity and transport kinetics in the GLUT2 and GLUT3 isoforms.
4.1.3 Kinetic Characterisation of the Other Glucose Transporter Isoforms.
Endogenous expression of multiple GLUT isoforms is common to most 
cell types and for this reason it is difficult to measure the kinetics of the other 
isoforms in their native cell. However, the availability of cDNAs for these 
isoforms has enabled the heterologous expression of the transporters in the 
Xenopus  oocyte system. These cells have a very low level of background 
endogenous transport, which allows the accurate m easurement of isoform 
specific kinetics. A summary of the extensive kinetic characterisation of the
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various isoforms perform ed in this expression system by this and other 
laboratories is presented in Table 4.1.
The transport kinetics of all the isoforms are quite distinct, but the 
GLUT2 and GLUTS isoforms are particularly disparate. GLUT2 has a high Km 
for the zero-trans  entry of deGlc into oocytes (11.2mM), while GLUTS has a 
relatively low Km for this transport event (1.4mM). The Km values of these 
isoforms for 3-O-methylglucose equilibrium  exchange are equally distinct 
(42.3mM and 10.6mM respectively) and their substrate selectivities are also 
unique; only GLUT2 is capable of fructose uptake for example, while GLUTS is 
a high affinity galactose transporter. GLUT2 can also transport galactose, but 
with a much lower affinity.
As discussed below, these distinctions were chosen as the basis of an 
assay to identify regions involved in substrate selectivity and high affinity 
deGlc transport.
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4.2 Methods.
In an effort to identify the structural features of the protein which 
dictate the substrate selectivity and the affinity deGlc, GLUT2 and GLUTS were 
chosen as suitable candidates for the generation of chimeric molecules. Using a 
PGR based approach outlined in Figure 4.1, a panel of constructs were 
engineered by Margaret Arbuckle, cloned into the pSP64T vector (Figure 2.1), 
and expressed in the Xen o p u s  oocyte system. These are shown in Figure 4.2, 
and are presented as two separate series of constructs. The first of these series 
(the GLUT2 series), are essentially GLUT2 molecules in which lengths of 
sequence from the start of helix 7 to the end of the C-terminal cytoplasmic tail, 
have been replaced by the equivalent sequences of GLUTS. Investigation of the 
GLUT2-series of m utants should delineate sequences im portant for the 
"GLUT2-like" property of fructose recognition. Mirror image constructs have 
also been produced and are shown as the GLUTS-series of mutants in Figure 
4.2. These constructs are GLUTS molecules in which various lengths of 
sequence in the C-terminal half are replaced with those of GLUT2. The 
junction points of these chimeras are identical to those in the GLUT2-series. 
Analysis of these chimeras should identify the regions im portant in the 
"GLUTS-like" properties of high affinity deGlc and high affinity galactose 
transport. Furthermore, because these two series of mutants are mirror images, 
then the data resolved from either of the series should reflect and substantiate 
the data from the other. Therefore, the involvement of a particular sequence 
in fructose recognition, for example, should be detected in both the GLUT2 
series and the GLUTS series.
This approach focuses on the investigation of the C-terminal half of the 
protein (i.e. from the start of the seventh helix to the end of the C-terminal 
tail). The rationale behind this is based on evidence from structural studies of 
GLUTl, where helices in the C-terminal half have been found to be important
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both in ligand binding and in mediating conformational change in the protein 
(sections 1.6 and 1.8). On the basis of this, it seems likely that the sequence 
information that is im portant in determ ining the kinetic param eters and 
substrate preferences of the other isoforms will also be found in this half of the 
molecule.
P relim inary  characterisa tion  of these constructs th rough  their 
expression in the oocyte system has been successful in identifying regions of 
importance for the kinetic parameters of deGlc transport. This data is presented 
in Table 4.2 in conjunction with the results obtained in this study. Note that 
the deGlc kinetic data and maltose inhibition values presented in this table 
were obtained by Dr. Margaret Arbuckle in this laboratory. Also included are 
values of these kinetic parameters for the wild type proteins, which were 
measured by previous workers in this group (Colville et al., 1993b), and in 
some cases confirmed in parallel experiments with the chimeric species.
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4.3 Aims of this study.
1. To measure the Km for D-fructose uptake in those chimeras which are
capable of fructose recognition.
2. To measure the Km for galactose transport for the GLUTS chimeras.
3. To build a model of substrate selection by the GLUT2 and GLUTS
isoforms, on the basis of the results obtained from the above.
150
4.4.1 Results.
The Km values of D-fructose and D-galactose uptake were determined by 
measuring the rate of transport of trace radiolabelled sugar over a range of 
external sugar concentrations into oocytes that had been incubated in sugar 
free medium for at least 48 hours (section 2.4). By measuring rates of zero-trans  
entry as a function of substrate concentration, Lineweaver-Burk plots were 
constructed, and the Km values determined from the equation of the line as 
described (section 3.3.1).
Oocytes were exposed to radioactive fructose or galactose for 60 and 30 
minutes respectively. Previous studies have shown that accumulation of 
radiolabel increases linearly with time over this time period (Colville et aL,
1993b). These experiments also demonstrated that no significant amount of 
radiolabeled non-phosphorylated sugar accumulated in the oocyte during this 
time period. Such studies indicate that transport across the membrane is the 
true rate limiting step and this measurement is not compounded by rates of 
sugar phosphorylation by hexokinase.
The graphs presented in Figures 4.3-4.8 are each representative of one of 
at least three separate measurements. Km values ±  SEM calculated from a 
number of such experiments are shown in Table 4.2.
4.4.2 Measurement of Fructose Transport.
Figure 4.3 shows a representative Lineweaver-Burk plot of fructose 
transport by G2(12Ed). The Km values for this chimera was calculated to be 
139i21mM respectively. This value is shown in the context of wild type values 14 
iin Table 4.2.
A
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A Lineweaver-Burk plot of fructose transport by the only member of the 
GLUTS series capable of fructose recognition- G3(7St), is shown in Figure 4.4. 
The Km value for this chimera was calculated to be 365+2ImM (Table 4.2).
4.4.3 Measurement of Galactose Transport.
Figures 4.5-4.S show Lineweaver-Burk plots of galactose transport by the 
GLUTS series of chimera: G3(7St), G3(7Ed)/ GS(lOEd), and G3(12Ed) respectively. 
The Km values measured for these mutants were 25.4i-2.lmM, 2.55i0.4mM, 
2.8i0.9mM, and 4 .8 i 0.9 mM respectively (Table 4.2).
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Figure 4.1
Diagram of Recombinant PCR Used to Construct GLUT2/GLUT3 Chimeric 
Transporters.
This diagram  describes the PCR m ethod used to construct the first 
generation chimeric transporters. The generation of GLUT2- and GLUT3-based 
primary products is acheived by using wild type GLUT2 and GLUTS, along with 
appropriate primers in separate reactions. The external primers for each of these 
reactions have tails which encode Sal I restriction sequences, and the internal 
primers have tails which are complementary in sequence to the opposite primary 
PCR fragment. Therefore, as can be seen from the diagram, in the secondary PCR, 
the primary fragments themselves act as templates: upon strand dissociation and 
re-annealing, the overlapping tail regions bind, and the sequence is extended to 
produce a full length construct. Prior to ligation into a suitable vector, the PGR 
products are restricted with Sal I. This produces sequence overhangs which 
enables cloning into the Sal I restricted vector. This diagram specifically shows the 
construction of a representative GLUT2 series member, however, the GLUT3 
series constructs were made in a similar way, with GLUT3 acting as the template 
for generation of primary fragment "a", and GLUT2 for primary fragment "b”. In 
this diagram, GLUT2 sequence is represented in black ink, and GLUT3 in red.
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Figure 4.1 Recombinant PCR Approach.
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▼ A 3 ' ------------
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overlapping
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templates in the secondary PCR
G2 Start
V
G2End
I Secondary 
▼ PCR
G LUT2 sequence G LUT3 sequence
7
Sal  I site  junction point S a l l s i t e
Sa i l  restriction and subsequent ligation into vector.
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Figure 4.2
Diagram Showing the Junction Points of the GLUT2 and GLUTS Series Chimeras.
This diagram  shows the junction points of the GLUT2 and the GLUT3 
chimeras. GLUT2 sequence is shown in black ink, and GLUTS in red. The amino 
acid numbers shown correspond to either GLUT2 cDNA sequence or GLUTS 
cDNA sequence, and refer to the sequences above which they are positioned. The 
first member of the GLUT2 series shown therefore is G2(7St). The GLUT2 portion 
of this chimera stretches from the N-terminus of GLUT2 to the end of the central 
loop, i.e. GLUT2 amino acids 1-S02. The remaining portion is GLUTS sequence 
from the end of the (GLUTS) central loop to the end of the C-terminus, i.e. GLUTS 
amino acids 269-496.
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Figure 4.2
Diagram Showing the Junction Points of the GLUT2/GLUT3 Chimeric 
Transporters.
GLUT2 SERIES
1-302 269-496
1-324
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1-482
GLUTS SERIES
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1-290 
1-388
1-448
end of central loop
end of helix 7
end of helix 10
291-496
389-496
449-496
G 2(7St)
G2(7Ed)
G2(10Ed)
G2(12Ed)
end of helix 12
end of central loop
end of helix 7
303-524
325-524
423-524
G 3(7St)
G3(7Ed)
G3(10Ed)
end of helix 10
483-524
end of helix 12
G3(12Ed)
GLUT2 sequ en ce  
GLUTS sequ en ce
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Figure 4.3.
Lineweaver-Burk Plot of the Uptake of D-Fructose by G2(12Ed)-Injected Oocytes.
Each point is the mean of the transport rate determined from groups of at 
least 10 oocytes, (section 2.4). Rate of transport was determined by exposure of the 
oocytes to radiolabeled fructose for 60 mins and the counts per m inute 
determined as described (section 2.4). For each experiment endogenous oocyte 
transport was measured by a parallel incubation of uninjected "control" oocytes in 
trace radiolabeled fructose. The values obtained for the control oocytes at each 
concentration were subtracted from the values obtained from the chimera- 
injected oocytes to obtain the heterologous transport rate. Transport rates in 
control oocytes were typically 10% of the injected oocytes. Error bars are excluded 
for clarity, but the range of error was typically 10%. The data shown in this 
particular plot and in other plots presented in this chapter, are representative of at 
least four separate experiments.
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Figure 4.3.
Lineweaver-Burk Plot of D-Fructose Transport by Chimera G2(12Ed)-Injected
Oocytes.
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Figure 4.4
Lineweaver-Burk Plot of the Uptake of D-Fructose by Chimera G3(7St)-Injected
Oocytes.
In the plot from this representative experiment, values for the transport 
rate of D-fructose by G3(7St) expressing oocytes were determined as described. Each 
point is the mean of at least 10 individual oocytes at each substrate concentration. 
Values are corrected for endogenous oocyte transport as described (Figure legend 
4.3). The range of error was typically 10%, but error bars are omitted for clarity. 
Note that not all data points are shown.
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Figure 4.4.
Lineweaver-Burk Plot of the Uptake of D-Fructose by Chimera G3(7St)-Injected
Oocytes.
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Figure 4.5.
Lineweaver-Burk Plot of the Uptake of D-Galactose by Chimera G3(7St)-Injected
Oocytes.
In the plot from this representative experiment^ values for the transport 
rate of D-galactose by G3(7St) expressing oocytes were determined as described. 
Each point is the mean of at least 10 individual oocytes at each substrate 
concentration. Values are corrected for endogenous oocyte transport as described 
(Figure legend 4.3). The range of error was typically 10%, but error bars are omitted 
for clarity. Note that not all data points are shown.
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Figure 4.5.
Lineweaver-Burk Plot of the Uptake of D-Galactose by Chimera G3(7St)-
Injected Oocytes.
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Figure 4.6.
Lineweaver-Burk Plot of the Uptake of D-Galactose by Chimera G3(7Ed)-Injected
Oocytes.
In the plot from this representative experiment, values for the transport 
rate of D-galactose by G3(7Ed) expressing oocytes were determined as described. 
Each point is the mean of at least 10 individual oocytes at each substrate 
concentration. Values are corrected for endogenous oocyte transport as described 
(Figure legend 4.3). The range of error was typically 10%, but error bars are omitted 
for clarity. Note that not all data points are shown.
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Figure 4.6
Lineweaver-Burk Plot of the Uptake of D-Gaiactose by Chimera G3(7EcD-
Injected Oocytes.
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Figure 4.7.
Lineweaver-Burk Plot of the Uptake of D-Galactose by Chimera G3(10Ed)-Injected
Oocytes.
In the plot from this representative experiment, values for the transport 
rate of D-galactose by G3(10Ed) expressing oocytes were determined as described. 
Each point is the mean of at least 10 individual oocytes at each substrate 
concentration. Values are corrected for endogenous oocyte transport as described 
(Figure legend 4.3). The range of error was typically 10%, but error bars are omitted 
for clarity. Note that not all data points are shown.
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Figure 4.7.
Lineweaver-Burk Plot of the Uptake of D-Galactose by Chimera G3(10Ed)-
Injected Oocytes.
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Figure 4.8
Lineweaver-Burk Plot of the Uptake of D-Galactose by Chimera G3(12Ed)-Injected
Oocytes.
In the plot from this representative experiment, values for the transport 
rate of D-galactose by G3(12Ed) expressing oocytes were determined as described. 
Each point is the mean of at least 10 individual oocytes at each substrate 
concentration. Values are corrected for endogenous oocyte transport as described 
(Figure legend 4.3). The range of error was typically 10%, but error bars are omitted 
for clarity. Note that not all data points are shown.
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Figure 4.8
Lineweaver-Burk Plot of the Uptake of D-Galactose by Chimera G3(12Ed)-
Injected Oocytes.
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Figure 4,9
Structures of p-D-Glucose and p-D-Maltose.
This diagram shows the structures of p-D-glucose (Compound I) and p-D- 
maltose (Compound II). As can be seen from these structures, maltose is a 
disaccharide of D-glucose in a(l-4) glycosidic linkage. Maltose is used as an 
inhibitor of sugar transport as it can bind to the transporter is not transported.
The C-1 position of the first glucose "subunit" of maltose enters the 
exofacial binding pocket of the transporter in a D-glucose-like manner. The sugar 
hydroxyls at positions C-3 and C-6 are also analogous, so it is expected that these 
will interact with the binding site in a "p-D-glucose-like" manner. However, the 
bond with the C-4 hydroxyl will not be formed because this carbon is involved in 
the glycosidic linkage with the other glucose "subunit" of maltose. This other 
glucose unit effectively acts as a large bulky group at the C-4 position of the first 
glucose unit, which prevents closing of the transporter around the sugar 
molecule. It is also possible that the interaction of the C-3 and C-6 carbons with the 
exofacial binding site may also be affected by the presence of the large bulky group 
at the C-4 position.
169
Figure 4.9
Structures of p-D-Glucose and p-D-Maltose.
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Figure 4.10
King-Altman Diagram Showing the Competition of DeGlc and Maltose at the 
Exofacial Binding Site of the Transporter.
This model shown in this diagram is based on kinetic data which has been 
established for GLUTl, although it is generally believed that this model will also 
apply to the other isoforms. The diagram describes the cycling of the transporter 
from an outward-facing conformation- Tq, to an inward-facing conformation- Ti, 
and back again, either in the presence or absence (±S) of deClc. Kgo and Kgi 
represent the dissociation constants at the outward-facing and inward-facing sites 
respectively, and ki, k2, k_i and k-i describe the rate constants of the steps 
indicated. This schematic also describes the competition between deClc and 
maltose. It can be seen from the diagram that this event is m ediated at the 
exofacial binding site. Maltose binds at the exofacial binding site (i.e. T^), but is not 
transported to the other side of the membrane. Therefore the rate constants which 
govern this event are not dependent on the movement of the loaded carrier to 
the inward-facing conformation (k2), dissociation of the sugar (Kgi), or re­
orientation of the empty carrier (k_i). The kinetics of deClc transport are 
dependent on all of these steps. Therefore, while the interaction of deClc at the 
exofacial binding site is influenced by other steps in the transport cycle, the 
interaction of maltose is dependent only on the rate of association and 
dissociation of this sugar at the exofacial site. Hence, when the ability of maltose to 
inhibit deGlc transport is measured, the resulting Ki value which is generated is 
independent of transporter turnover number.
171
Figure 4.10.
King-Altman Diagram Showing the Competition of DeGlc and Maltose at the 
Exofacial Binding Site of the Transporter.
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Figure 4.11
Diagram Showing Regions of the Transporter Structure Involved in  Substrate 
Selectivity and Transport Kinetics.
This diagram is based on the results of the chimera work. The N-terminal 
helices (shown in blue), are indicated in this model to be important in structural 
packing. We have shown that this region of the transporter influences the 
transport kinetics of GLUT2 and GLUTS in an isoforms-specific m anner. 
However, we also propose that this influence is probably due to general structural 
stability, rather than a direct involvement. This suggestion is supported by 
previous work by others, which suggests that this region of the transporter is not 
directly involved in forming the exofacial or endofacial binding sites, but is 
required for correct structural packing of helices in the C-terminal half which play 
a more intimate role in substrate binding (Cope et al., 1994).
Helix 7 (indicated in red), has been shown to contain information which is 
absolutely required for fructose recognition by GLUT2. Furthermore, sequence 
information contained the helix 7 of GLUT3 is responsible for the high affinity 
deGlc transport property of this isoform.
The region shown in yellow has been indicated by the chimera data to be of 
influence in the affinity of GLUT2 and GLUTS for maltose. This may indicate a 
possible interaction between this region and the G-4 sugar hydroxyl, although 
further work is needed to characterise the nature of this involvement.
The regions which are not involved in substrate selectivity (as indicated by 
our experiments) are shown in grey. Note that although the loops connecting the 
helices in the N-terminal half, and in the C-terminal half are not colour-coded, 
they may also be involved in the various functions.
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Figure 4.11
Diagram Showing Regions of the Transporter Structure Involved in Substrate 
Selectivity and Transport Kinetics.
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Figure 4.12
Comparison of the Helix 7 Amino Acid Sequences of Human GLUTs 1, 2, 3, 4 and 
5.
This diagram shows a comparison of the helix 7 amino acid sequences of 
GLUTs 1, 2, 3, 4 and 5. There is a high level of conservation in this helix 
throughout the family. However, notably GLUTs 1, 3 and 4, which are all high 
affinity deGlc transporters, have a conserved QLS motif, while GLUT2 and GLUT3 
do not. This may indicate that this motif is im portant in high affinity deGlc 
transport. GLUTs 2 and 5 are capable of fructose transport, while the other family 
members are not. The QLS motif is also absent from other fructose transporters 
such as the transporter of the parasite Tryjjanosoma hruceii. Recently, it has been 
shown that the corresponding HVA motif in GLUT2 is responsible for fructose 
recognition (M.J.Seatter and G.W.Gould-unpublished data).
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Figure 4.12
Comparison of the Helix 7 Amino Acid Sequences of Hum an GLUTs 1, 2, 3, 4 
and 5.
ILIAWLQLSQQLSGINAVFY g l u t i  
IIISIVLQLSQQLSGINAVFY g l u t s  
LIIAWLQLSQQLSGINAVFY g l u t l
ILVALMLHVAQQFSGINGIFY g l u t 2 
LLSIIVLMGGQQLSGVNAIYY g l u t s
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4.5.1 Discussion.
From previous preliminary characterisation of these chimeras, it has 
been shown that helix 7 is important in fructose recognition by GLUT2 and 
high affinity deGlc recognition by GLUT3. The data from studies in this chapter 
have supported these initial proposals and have further defined the following 
conclusions:
4.5.2 Analysis of the GLUTS series.
4.5.2a Kinetics of DeGlc Transport in the GLUTS Series.
Previous studies of the GLUTS series chimeras (Table 4.2), have 
identified helix 7 as a region of importance in high affinity deGlc transport. 
This is demonstrated by G3(7St): this construct has a Km value for deGlc 
transport of 7.3mM, which is higher than that of wild type GLUTS (1.4mM), 
and is approaching that of wild type GLUT2 (11.2mM). If the sequence of 
GLUTS is replaced with that of GLUT2 at any point after the e n d  oi helix 7, i.e. 
GS(7Ed), GS(lOEd) or GS(12Ed), then the resulting transporter is capable of high 
affinity deGlc recognition. The Km values measured for deGlc transport by 
constructs GS(7Ed), GS(lOEd) and GS(12Ed) are virtually indistinguishable from 
the wild type GLUTS Km value. These data argue a role for helix 7 in 
determining isoform-specific kinetics of deGlc transport. The aim of the work 
presented in this chapter was to examine the substrate selection of these 
chimeras.
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4.5.2b Fructose Recognition in the GLUT3 Series.
The results of this study show that G3(7St) retains the ability to transport 
fructose, whereas G3(7Ed) and the other chimeras in this series do not. The Km 
value obtained for fructose transport by G3(7St) was 365±21mM, which is 
approximately four-fold higher than that of wild type GLUT2 (Figure 4.4, Table
4.2).
The fact that G3(7Ed), and the other chimeras in this series, can transport 
deGlc with "GLUT3-like" high affinity properties precludes the possibility that 
lack of fructose recognition displayed by these constructs is due to a non­
specific structural error which causes general transport dysfunction. Rather, we 
suggest that these results indicate that helix 7 plays an essential role in fructose 
recognition by GLUT2 (or lack of fructose recognition by GLUT3).
The observation that the Km value for fructose transport exhibited by 
G3(7St) is almost five-fold higher than wild type GLUT2 suggests that the 
kinetics of fructose transport may also be influenced by the N-terminal half of 
the protein. The nature of such influence will be discussed later (section 4.6.1b).
4.5.2c Galactose Transport in the GLUTS Series.
It can be seen from Table 4.2 that all the chimeras in the GLUT3 series 
retain the ability to transport D-galactose. Km values were measured, and these 
results also implicate helix 7's involvem ent in determ ining the transport 
kinetics of this substrate. G3(7St) has a Km value for galactose transport of 
24.3±2.7mM which is "GLUT2-like" (although the affinity of this construct for 
galactose is slightly higher than that of wild type GLUT2), whereas G3(7Ed), 
exhibits a marked change to "GLUT3-like" behaviour (-the G3(7Ed) galactose 
Km is 2.55+0.4mM). The rem aining chimeras in the GLUT3 series, G3(10Ed) 
and G3(12Ed), also exhibit similar "GLUT3-like" galactose Km values (Table
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4.2). G3(7St) and G3(7Ed) are essentially identical, except for the sequence of 
helix 7.
G3(7St) displays galactose transport kinetics which we have referred to as 
being "GLUT2-like". However, the galactose Km value of G3(7St), although 
more "GLUT2-like" than "GLUT3-like", is still almost four-fold lower than 
that of wild type GLUT2. This suggests that the GLUT3 N-terminal half in this 
construct also exerts some influence on its kinetic behaviour, at least with 
regard to galactose transport.
To summarise, helix 7 is implicated as playing an im portant role in 
determ ining the substrate selectivity of GLUT2 and GLUTS, and also in 
determining the kinetic behaviour of these isoforms in the transport of their 
alternative substrates. Furthermore, the GLUTS series data also suggests that 
the N-terminal half of the protein exerts an influence on the transport kinetics 
of alternative substrates.
4.5.3 Analysis of the GLUT2 Series.
Expression of three of the chimeras from the GLUT2 series has been 
problematic: functional expression of G2(7St) or G2(10Ed) has not been 
achieved. Furtherm ore, chimera G2(7Ed) gave consistently low levels of 
expression, (occasionally micro-injection of G2(7Ed) mRNA produced no 
increase in substrate uptake by oocytes at all). Possible explanations for these 
problems will be discussed later in this chapter (section 4.6.3).
The only member of the GLUT2 chimera series to express consistently 
was G2(12Ed): this molecule was "GLUT2-like" w ith regards to fructose 
recognition and deGlc transport kinetics. The problem s w ith G2(7Ed) 
expression meant that only a limited number of experiments were performed 
on this chimera, but the results of this preliminary data suggest that this 
molecule is also markedly "GLUT2-like" with regard to fructose recognition
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and deGlc transport kinetics (Table 4.2). The limited fructose data suggests that 
this chimera has a value for fructose transport of ~180mM, which is higher 
than that noted for wild type GLUT2 (Km ~76mM). This result is difficult to 
interpret in the absence of functional expression of G2(7St). Additionally, the 
measurement of Km for G2(7Ed) was only performed twice, although the two 
values obtained for this chimera were similar (n%=166mM, n2=195mM), and 
may therefore be assumed to be reasonably accurate.
There have been no problems expressing G2(12Ed), and the kinetic 
characteristics of this construct have been well defined. The Km value for 
fructose transport by G2(12Ed) was found to be 139±21mM. This value is higher 
than that of wild type GLUT2, as is the fructose Km of G2(7Ed). This may 
suggest that full "GLUT2-like" behaviour would require the presence of the 
GLUT2 cytoplasmic C-terminal tail.
However, it should be noted that at such high substrate concentrations 
(i.e. >100mM), it becomes difficult to measure accurate Km values. This is 
mostly due to the d ilu tion  of trace radiolabelled substrate with high 
concentrations of non-labelled substrate. For this reason, we cannot be certain 
that the difference between the G3(12Ed) Km and the wild type GLUT2 Km is 
significant. Also, substitution of the GLUT2 tail into a GLUT3 transporter (i.e. 
G3(12Ed)), clearly does not influence this isoforms deGlc transport behaviour. 
This therefore, suggests two possible situations: either (1) the GLUT2 tail is 
important for "GLUT2-like" fructose transport, but only in the context of a 
GLUT2 molecule, perhaps via the interaction of the tail with other GLUT2 
sequences, or (2) the kinetics of G2(7Ed) and G2(12Ed) are truly "GLUT2-like", 
and the differences shown in the data for these and wild type GLUT2, are due 
to the inaccuracy of m easuring Km values at such high substra te  
concentrations.
The influence of the N-term inal half of the protein in the fructose 
transport kinetics of GLUT2 can be seen from comparison of G2(12Ed) and
G3(7St). The C-terminal six helices of these two constructs are identical; the 
major difference between them being that G3(7St) does not have the GLUT2 
amino terminal half. This construct has a much lower affinity for fructose (Km 
of 365+21mM) than G2(12Ed)- which does have the GLUT2 N-terminal half, 
and has an affinity for fructose (Km of 139±21mM), which is much closer to 
that of wild type GLUT2 (Km of 76±12mM).
Therefore, these results support the implication of the GLUTS series, 
that helix 7 is necessary for fructose recognition. However, the information 
contained in helix 7 is not sufficient to confer complete "GLUT2-like" kinetic 
behaviour upon chimeric transporter molecules. Other regions in addition to 
helix 7 are thought to influence fructose and galactose transport kinetics: these 
regions lie within the N-terminal half of the protein.
4.5,4 Maltose Inhibition of DeGlc Transport.
Until now, in this chapter, it has been assumed that the parameter that 
is determined when measuring and comparing Km values for deGlc transport 
is the affinity of the exofacial glucose binding site for deGlc, The transport of 
deGlc into the oocyte is rapidly  followed by its phosphorylation. This 
phosphorylation step is not rate limiting. DeGlc-6-phosphate cannot be 
transported back out of the cell, and so does not interact with the endofacial 
binding site. Therefore, it is assumed that the measurement of Km is a function 
of the affinity of the substrate at the exofacial binding site only, and that 
interaction of substrate with the endofacial site is negligible. In this respect, the 
use of deGlc is preferential to D-glucose.
However, the Km of deGlc is a function not only of substrate binding to 
the exofacial site, but also of re orientation of the transporter from the 
outward-facing conformation to the inward-facing conformation, and back 
again. So, the Km parameter can be influenced by the catalytic turnover of the
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transporter (i.e. the rate of re-orientation). In this experiment, measurement of 
Km is used as a method of assessing the affinity of the exofacial binding site of 
chimeric transporter proteins. Therefore it may be important to determine that 
the observed effect on the Km of a particular mutant is not a function of a 
change in catalytic turnover. Unfortunately, we have not found it possible to 
accurately m easure transporter turnover num bers in the oocyte system 
(section 4.6.3).
The ability of maltose to competitively inhibit deGlc uptake can be used 
to identify changes in the affinity of the chimeric transporter for substrate. 
Maltose is a disaccharide of two molecules of D-glucose linked in a(l-4) 
glycosidic linkage (Figure 4.9). It therefore binds to the transporter in a D- 
glucose-like manner, but is too large to be transported. The Ki values for 
maltose inhibition of deGlc transport therefore, represent a true measurement 
of an event mediated at the exofacial binding site, which is independent of 
transporter turnover number (Figure 4.10). However it should be considered 
that the Ki value that is generated, can also be considered effectively as a 
measurement of the affinity of the exofacial binding site for maltose.
The maltose Ki values m easured for the G LUT3 series of mutants 
support the prem ise that helix 7 is im portant in high affinity deGlc 
recognition. Chimera G3(7St) is "GLUT2-like" with respect to its maltose Ki, 
whereas G3(10Ed) and G3(12Ed) are "GLUT3-like". However, unlike the sharp 
change in deGlc Km values observed after the substitution of helix 7, G3(7Ed) 
exhibits an interm ediate Ki for maltose inhibition of deGlc uptake. This 
implies that the GLUT3 sequence that lies between the end of helix 7 and the 
end of helix 10 (referred to forthwith as the H7end~H10end sequence), is in some 
way responsible for the change between an intermediate maltose K| (as in 
G3(7Ed)) and a "GLUT3-like" maltose Ki (as in G3(10Ed)).
As discussed before, the Ki measurement represents an effect mediated 
at the exofacial binding site, however, it is important to realise that this "effect"
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involves the competition of two substrates* for the exofacial binding site. 
Therefore the intermediate Ki value exhibited by G3(7Ed) may represent two 
possible affinities. It may be a true representation of an intermediate affinity of 
the exofacial binding site, either for deGlc, or for maltose.
Firstly, let us assume that the maltose Ki value of G3(7St) represents a 
true measurement of affinity for deGlc at the exofacial binding site of this 
chimera: tins Ki value suggests that the affinity of the exofacial binding site for 
deGlc is not truly "GLUT3-like", rather, it is intermediate between the two 
isoforms. Therefore, it implies that the turnover num ber of G3(7Ed) has 
increased, and it is this turnover effect which gives rise to the "pseudo-GLUT3- 
like" deGlc Km value exhibited by this construct. This being the case, it has to be 
concluded that the sequence that lies between the H7end~H10end sequence is 
important, in the context of the GLUT3 transporter, in the formation of a high 
affinity deGlc binding pocket. The reason why this is not seen in the deGlc Km 
data is because the turnover number of the transporter has increased, thereby 
artificially lowering the K^v and thus masking the true deGlc affinity.
This explanation is possible. However, GLUT3 is a low  capacity 
transporter, i.e. its value for the parameter of Vmax is lower than that of 
GLUT2. Therefore, it seems likely that if more GLUT3 sequence is added to a 
chimeric transporter, the expected effect would be that the turnover number 
would become more "GLUT3-like" (i.e. lower), especially in a construct such as 
G3(7Ed), where the entire N -term inal half is also composed of GLUTS 
sequence. However, in the G3(7Ed) construct (if we assume that the Kj value 
represents deGlc affinity), the turnover number has apparently increased. This 
effect does not make "isoform-specific sense".
An alternative explanation for this effect may be found if we consider 
that the in term ediate maltose Ki value of G3(7Ed) may represent an 
intermediate affinity of the exofacial binding site for maltose. In this situation.
* Note that maltose is not technically a "substrate" as it is not transported.
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replacing the H7erd-H10end sequence of GLUTS (i.e. from G3(7Ed) to G3(10Ed)), 
restores the affinity of the exofacial binding site of the chimeric transporter to a 
complete "GLUT3-like" level. It can be concluded from this that the H7-H10 
sequence of GLUTS allows a tighter binding of maltose, thereby lowering the 
concentration of maltose required to efficiently compete with the deGlc for the 
binding site, which results in a lower Ki value.
4.6 Conclusions.
4.6.1 Working Model for Substrate Recognition and Isoform-Specific Kinetics.
Based on the results of this work, we propose that helix 7 contributes to 
the exofacial binding site of both GLUT2 and GLUTS in such a way as to define 
substrate recognition by GLUT2 (or lack of fructose recognition by GLUTS). 
Furthermore, helix 7 also plays an important role in defining isoform-specific 
kinetics.
The N-terminal half of the transporter structure is implied to exert an 
influence on the transport kinetics of GLUT2 and GLUTS. This influence is 
probably related to an involvement in the structural packing of the helices if 
the C-terminal half, rather than a direct involvement in the exofacial binding 
site (see below).
This model explains the observation that a region between the end of 
helix 7 and the end of helix 10 apparently contributes to the affinity of the 
exofacial binding site.
4.6.1a The Role of Helix 7.
The im portance of helix 7 is dem onstrated most dram atically in 
chimeras G3(7St) and G3(7Ed). These constructs are identical in all respects.
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with the exception of the sequence of helix 7. In the construct G3(7St) helix 7 is 
composed of GLUT2 sequence, whereas in G3(7Ed) this sequence is replaced by 
that of GLUTS. The complete loss of fructose transport associated with the loss 
of the GLUT2 helix 7 sequence is compelling evidence that this single 
transm em brane region contains sufficient inform ation to define fructose 
recognition (i.e. by GLUT2), or lack of fructose recognition (i.e. by GLUT3).
These two constructs also highlight the im portant role of helix 7 in 
contributing to the transport kinetics of deGlc by both GLUT2 and GLUT3. It 
has been shown that replacement of the GLUT2 helix 7 with GLUT3 sequence 
results in the restoration of ’’GLUTS-like" kinetic behaviour with regard to 
deGlc transport. If helix 7 is composed of GLUT2 sequence, the chimeric 
transporter displays "GLUT2~like" deGlc kinetics.
Inspection of the galactose data from G3(7St) and G3(7Ed) provides 
further evidence that helix 7 is involved in determ ining the galactose 
transport kinetics of both GLUT2 and GLUT3. These constructs show that the 
presence of a GLUT2 helix 7 produces "GLUT2-like" galactose transport 
kinetics. Replacement of the GLUT2 helix 7 with GLUT3 sequence restores 
"GLUT3-like" galactose transport kinetics.
This conclusion that helix 7 plays an im portant role in determining 
these aspects of the exofacial binding site is supported by a study from 
Hashirim oto et al, w hich suggests that this helix is im portant in the 
in te rac tion  betw een GLUTl and  the exofacial ligand , ATB-BMPA 
(Hashiramoto et al., 1992). The results presented here are also partly in 
agreem ent by work from Buchs et al, which suggests that the regions 
responsible for the unique kinetic param eters of GLUT2 reside in the C- 
terminal half of the protein, specifically in a region located between the start of 
helix 7 and the end of helix 12. This region has been shown to exert a partial 
influence on the Km and Vmax of GLUT2 (Buchs et al., 1995).
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4.6.1b The Role of the N-Terminal Half of the Transporter.
The results of this study also suggest that there may be other sequences 
in addition to helix 7, which influence the transport kinetics of GLUT2 and 
GLUTS. Several observations suggest that the N -term inal half of the 
transporter may play such a role, at least in the transport of the "alternative" 
substrates of these isoforms, i.e. fructose and galactose.
This is shown by G3(7St), which is the only chimera in the GLUTS series 
capable of fructose transport. The ability of this construct to recognise fructose 
is due to the presence of the GLUT2 helix 7 sequence. However, the Km for 
fructose transport by G3(7St) is very high, which may be due to the influence of 
the GLUTS N-terminal half in this construct. This suggestion is supported by 
the fructose transport data from G2(7Ed) and G2(12Ed), which have Km values 
for fructose transport that are more "GLUT2 like" than that of G3(7St).
The influence of the N-terminal half can also be seen in the galactose 
transport behaviour of G3(7St). This construct has a much lower affinity for 
galactose (as measured by Km) than the other constructs in the GLUTS series. 
This is due to the presence of the GLUT2 helix 7 sequence, which confers upon 
the protein  "GLUT2-like" galactose transport behaviour. However, the 
influence of the GLUTS N-terminal half in this construct is implied by the Km 
value for galactose transport by G3(7St), which, although more ”GLUT2-Iike" 
than "GLUTS-like", is still lower than that of wild type GLUT2.
The influence of the N-terminal half in the transport kinetics of deGlc 
by GLUT2 and GLUTS is difficult to determine from the present data. This is 
due to the lack of functional expression of G2(7St), which contains the 
important helix 7, but also has the N-terminal half of GLUTS. However, given 
that this region influences the transport kinetics of the alternative substrates of 
GLUTs 2 and 3, it can probably be assumed that it will play a role in the 
transport kinetics of the preferred substrate, deGlc.
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The nature of the influence of this region is probably related to the 
structural packing of helices in the tertiary structure of the protein, rather than 
involvement of specific N-terminal domain residues in the exofacial binding 
site. This conclusion is based on a study from Cope et al (section 1.8), where it 
is suggested that the C-terminal half of the protein contains sufficient 
inform ation to compose the exofacial and endofacial binding sites, but the 
presence of the N-terminal half is required for the correct structural packing of 
the C-terminal helices (Cope et al., 1994).
One observation in this work which does not agree with the role of the 
N-terminal half in influencing transport kinetics is that the maltose Kj value 
for inhibition of deGlc transport by wild type GLUT2 is identical to that for 
deGlc transport inhibition by G3(7St). On the basis of the analysis of this single 
chimera, it is difficult to draw  any certain conclusions. However, this may 
suggest that the structural role of the N-terminal half is more associated with 
the dynamics of transport, rather than the affinity of exofacial substrate 
binding. Until other chimeric transporters are constructed, which have 
junction points throughout the N-term inal half, the exact nature of the 
influence of this region in the transport mechanism will remain speculative.
4.6.1c Possible Involvement of the Cytoplasmic C-Terminal Tail of GLUT2.
Given that the N-terminal half comprises a large part of the transporter 
structure, the suggestion that it plays a role in transport kinetics as described 
above, seems more than likely. However, the possibility should not be 
dismissed that it is the lack of an appropriate cytoplasmic C-terminal tail that 
"restricts" the fructose transport kinetics by G2(7Ed) or G2(12Ed) from being 
completely "GLUT2-like", rather than the influence from the N-terminal half 
(see above, section 4.6.1b). Although the data presented here does not indicate 
that the GLUT3 tail is necessary for "GLUT3-like" behaviour, it is possible that
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the GLUT2 tail interacts with other GLUT2 sequences. This possibility has also 
been suggested by other studies (reviewed in section 4.1.2).
4.6.1d Possible Role for the H7end“Hl0end Sequence.
Therefore, it could be concluded from this that the increase in the 
affinity of the exofacial binding site for maltose, which occurs upon the 
addition of the GLUT3 H7end-H10end sequence, may indicate a subtle difference 
in the way GLUT2 and GLUT3 can accommodate the bulky group at the C-4 
position in maltose.
Therefore, we have suggested that the H7end-H10end sequence of GLUT3 
may allow a tighter fit of maltose at the exofacial binding site, possibly because
it lacks a spatial restriction that is present in the GLUT2 exofacial binding site.
It has been shown previously that the interaction of the C-4 hydroxyl of 
glucose is less important in the exofacial binding site of the GLUT3 isoform 
than the GLUT2 isoform (Colville et a l ,  1993a), an observation which may 
explain why GLUT3 can bind galactose, a C-4 epimer of D-glucose, with such 
high affinity. However, to draw  the conclusion that the C-4 position of the 
glucose pyranose ring is normally involved in an interaction with the H7end" 
HlOend sequence would be too speculative. The data does not directly suggest 
this, and even if we consider that this interaction does occur, the deGlc and 
galactose transport data would argue that the difference in the way that GLUT2 
and GLUT3 bind this C-4 hydroxyl is not important in determining the specific 
kinetics of these isoforms.
One interesting point, when considering the nature of maltose binding 
is as follows. It has been shown that maltose binding produces a 10% reduction 
in the a-helical content of GLUTl, as m easured by circular dichroism 
spectroscopy studies. The binding of D-glucose in contrast, produces a 10% 
increase in the a-helical content of GLUTl (Pawagi & Debber, 1987, Pawagi &
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Deber, 1990) (see also section 1.5.1). These observations are interpreted to 
indicate that the binding of maltose stabilises the transporter in the exofacial 
conformation, and the binding of D-glucose induces the movement of the 
transporter into an inward facing conformation. It is interesting to speculate 
(regardless of where in the transporter structure it binds) that the interaction of 
the C-4 position hydroxyl may be essential, or even instrumental in inducing 
the conformational change associated with substrate transport.
4.6.2 Speculation as to How Helix 7 Interacts with Substrate.
The defining role that helix 7 plays in fructose recognition and in the 
isoform specific kinetics of fructose, deGlc and galactose is striking. It is even 
more surprising that one single helix can mediate such influence, when the 
structures of these sugars are considered. It has previously been demonstrated 
that fructose is transported in a furanose ring form, while glucose and
•galactose are accepted as pyranose rings (Colville et a l ,  1993a). With this in 
mind, it is interesting to speculate as to which groups of these substrates helix 7 
binds to.
The major difference in the binding of fructose at the exofacial site, 
when compared to the binding of D-glucose, is probably the lack of hydrogen 
bonding betw een the C-1 position of fructose and the transporter. A 
comparison of helix 7 amino acid sequences from GLUTs 1, 2, 3, 4 and 5 is 
shown in Figure 4.12. From this it can be seen that there are many conserved 
residues in this helix throughout the family of isoforms. Notably, there is a 
QLS motif present in GLUTs 1, 3 and 4: these isoforms all transport deGlc with 
high affinity. This motif is absent in those transporters capable of fructose 
transport such as GLUT2 and GLUT5, and the fructose transporter of 
Trypanosoma bruceii (Fry et a l ,  1993) (section 3.1.5). The QLS motif may 
therefore be important in the interaction between the transporter and the C-1
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position of glucopyranose. This interaction w ould probably involve the 
glutamine in the QLS motif, as this residue is polar and can act as a hydrogen 
donor or a hydrogen acceptor. In the equivalent residues of GLUT2- HVA, 
histidine can act as a hydrogen acceptor at neutral pH. It is tem pting to 
speculate that this residue may be the site of hydrogen bonding between the 
oxygen of fructose and helix 7,
Recent advances in this laboratory indicate that this HVA motif in 
GLUT2 is the defining m otif in fructose recognition (M.J.Scatter and 
G.W.Gould, unpublished data). The substitution of the GLUT2 HVA motif 
into the helix 7 of a GLUTS transporter results in the ability of that molecule to 
accept fructose. Similarly, substitution of the GLUTS QLS motif into a GLUT2 
transporter abolishes fructose transport. It is not know n at this point if 
substitution of the QLS motif into the GLUT2 transporter results in high 
affinity glucose transport.
4.6.3 Problems w ith this Study.
This study has been successful in that it has indicated regions of 
importance in the structural basis of isoform specific kinetics and substrate 
selectivity. This has enabled other workers in this group to search for specific 
motifs which may be involved in the param eters mentioned above. This 
approach has proved to be successful in determining the precise sequence 
within helix 7 which is responsible for fructose recognition in the GLUT2 
isoform, and for high affinity glucose transport in the GLUTS isoform. With 
regard to the other regions that are indicated in this study to be of influence in 
substrate transport kinetics and selectivity, it is extremely unfortunate that 
expression of the entire GLUT2 series was not achieved, and that a more 
comprehensive investigation of the rem aining chimeras was hindered by 
problems with the expression system.
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The reasons for problem s w ith expression of the GLUT2 series 
constructs were not pursued in this study due to time restraints. However, 
several attempts have been made by other workers in this laboratory to re­
check the sequence of the problematic constructs, to re-make them, and to 
subclone them  into another vector (see Lisa Porter, PhD Thesis, to be 
submitted 1997, University of Glasgow). None of these procedures have been 
successful in locating or correcting the structural error which results in non­
expression. It may be possible that it is specifically the GLUT2 N-terminus 
which is not efficiently processed when placed in the context of a chimeric 
molecule. Recently, it has been reported by Andreas Buchs (Gwyn Gould 
-personal communication), that from a panel of fourteen GLUT2 chimeric 
constructs, only a few were expressed successfully. Therefore, to overcome this 
problem it was decided that swapping single helices or bundles of helices 
within a GLUT2 molecule (or a GLUTS molecule) would be more successful, 
however this approach proved to be technically difficult (Chapter 5).
General problems with the oocyte expression system impeded detailed 
investigation of the GLUTS series chimeras. Seasonal variation of oocyte 
batches, in addition to infection and animal housing problems, resulted in this 
system being extremely unreliable with regard to ease of use, and in terms of 
reproducibility of the data generated from it. Future solutions to this problem 
can only be solved by subcloning of the chimeric constructs into vectors 
suitable for use in other cell systems. Expression of these constructs in another 
cell line will enable us to perform more detailed inhibition and competition 
studies, to further understand the relationship between the substrate binding 
requirements of GLUTs 2 and 3 and the regions responsible for these isoform 
specific differences. This is work which is underway in this laboratory.
Although several methods have been investigated, it has not been 
possible in this laboratory, to obtain clean plasma membrane fractions in order 
to determine the amount of transporter protein at the oocyte surface (see Lisa
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Porter, PhD Thesis to be submitted 1997, University of Glasgow). Therefore, the 
use of another cell line to express these constructs, where the membrane 
fractionation procedures are simpler and more reproducible, will allow us to 
determine transporter numbers at the cell surface, which will subsequently 
enable the calculation of transporter turnover numbers. The measurement of 
this parameter is of key importance in any kinetic study. It not only has been 
absent in this study, but a general, reproducible, and comparable method for 
determining this parameter has been absent in all oocyte work to date.
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CHAPTER 5.
Construction of Second Generation 
GLUT2/GLUT3 Chimeric Transporters.
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5.1 Introduction
In an effort to test the model proposed in the last section (Chapter 4, 
sections 4.6.1-4.6.2), it was decided to construct a second panel of chimeras 
(referred to forthwith as the second generation chimeras), in which sequence 
regions proposed to be involved in substrate binding were swapped between 
GLUT2 and GLUTS. The diagram in Figure 5.1 shows the junction points of 
the sequence swaps in these constructs. As before, it was planned that mirror 
image constructs should be made.
It was thought that these constructs could be used to test various aspects 
of the model proposed in section 4.6: specifically, the helix 7 swap would: (1) 
test the hypothesis that helix 7 is solely responsible for fructose recognition in 
GLUT2 and for the isoform specific kinetics of galactose transport, (2) provide 
information on the nature and extent of influence of the N-terminal half of 
the transporter molecule, and (3) would indirectly test the proposal that the 
H7Gnd-hI10end sequence also influences the affinity of maltose binding.
It was proposed that the H7end“H10end sequence swap would: (1) 
specifically measure the extent of the involvement of this sequence in the 
exofacial b inding  of substrates -particularly of m altose and other C-4 
substituted glucose analogues, and (2) indirectly test the proposal that it is helix 
7 which is solely essential for fructose recognition by GLUT2, and the extent of 
the involvement of this sequence in the transport kinetics D-galactose by both 
isoforms.
The H10-H12 swap would: (1) test the proposal that sequences which lie 
beyond helix 10 (i.e. the cytoplasmic C-terminal tail) exert no effect on the 
substrate selection mechanism or on the transport kinetics of the two isoforms, 
and (2) act as a control for the mutagenesis procedure to show that the 
insertion of non-essential sequences did not produce any non-specific change 
in kinetic behaviour of each of these isoforms.
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Additionally, it was hoped that expression of the GLUT2 series of these 
second generation constructs, would be less problematic than the first generation 
constructs (section 4.6.3). The foreign sequences in these new constructs would be 
internal, not involving the N- and C- termini. So it is possible that the targeting to, 
and insertion into the membrane of the oocyte might be more efficient.
5.2 Methods.
5.2.1 PCR- Primary Reactions.
To produce these constructs, a PCR based approach was used which was a 
modified version of a method described by Katagiri et al (Katagiri et al, 1992). This 
method, outlined in Figure 5.2, involved the use of the first generation chimeric 
cDNAs as templates for the amplification of primary PCR products, which were 
then used in subsequent secondary reactions.
Oligonucleotide primers (37-6Tmers) were constructed for use in the 
amplification of PCR fragment corresponding to the N-terminal half of the 
chimeric molecule. The sequences of all oligonucleotide primers are shown in 
Table 5.1. These primers corresponded to the positive strand of the template DNA 
sequence, and bound to the region of sequence next to the appropriate junction 
point for each construct. Note that the template used in the construction of the 
primary product "a", i.e. the fragment which corresponds to the N-terminal part of 
the protein, was the first generation chimera. The junction points are also outlined 
in Figure 5.1, and the primer binding regions are given in Table 5.1. Additionally, 
the primers were designed with "tails" -extra stretches of sequence corresponding 
to the positive strand of the other isoform cDNA (e.g. if the primer bound to a 
sequence of GLUTS on the template cDNA, the "tail" would be composed of 
GLUT2 sequence).
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These oligonucleotides were com plim entary in sequence to other 
oligonucleotides (also 37-61'mers) w hich were designed for use in the 
amplification of the PCR fragment corresponding to the C-terminal half of the 
protein. These primers corresponded to the negative strand of the template 
sequence. The templates used for the construction of primary product "b" i.e. 
those which would correspond to the C-terminal portion of the chimeric 
protein, were wild type cDNA. GLUT2 encoded by pHTL217 was used as a 
template for the construction of the GLUT2 series, and GLUTS encoded by 
pSPGT3 was used for the construction of the GLUTS series.
The products of the primary PCR reactions were purified by agarose gel 
electrophoresis, the bands of appropriate size excised and the DNA recovered 
and purified by procedures described (section 2.6.4-2.6.6). For the helix 7 
chimeras, the sizes of the primary PCR products "a" and "b" were 975bps and 
725bps respectively. Likewise, for those with the helix 8 to helix 10 swaps the 
sizes of the fragments were 1170bps and 430bps, and for those with the helix 10 
to helix 12 swaps, 1350bps and 250bps. Purified primary products for the GLUT2 
mutants are shown on an agarose gel in Figure 5.3.
5.2.2 PCR- Secondary Reactions.
Primary PCR products "a" and "b" served as templates for the secondary 
reactions. See Figure 5.2. The last 30 bases of the 3' end of primary product "a" 
were complimentary to the last 30 bases of the 3' end of primary product "b". 
Upon the initial melt in the secondary PCR reaction, these overlapping ends 
anneal. Only external primers are added to the secondary reaction. These are 
complimentary to the 5' ends of the negative strand of the primary PCR 
fragments. After the initial melt and subsequent cooling the primary strands 
have annealed as described and the external primers have annealed as shown 
in the diagram. Each strand of this complex acts as a prim er for extension of
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the opposite strand, resulting in the amplification of a full length chimeric 
construct. After a few cycles of PCR a large proportion of the primary fragment 
strands will have annealed and been extended to form full length constructs. 
These serve as templates for the binding and extension of the external primers 
in subsequent rounds of PCR. This results in the amplification of the full 
length chimeric construct.
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5.2.3 Vector and Cloning Procedure.
The cDNAs encoding each of the different glucose transporter isoforms 
have been cloned into several vectors for use in various expression systems. The 
vector pSP64T has been developed for expression of proteins in the Xenoptis 
oocyte system. Each of the GLUT cDNA’s have been cloned individually into the 
multiple cloning sites of pSP64T (Kayano et ah, 1990).
This vector contains two regions of untranslated sequence (UTR's) from the 
Xenopus p-globin gene. These sequences flank the cDNA open reading frame 
(ORE). The purpose of the UTR's is to aid recognition of in vitro transcribed mRNA 
by the Xenopus ribosome. This is thought to increase the efficiency of translation. 
The UTR's are also believed to further increase the efficiency of translation by 
increasing the stability of the mRNA in the cytosol of the oocyte, and thus 
prolonging the half life of the message (Kayano et al, 1990).
Transcription of the coding region is driven by the powerful SP6 promoter. 
SP6 polymerase is commercially available. The SP64T vector encodes an ampiciUin 
resistance gene for use in screening of positive clones. The backbone of this vector 
was obtained by digestion of the plasmid pSPGT4 with Sal I (Figure 2.1). Plasmid 
pSPGT4 has the cDNA of GLUT4 cloned into the pSP64T between the 5' and the 3' 
UTR's. Sal I restriction of this vector released both the GLUT4 coding sequence 
and a 200 base pair sequence which is part of the 3' UTR. The PCR fragments were 
cloned into the Sal I site (Figure 2.3). It was assumed that the loss of the 3’ UTR 
sequence would not have a significant effect on the integrity of in vitro transcribed 
mRNA.
Ligations, transformations, and screening of colonies were performed as 
described (sections 2.5.3-2.5.S).
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5.3 Results.
5.3.1 Results Using Taq  DNA Polymerase.
Taq polymerase was the first enzyme that was used in the attempt to 
construct these mutants. This enzyme is commercially available. It is produced 
by the archaebacterium Thermus aquaticus, which was originally isolated from 
hot springs, explaining why the polymerase displays extreme heat resistance. 
This property of heat resistance is exploited in PCR.
It was found that this enzyme produced high yields of primary product 
and secondary product for both series of chimeras. These are shown in Figures
5.3 and 5.4. The secondary products were restricted with Sal I and were cloned 
into the pSPCT vector backbone (Figure 2.3). Figure 5.4 shows samples of 
ligated construct and "empty" re-ligated vector as analysed by agarose gel 
electrophoresis. The ligated constructs were used to transform DH5a E.coli 
cells as described (section 2.5.7), and the plasmid DNA extracted from the 
resu lting  colonies and sequenced as described (sections 2.7.1-2.7.9). 
Oligonucleotides used to sequence the mutants are shown in Table 5.2.
The efficiency of production of colonies with the desired product was 
never 100%. The cloning of the secondary PCR fragm ents into the vector 
backbone was not directional and therefore some of the colonies recovered 
from transformation contained the vector with the coding sequence in the 
wrong orientation. These were not selected for sequencing. Often the colonies 
recovered from the transformation contained re-ligated vector alone.
Several clones were selected for each chimeric construct which, from 
agarose gel and restriction digest analysis were thought to be positive for the 
plasmid with the insert in the correct orientation. Sequencing of these showed 
that the PCR mutagenesis approach had been successful in producing each of 
the desired domain swaps. However, in each clone that was analysed the
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fidelity of tfie sequence was compromised. It was found that Taq polymerase 
misincorporated bases at a rate of at least two mismatches per one thousand 
bases. Often in many of the clones this rate was higher.
At this point it was decided that the procedure would benefit from the 
use of newly commercially available polymerases- Pfu  and Vent, both of which 
have an exonuclease proof reading activity.
5.3.2 Results Using Pfu  DNA Polymerase.
This enzyme was used in an attem pt to overcome the infidelity 
problem s encountered w ith  Taq polymerase. Pfu polym erase is just as 
thermostable as Taq, but has a higher fidelity of copying than Taq due to a 3' to 
5' exonuclease proof-reading activity.
The reaction conditions used initially with this enzyme were identical 
to those used in a Taq reaction. However, the polymerase produced little or no 
primary PCR products with these conditions, and a large amount of primer- 
dimer extension product was produced. Primer-dimer extensions occur when 
the primers anneal to each other instead of to the template. This can occur if 
the annealing temperature is not correct, or if the primer anneal to themselves 
and begin to extend before the initial melt. To reduce the chance of this 
occurring the "Hot Start" PCR technique was employed (section 2.6.3). In this 
method the reaction mix is kept on ice until all the reagents have been added 
-with the exception of the polymerase. The PCR tubes are quickly transferred to 
the thermal cycler and an initial melt of %°C for 10 mins is started -without 
the polymerase. After the initial melt all the strands of double helix DNA will 
have separated. On cooling down to the annealing temperature, the primers 
will anneal preferentially to the template rather than to themselves or to 
contam inating DNA fragm ents -events w hich w ould  only occur at 
tem peratures low er than the annealing tem perature. A dditionally, this
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technique is thought to prolong the activity of the enzyme, since the 
proceeding melts after the enzyme has been added only last for a minute.
The yields of primary product were increased by the use of the hot start 
technique, but the yields of secondary PCR product remained extremely low. it 
was not possible to produce sufficient secondary PCR product for cloning into 
the pSPGT backbone. This problem was exacerbated by the fact that Pfu 
polymerase produces blunt-ended PCR fragments. Prior to ligation of the 
secondary PCR product to the vector backbone, the fragment was digested with 
Sal l Xo  produce sticky overhangs that would be complimentary in sequence to 
the overhangs in the vector. However, for efficient cutting, Sal I requires a 
longer stretch of DNA sequence at each side of the restriction sequence than 
would be produced by a polymerase which produces blunt ended fragments. 
Subsequently, in an attempt to overcome the problem of low product yield, 
Vent polymerase was used.
5.3.3 Results Using Vent DNA Polymerase.
Vent polymerase also has a 3' to 5’ exonuclease proof-reading activity, 
and therefore has a higher fidelity of copying than Taq polymerase. The 
manufacturers of this commercially available enzyme also claim that Vent 
produces higher yields of product than Pfu. For this reason it was decided to 
try Vent as an alternative to Pfu  to overcome the problems of low yield.
The PCR parameters used with Vent were changed according to the 
manufacturers recommendations (section 2.6.3c), and hot start PCR was also 
performed. In using this enzyme, it was important that the extension time was 
strictly controlled to one minute per kilobase of sequence, in order that the 
exonuclease activity of this enzyme did not digest the ends of synthesised 
fragm ents and destroy the restriction sites, and also the regions of 
complimentary sequence in the primary fragments.
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The yield of both primary and secondary PCR products gained with Vent 
was generally much liigher than that obtained using Pfu. polymerase. Ligating 
the Sal I cut secondary PCR product was difficult, as in the case of the Pfu- 
produced fragments, possibly because Vent also produces blunt ended 
fragments which are difficult to restrict with Sal I.
Several clones from the GLUTS series were chosen initially to screen. 
The DNA extracted and purified from these clones was subjected to restriction 
digest and agarose gel analysis, the results of which suggested that the colonies 
were transformants. However sequence analysis showed that the mutagenesis 
procedure had not been successful. The sequence that was cloned into the 
vector was template sequence. In all the clones analysed, the template sequence 
that was carried over was always the template from the production of the 
primary fragment "a". The reason for this is not known since theoretically 
carry-over of template from the primary reaction is not possible.
This approach was not pu rsued  due to time restrictions. The 
amplification of secondary products and the ligation of the fragments produced 
in this procedure proved consistently problem atic. Reasons for these 
difficulties may lie in the fact that the procedure requires the use of template 
that is the product of several previous rounds of PCR (i.e. the templates for the 
prim ary fragment "a"), and that Sal I is not a good choice of restriction 
sequence for the end primers.
204
Figure 5.1
Diagram of Second Generation GLUT2/ GLUT3 Chimeric Constructs.
This diagram  shows a plan of the second generation GLUT2/GLUTS 
chimeric constructs. The areas shown in black denote GLUT2 sequence, and the 
red regions GLUTS sequence. Where the notation is GLUT2 H7, the construct is a 
GLUT2 molecule with a GLUTS helix 7. Where the notation is GLUT2 H8-H10, 
the construct is a GLUT2 molecule with a GLUTS sequence region from the start 
of helix 8 to the end of helix 10. Residue numbers of sequence regions of GLUTs 2 
and 3 are shown above the corresponding junction points.
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Figure 5.1
Diagram of Second Generation GLUT2/ GLUTS Chimeric Constructs.
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1-290
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GLUTS sequ en ce
389-488 483-524
GLUT2 H7
GLUTS H7
GLUT2 H 8-H 10
GLUTS H 8-H 10
G LUT2 H 10-H 12
423-482 488-496
GLUTS H 10-H 12
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Figure 5.2.
Recom binant PCR M ethod Used to Construct Second G eneration Chimeric 
Transporters.
This method was first described by Katagiri et al 1992, and it is similar to 
that used in the construction of the first generation chimeras. In this case 
however, the first generation chimeras themselves are used as templates for the 
generation of primary products "a", i.e. the fragments which correspond to the N- 
terminal portion of the resulting chimeric molecule. The template used for the 
generation of primary fragments "b" (which correspond to the C-terminal portion 
of the protein in the resulting chimeric protein) are wild type GLUT2 (for the 
GLUT2 series construction), or GLUTS (for the GLUTS series construction).
This diagram  describes the construction of the GLUT2-H7 chimera (a 
GLUT2 molecule in which the helix 7 sequence is replaced with that of GLUTS), 
but this general method was also employed to make the other constructs.
The internal primer used to amplify primary fragment "a" for this mutant 
was designed to bind to the GLUTS helix 7 sequence of the first generation 
chimera G2(7St). This prim er also had a tail sequence which was GLUT2 in 
sequence. Tliis would overlap with the GLUT2 sequence of primary product "b". 
Primary product "b" was amplified from GLUT2 cDNA, using a prim er which 
bound to a region adjacent to helix 7, but which had a tail composed of GLUTS 
sequence of helix 7. This sequence would overlap with the GLUTS helix 7 
sequence in primary product "a".
These primary products acted as templates in the secondary PCR reaction. 
After annealing, the overlapping lengths of primary sequence were extended to 
produce a full length chimeric construct, which was in turn amplified further in 
subsequent rounds of PGR. The GLUT2 external primers used in this reaction 
were designed with Sal 1 restriction sites. This allowed restriction of the full 
length PCR product to allow cloning into a S a i l  restricted vector (Figure 2.S).
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Figure 5.2 Recombinant PCR Method Used to Construct Second Generation 
Chimeric Transporters.
Templates for Primary 
PCR Reactions.
GLUT2sequence GLUT3sequence
/Chimera G2(7St) \
helix 7 helix 7 GLUT2cDNA
Generation of Primary PCR Fragments. 
___________ 3" 5' 3'
G2 Start
\ _
3'
internal primer
internal primer 
5' 3' ^
G2End
5'
helix 7 helix 7
Primary product "a' Primary product "b'
V helix 7 \  ^ helix 7overlapping sequences
G2 Start
GUJT2
Sal I site
♦
helix 7I
G2End
GIUT3 GLUT2
Primary fragments 
"a" and "b" act as 
templates for 
generation of 
secondary full 
length PCR product
S al I site
Sa 11 restriction and subsequent ligation into vector
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Figure 5.3
Agarose Gel of Primary Taq PCR Products.
Agarose gel showing the primary PCR fragments of the GLUT2 series of 
chimeric constructs. These fragments were run on a 1.6% agarose gel alongside 
BstE cut X DNA markers (not shown). The samples on the gel are as follows:
Lane Sample Size
1 GLUT2-H7 "a" 975bp
2 GLUT2-H8-10 "a" 1170bp
3 GLUT2-H10-12 "a" 1350bp
4 GLUT2-H7 "b" 725bp
5 GLUT2-H8-10 "b" 430bp
6 GLUT2-H10-12 "b" 250bp
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Figure 5.3
Agarose Gel of Primary Taq PCR Fragments.
Lane 1 2 3 4 5 6
3675bps
23231929
1371
1264
702
224
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Figure 5.4
Agarose Gel of Secondary PCR Fragments, Unligated Vector and Ligated Chimeric
Constructs.
This diagram shows a 1% agarose gel with samples of vector backbone (see 
Figure 2.3) which is self-ligated (Lane 2), uncloned secondary PCR product (Lane 
3), and cloned secondary PCR product (Lane 4). BsiE 11 cut lambda DNA markers 
are also shown on the gel (Lane 1).
Transformed DH5a colonies which contained cloned PCR product were 
screened by running samples of minipreped plasmid DNA alongside self-ligated 
vector. Clones which contained vector + ligated PCR fragment were apparent by 
size.
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Figure 5.4
Agarose Gel of Secondary PCR Fragments, Unligated Vector and Ligated 
Chimeric Construct.
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Table 5.2
Sequencing Primers.
This table shows a list of the oligonucleotide primers which were used to 
sequence the second generation chimeric constructs. Oligonucleotide sequences 
are written 5’ to 3'. Primers designated "T" were of sense (top) strand sequence, 
and therefore bound to the antisense strand of the cDNA, and those designated 
"B" corresponded to the antisense (bottom) sequence, and therefore bound to the 
sense strand of the cDNA.
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Table 5.2
Sequencing Primers. 
GLUT2 Primers.
02 9T TCCOCACAAOACCrO
02 7T ocAOciocrcAAcr
02 6T 111 CATCAOCrOOCC
02 5T OAAOAAOCATCOAOT
02 4T ATTOOAATOAOTOOO
02 3T ccACOTCCTocrocr
02 2B AATTTCCTCAAAAOA
02 3B AOCAOCAOOCOTOO
02 4B CCCACTCATTCCAAT
02 5B ACrCOATOCTTCTTC
02 6B OOCCAOCTOATOAAA
02 7B AAAOCTOOAATACAO
GLUT3 Primers.
03 7T TCACCCCTAOATCTTTC
03 6T CTCTO ATA ITT OCCA
03 5T OACTOTOTAAAOTAO
03 4T CCAOATTTTT OCTCA
03 3T ATCTATOCCACCATC
03 2T ACTOOACCTCCAACT
03 IB OOOAOAOOTOOCTTT
1535 CAOTCATOAOCOOT
03 3B OTAOCTOOACACrCT
03 4B TOAOCAAAAATCTOO
03 5B CTACITT ACACAOTC
03 6B TOOCAAATATCAOAO
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CHAPTER 6
Kinetic Analysis of GLUT3 Helix 8 Mutants.
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6.1 Introduction.
In Chapter 4, a working model was proposed for substrate recognition by 
GLUT2 and GLUT3 (section 4.6). In this model, helix 7 was proposed to play an 
im portant role in substrate selection and in determ ining the kinetics of 
transport. Furthermore, a region between the end of helix 7 and the end of 
helix 10 was shown to influence the affinity of the exofacial binding site in 
GLUT2 and GLUT3 for maltose, and it is was speculated that, in the exofacial 
binding site, this region may interact with the C-4 hydroxyl of glucose.
It has been proposed that five of the twelve putative transmembrane 
regions are m oderately amphipathic: these are helices 3, 5, 7 ,8 and 11 
(Mueckier, 1985). It was hypothesised that these helices may form an aqueous 
channel through which glucose could move during the transport process. 
Recent evidence suggests however, that the C-term inal portion of the 
transporter is directly involved in the formation of the exofacial and the 
endofacial binding sites, while the N-terminal half may provide a packing 
surface which allows the correct aligmnent of the helices of the C-terminal half 
(Cope pf ah, 1994) (section 1.8). Therefore, the helices in the C-terminal half of 
the transporter which are moderately amphipathic are helices 7, 8 and 11. 
Cytochalasin B is thought to bind to a region between helices 10 and 11 
(Holman & Rees, 1987), and ATB-BMPA is thought to bind to a region between 
helices 7 and 8. (Davies et al., 1991) (section 1.6).
Helices 7 and 8 contain many conserved polar residues (Figure 1.2). 
Several of these have been shown by site directed mutagenesis studies to be 
important in the formation of the exofacial and endofacial binding sites and in 
the conformational change of the protein which is associated with transport 
(Table 6.1).
On the basis of these observations it was decided that helices 7 & 8 
would be excellent targets for site directed mutagenesis studies. This chapter
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deals with the study of the eighth helix of GLUTS. GLUT3 was chosen for this 
study for the following reasons. (1) Most site directed mutagenesis studies have 
focused on GLUTl as a template for mutagenesis, and so there is a lack of 
information on the GLUT3 isoform. (2) The study of GLUT3 may serve to 
build on the working model we have proposed for substrate selection by 
GLUT2 and GLUT3. (3) The information collected from the study of this helix 
in this isoform may be directly compared to data from previous GLUTl helix 8 
studies.
Additionally, it may be possible to use the substrate analogue approach 
to investigate the exact nature of the effect (if any) on each of the substitutions. 
This could provide information on the nature of substrate binding in terms of 
which carbon position binds to which residue, either at the exofacial binding 
site, at the endofacial binding site, or within the channel.
6.2,1 Use of Site Directed Mutagenesis.
Site directed mutagenesis is a powerful tool in the structural dissection 
of proteins. Studies have been conducted on various regions of the transporter 
structure throughout both the N -term inal and C-term inal halves of the 
p ro te in , w ith in  the p u ta tiv e  transm em brane helices and in the 
extramembranous loops. The majority of this work has used GLUTl as a 
template for site directed mutagenesis, however there are some studies on the 
other isoforms. GLUT4 is often the focus of this type of study: however in this 
case the technique has been employed in attempts to identify residues of 
importance in targeting and translocation of this isoform  to the plasma 
membrane in response to insulin.
Table 6.1 summarises all the information derived from site directed 
mutagenesis studies (i.e. single amino acid substitution studies) to date, 
including those mutations which were found to have no effect on structure
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and transport activity. The expression system used for each m utant transporter 
and details of the specific effects of the mutation are shown in this table, along 
w ith references for the publication of each study. Some of the im portant 
findings of this work are discussed below.
6.2.2 Substitution of Conserved Polar Residues.
As discussed previously, helices 3, 5, 7, 8 and 11 are predicted to be 
moderately amphipathic and may be able to form the aqueous channel 
through which glucose will pass during transport. There are many conserved 
residues distributed throughout these helices. These include serine, threonine, 
asparagine, glutamine and tyrosine residues, all of which have side chains 
capable of interaction with glucose via hydrogen bonding.
In an effort to map the residues involved in the formation of the 
exofacial and endofacial binding sites, and in the formation of the channel, 
several of these conserved polar residues have been substituted in the GLUTl 
molecule, and parameters such as ATB-BMPA binding examined.
ATB-BMPA has been shown to bind to the exofacial binding site, and it 
has been shown to photolabel a region between helices 7 and 8 (Davies et aL, 
1991) (section 1.6). The site of binding and the site of photolabelling need not be 
identical, but it is likely that they are in close proximity.
Three conserved polar residues in helices 7 and 8 of GLUTl have been 
substituted with non polar residues. The substitutions were Asn^®^-> Ile^ss 
and Gln282-> Leu^^z helix 7 and Asn3t^-> Ile^i^ in helix 8 (Hashiramoto et 
aL, 1992) (Table 6.1). The substitution of Asn^^s and Gln282 resulted in a 50% 
reduction in deGlc transport activity in comparison to wild type GLUTl deGlc 
transport. The endofacial binding site was not disrupted by any of the three 
substitutions, as each of these mutants could be labelled with cytochalasin B at 
levels comparable to wild type GLUTl. However, the Gln282 substitution
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resulted in disruption of the exofacial binding site: this m utant displayed a 
severe loss of ability to bind ATB-BMPA, and was labelled at a level which was 
only 5% that of wild type GLUTl. The Ki for 4,6-O-ethylidene-D-glucose 
inhibition of deGlc transport by the Gln^ss m utant was 10-fold higher 
compared with wild type GLUTl. Since this compound interacts competitively 
with the exofacial binding site, this is further evidence that this substitution 
results in disruption of the exofacial binding site. Hashirimoto et al concluded 
that Gln282 (located in helix 7) is part of, or very near to, the exofacial binding 
site.
Other conserved polar residues in GLUTl have been substituted: Asn^^^ 
(helix 3), Gln^^i (helix 5), Tyr^92 (helix 7) and Tyr^93 (helix 7) have been 
replaced sequentially with hydrophobic residues (Mueckier, 1994a). These are 
shown in Table 6.1. In this study, none of the substitutions had any effect on 
transport activity, w ith the exception of Gln^^^. The non-conservative 
substitution of this residue with leucine produced a 50-fold decrease in the 
transport of deGlc w ith comparison to wild type GLUTl. However if this 
residue was substituted with asparagine which, like glutamine also has a polar 
side chain, the transport activity was reduced by only 10-fold. When the Gln^^i 
->Asn m utant was further analysed, it was found that this decrease in 
transport activity was due not to a decrease in the Km of the transporter for 
zero-trans  deGlc uptake. Rather the effect was due to a decrease in turnover 
number by 7.5-fold with comparison to wild type GLUTl. However, it was also 
noted that the Kj for 4,6-O-ethylidene-D-glucose inhibition of deGlc transport 
was also increased by 18-fold with respect to wild type GLUTl. Based on these 
results it was suggested that GW ^i may comprise part of the exofacial binding 
site, and may also be important in the ability of the molecule to undergo the 
conformational change associated w ith transport. The im portance of this 
residue in the conformational change mechanism was specifically suggested by 
the decreased turnover number of the mutant.
220
...I
In marked contrast with the above study, Mori et al have shown that 
substitution of Tyr293 with He results in a drastic reduction in V^ax lor deGlc 
transport (Mori et aL, 1994). Also, this reduction in transporter activity is 
associated with a complete loss of cytochalasin B binding, and photolabeling. 
Mori et al have interpreted this to indicate that the Tyr^^s „> pg locks the 
transporter in an outward-facing conformation. Furthermore, Mori et al have 
observed that this m utant can still bind non-transported C-4 and C-6 
substituted hexose analogues, but cannot catalyse transport. From this, they 
have concluded that Tyr^93 jxiay be involved in closing the exofacial binding 
site of the transporter around the C-4 and C-6 of D-glucose (see also section 
4.6.Id  for discussion of the possible involvement of the C-4 hydroxyl in 
exofacial binding).
Tyrosine residues Tyr^s (helix 1), Tyr^^s (helix 3), Tyr^92 (helix 7), Tyr^o^ 
(helix 8) and Tyr^32 (helix 12) are conserved in all the GLUT isoforms (residue 
numbers correspond to those of GLUTl). These residues in GLUT4 have all 
been individually replaced with phenylalanine and expressed in LTK cells 
(Wandel et aL, 1994). Transient expression levels and subcellular distribution 
were found to be comparable to wild type GLUT4. Transport activity of the 
Tyri43 and Tyr^92 mutants was decreased, as was the ability of these constructs 
to be photolabelled with cytochalasin B. The Tyr^^s mutant also displayed loss 
of ability to be photolabelled by cytochalasin B but showed no decrease in 
transport activity. Additionally, the exofacial binding of 4,6-O-ethylidene-D- 
glucose and ATB-BMPA labelling were unaffected. Wandell et al concluded 
from this that Tyr^^s ^nd Tyr^^^ may be important transport catalysis by GLUT4 
and Tyr293 may be part of the cytochalasin B binding site.
Finally, a s p a r a g i n e ^ i s  m helix 11 of GLUTl was substituted with 
aspartate (Ishihara et aL, 1991). This substitution resulted in severely impaired 
transport activity. This was thought to be due to disruption of transporter
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structure, caused perhaps by the introduction of a negative charge into a 
membrane spanning helix.
6.2.3 Substitution of Conserved Tryptophan Residues.
Cytochalasin B has been shown to photolabel a tryptic fragment of 
GLUTl (residues 389-412), which comprises part of the loop connecting helix 10 
and helix 11, and part of helix 11 itself (Holman & Rees, 1987). Trp^ss (helix 10) 
and Trp4i2 (helix 11) are in proximity to this site, and have been implicated as 
being important in the transport mechanism because they have a fluorescence 
excitation w aveleng th  sim ilar to that requ ired  for cytochalasin B 
photoactivation (Inukai et aL, 1994).
It has been shown by several studies, that replacement of either of these 
tryptophan residues with either glycine or leucine, results in decreased deGlc 
or 3-0- me thy Iglu co s e transport, when expressed in either Xenopus  oocytes, 
CHO or COS-7 cells (Garcia et aL, 1992, Katagiri et aL, 1993, Schurman et aL, 
1993a). The substitution of residue Trp^io with leucine in GLUTS (Trp^^o is the 
GLUTS equivalent of Trp4i2 in GLUTl) also produces a decrease in deGlc 
transport activity (Burant & Bell, 1992b).
Although there is conflicting evidence, the substitution of Trp4^2  ^ has 
been reported by two groups to produce a significant decrease, but not abolition 
of cytochalasin B binding and photolabeling (Katagiri et aL, 1991, Schurman et 
ah, 1993b). These studies also show that substitution of Trp4i2 has no effect on 
labelling by ATB-BMPA or lAPS-forskolin. Additionally, it has been reported 
that the endofacial binding of the non-transported sugar analogue n-propyl-(l- 
D-glucoside, is significantly diminished by the Trp4i2 substitution (Katagiri et 
aL, 1991). These results suggest that the endofacial binding site is altered by this 
substitution. Also, since the decrease in transport activity reported in these 
studies is associated with a decrease in Vmax/ it is thought that the Trp4i2
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substitution alters the rate of alternation between the inward- and outward- 
facing conformations. The substitution of Trp^^^ in GLUTl has also been 
reported to decrease photolabelling by cytochalasin B, and by forskolin (Inukai 
et aL, 1994, Katagiri et aL, 1993, Schurman et aL, 1993a). These studies, which 
have collectively reported a role for both Trp4i2 and Trp^^s cytochalasin B 
photolabeling, led Inukai et al to replace both of these residues in GLUTl with 
leucine (Inukai et aL, 1994). The transport activity of this mutant is comparable 
to that displayed by the substitution of the single Trp4^2 a m utant 
constructed and expressed in the same system (Inukai et aL, 1994). However, 
with the double substitution, deGlc transport is abolished, and this is associated 
with a complete loss of cytochalasin B photolabelling. From this, Inukai et al 
have proposed a model in which cytochalasin B can photolabel the transporter 
at either Trp4i2 or Trp388.
6.2.4 Substitution of Conserved Proline Residues.
It has been reported that there is a high frequency of occurrence of 
proline residues in the transm em brane segments of integral membrane 
transport proteins (Brandi & Deber, 1986, Williamson, 1994). Prolines display a 
unique ability to produce not only large kinks, but localised movement within 
their helices via cis-trans isomérisation of the Xaa-Ÿxo peptide bond {Xaa ~ an 
unspecified amino acid). This has led to speculation that prolines may play a 
dynamic role in the molecular mechanism of the glucose transporters (Tamori 
et aL, 1994).
Based on this, the presence of several prolines in the highly conserved 
sequence FFEVGPGPIPW (residues 378-388 in helix 10 of GLUTl), was thought 
to be of significance, since studies utilising tryptophan fluorescence have 
indicated that helix 10 may be a highly mobile region (Pawagi & Deber, 1990) 
(section 1.5.1).
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Proline^®^ has been substitu ted w ith isoleucine and glycine, and 
expressed in CHO cells (Tamori et aL, 1994). The Pro38^->Gly substitution 
produced no detectable change in transport activity or in ligand binding. 
However, substitution of this residue by isoleucine resulted in severely 
reduced transport activity and a substantial loss of ATB-BMPA labelling. 
Labelling with cytochalasin B was comparable with wild type levels. Tamori et 
al concluded that disruption in the transport function was therefore due to 
disruption of the exofacial binding site. The substitution of this proline residue 
by glycine was thought to maintain the atomic arrangement of the conserved 
motif because the glycine did not interfere with the mobility of Pro^^s and 
Pro387, and thus conformational change was still possible. Therefore, it was 
suggested that Pro^ss was involved in mediating a conformational change in 
helix 10 which facilitated the packing of helices in an arrangement which 
either exposed the exofacial or the endofacial binding sites.
In a subsequent study however, all the prolines in helices 6 and 10 were 
individually replaced either by alanine or glycine. The three proline residues 
in helix 6 of GLUTl are conserved between all of the hum an glucose 
transporter isoforms, with the exception of GLUT2. Therefore, these helix 6 
residues were also substituted with the equivalent residue of GLUT2 (Wellner, 
1995). None of these substitutions were shown to have any effect on transport 
activity, but changing the helix 10 prolines with glutamine almost completely 
abolished deGlc transport. Since glutamine is a neutral, polar residue, it 
was inferred that the specific chemical structure of the substituted amino acid 
side chain was essential, but the unique property of proline for cis-trans 
isomérisation was not important.
It is still unknown however, if the collective role of these prolines is 
im portant in transporter function. Substitution of one proline residue for 
example might be adequately compensated for by neighbouring prolines. What 
is required to clarify this situation, is a study in which the collective role of
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prolines is investigated. Such a study might involve the substitution of several 
or all of the prolines in the same helix, or in the entire transporter molecule.
6.2.5 Substitution of Conserved Cysteine Residues.
It has been suggested that cysteines may play a role in transporter 
conformational stability (reviewed in Carruthers, 1990, Walmsley, 1988), and 
in the oligomerisation of glucose transporters (Herbert & Carruthers, 1992).
W ellner et al have made the following single cysteine substitutions in 
GLUTl: Cysi33->Ser, Cys20i->Gly, Cys207_>Ser, Cys347_>Ser, Cys42i->Arg and 
Cys429_>Ser (Wellner, 1994). None of these individual substitutions produced 
any change in transport activity. However, it was show n from these 
substitutions that Cys429 in the sixth external loop and Cys209 in the large 
cytoplasmic loop are those which are modified by various thiol-group reactive 
agents including p-chlorom ercuribenzenesulphonate (pCMBS) prior to 
transporter inactivation.
This finding that none of the individual cysteine substitutions produced 
any changes in on the catalytic turnover of GLUTl, questions the suggestions 
of Carruthers, Walmsley, and Herbert, that disulphide bridges are involved in 
GLUTl intramolecular stability, and transporter oligomerisation.
Further to the above study. Due et al have constructed a GLUTl 
transporter in which all six cysteines have been replaced. This mutant retains 
GLUTl kinetics, therefore, this study also argues against the involvement of 
disulphide bridges in transporter stability and oligomerisation. The initial 
purpose of constructing this cysteineless m utant was for use in structure 
function studies. The cysteineless construct can serve as a template for the 
réintroduction of cysteines into other sites of interest. These can be chemically 
m odified by sulphydryl-specific agents, thereby allowing the topological 
mapping, and assessment of the importance of the specific residues of interest.
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This technique is known as cysteine scanning mutagenesis. A modification of 
this technique, known as excimer fluorescence may also be applied to this 
cysteineless mutant. This technique has been extremely useful in the study of 
the tertiary structure of the lactose permease transporter of E.coli (section 6.6).
6.2.6 Residues in  Extramembranous Regions.
It has been shown that substitution of Asn^s in the large extracellular 
loop with either Asp, Trp or Gin abolishes N-linked glycosylation of GLUTl 
(Asano et aL, 1991). This subsequently leads to a 2-fold decrease in the affinity 
of the transporter for D-glucose as measured by Km- It is known that N-linked 
glycosidic groups can stabilise the tertiary structure of proteins and, in 
membrane proteins, can help to anchor the protein in the lipid environment 
by interaction w ith some lipid components (Stryer, 1988). W hether this 
happens with the GLUTs is not known. Certainly the glycosylation of GLUTl is 
important in its function since the affinity of the aglyco-GLUTl molecule for 
glucose is decreased 2-fold. This also leads us to question the effect of 
expression of the glucose transporters in heterologous systems such the 
X enopus  oocyte, where glycosylation may be altered.
6.2.7 The C-Terminal Cytoplasmic Tail.
The C-terminal cytoplasmic tail (residues 450-492) has been shown to be 
im portant in the ability of the molecule to undergo conformational change. 
The single-site alternating conformation model is shown in Figure 1.3. Oka et  
al have shown that removal of the last 37 amino acids from the C-terminal tail 
of GLUTl results in abolition of transport (Oka, 1990). This loss of transport is 
accompanied by a complete loss of ATB-BMPA binding, however cytochalasin 
B binding is not reduced. Oka et al have concluded form this, that the
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transporter is locked In an inward-facing conformation. Removal of the last 12 
amino acid residues from GLUTl does not produce this effect (Lin et ah, 1992).
In order to establish the minimum length of cytoplasmic tail needed for 
the molecule to achieve the conformational change necessary for transport, 
M uraoka et al have constructed a range of C-terminally deleted mutants 
(Muraoka, 1995). It has been shown that deletion of more than 24 amino acid 
residues from the cytoplasmic tail results in perturbation or abolition of 
transport activity. Furthermore, substitutions of residues Phe^^^ and Arg^66 
produced no significant effect. These highly conserved residues are at the 
seemingly critical positions of 26 and 27 residues from the end of the 
cytoplasmic tail, and yet their substitution produced no significant effect. 
Therefore, Muraoka et al have concluded that it is the length of the tail that is 
critical for function rather than the amino acid content.
Katagiri et al have also investigated the importance of the C-terminal 
tail in transporter function. With the observation that the C-terminal 
cytoplasmic tail of each of the isoforms was variant in size and sequence, 
Katagiri et al proposed that perhaps this region of the transporter was 
responsible in determining the specific kinetics of each isoform. The last 37 
amino acids of the cytoplasmic tail of GLUTl were replaced with those of 
GLUT2 (Katagiri et al., 1992). This chimeric construct was expressed in CHO 
cells and the Km for deGlc was found to be 3-fold higher than that of wild-type 
GLUTl. It was also shown that the Vmax of this construct was -4-fold higher 
than wild type GLUTl. From this, it was inferred that the C-terminal tail of 
GLUT2 was conferring "GLUT2-like" kinetic p roperties on the GLUTl 
molecule. However the Kd value of this m utant for cytochalasin B was 
unchanged with comparison to wild type GLUTl, suggesting that the changes 
in transport kinetics were brought about by changes in the turnover number. 
As was discussed in Chapter 4, additional problems with this study result in 
the need for caution in the interpretation of these results.
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The C-terminal cytoplasmic tail was again implicated as being important 
in transport kinetics in a study by Buchs et al (Buchs et ah, 1995). Replacement 
of the last 30 residues of the carboxy-terminus of GLUT4 with residues 
corresponding to GLUT2 resulted in a transporter which displayed an affinity 
for 3-O-methyl glucose which was intermediate between GLUT2 and GLUT4. 
Replacing a region from the start of the large intracellular loop of GLUT4 to 
the end of the carboxy-terminus with corresponding GLUT2 sequence resulted 
in transporter which displayed transport kinetics similar to GLUT2.
Further to the above study. Due et al replaced the terminal 29 amino 
acid residues of GLUTl with those of GLUT4 (Due et ah, 1995b). This had the 
effect of reducing the Vmax of the GLUTl molecule. Also replacing 29 or 73 
amino acid residues of GLUT4 with those of GLUTl increased V m ax lo between 
a third and a half of GLUTl wild type, although the affinity for substrate 
decreased by half. It was concluded from this that the C-terminal cytoplasmic 
tail was important in determining transporter function and the last 29 amino 
acid residues are im portant in determ ining the transporters affinity for 
substrate.
It has been shown that GLUTl exhibits the property of accelerated 
exchange i.e. the presence of substrate on the opposite (trans) side of the 
membrane stimulates the transport exchange rate by increasing the rate of 
reorientation of carrier from the inward-facing conformation to the outward- 
facing conformation (or vice versa). This phenomenon is also known as trans- 
acceleration (section 1.4.3.3). The GLUT4 isoform does not display this 
phenom enon. Dauterive et al have examined the role of the C-terminal 
cytoplasmic tail in this property of murine GLUTl (Dauterive et ah, 1996). In 
this study it was shown that replacement of the murine GLUT4 cytoplasmic 
tail onto a GLUTl molecule abolished the GLUTl property of accelerated 
exchange. This also had the effect of increasing turnover number by 1.6-fold. 
However, replacing the GLUT4 tail with that of GLUTl did not confer the
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accelerated exchange property of GLUTl onto the GLUT4 molecule. It did 
however, produce an increase the turnover number of this construct. The 
conclusion that these authors arrived at was that the GLUTl C-terminal 
cytoplasmic tail permits the accelerated exchange phenomenon, however it is 
not solely responsible for it, and it may require interaction with other 
sequences in the same GLUTl molecule. Also, from their findings Dauterive et 
al further concluded that the C-terminal tail may act to restrict the kinetics of 
each transporter isoform, since mutations in both the GLUTl and GLUT4 
isoforms can act to increase the transport activity of the transporter. Thus they 
have taken this to indicate that the C-terminal tail may be a target for 
physiological factors which may, through covalent modification or direct 
binding, regulate the intrinsic activity of both GLUTl and GLUT4. This aspect 
of transport is not discussed in this thesis, however evidence to suggest that 
the intrinsic activity of GLUTl and GLUT4 is regulated by cellular factors is 
(reviewed in Stephens, 1995).
This has not been observed in human chimeric transporters where the 
carboxy-terminus is exchanged between human GLUTl and human GLUT4, or 
between human-rat GLUT1-GLUT4 chimeras (Burant & Bell, 1992a, Pessino,
1991).
6.2.8 Naturally Occurring Mutations.
Two naturally occurring polymorphisms have been reported in the 
hum an GLUT2 gene (Tanizawa et al., 1994). These were Ile^i^ which had 
m utated to Thr, and VaB^z which had m utated to lie. The IleiiO->Thr 
polymorphism was found to occur at equal frequencies in patients with non­
in su lin  d ep en d en t d iabetes and  control subjects. The VaB^^->Ile 
polymorphism  was found in a female patient who developed gestational 
diabetes. However, the relevance of this genotype to the diabetic state of this
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patient was not clear, as she made a full recovery after her pregnancy was over. 
Therefore, to test the specific effects of these polym orphism s on GLUT2 
function, Mueckler et al have created the mutations individually in plasmid 
encoded GLUT2 and expressed these constructs in X en o p u s  oocytes (Mueckler, 
1994b). They have shown that the Ile->Thr mutation results in a transporter 
which exhibits identical behaviour to wild type GLUT2. However, the Val->Ile 
m utation abolishes deGlc transport. Although Val->Ile is a conservative 
substitution, the increased size of the isoleucine side chain relative to valine 
may act to block the transport of deGlc.
6,2.9 Transmembrane Helix 8 of GLUTl.
There have been several models proposed which describe the tertiary 
packing of the transmembrane helices of GLUTl. Baldwin has described two 
possible packing schemes whereby a channel is formed by the clustering 
together of helices 1, 5, 6, 7, 11 and 12, or alternatively by the clustering of 
helices 7, 8, 10 and 11 (Baldwin, 1993). Cope et al have suggested that the helices 
of the N-terminal half of the protein do not form the channel directly, but are 
necessary for the overall helix packing arrangem ent (Cope et ah, 1994). 
Recently, Zeng et al have utilised advances in protein structure prediction 
algorithms to build two models which describe the helical packing of GLUTl 
(Zeng et al., 1996). These are shown in Figure 1.9. It is interesting to note that in 
both these models helices 7, 8 and 11 line the channel. Zeng et al note in their 
study that three of the four critical residues that have been identified by 
mutagenesis studies all lie in the channel lining helices of both these models. 
Gln282 (Hashiramoto et ah, 1992) lies in helix 7, and Trp4t2 (Garcia et al., 1992, 
Inukai et ah, 1994, Katagiri et al., 1991, Schurman et al., 1993a) and AsM^s 
(Ishihara et al., 1991) both lie in helix 11.
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In view of the importance of helix 8 in the binding site of ATB-BMPA 
and as suggested by its place in these hypothetical models, it is surprising that 
no critical residues have so far been identified in this helix. In Chapter 4 a 
m odel for substrate selection and isoform specific transport kinetics was 
proposed in which a region between the end of helix 7 and the end of helix 10 
was suggested to be involved in determining the affinity of the exofacial 
binding site. It is possible that helix 8 is involved in this sequence.
There are several polar residues in this helix which are conserved 
throughout the GLUT family. These include a tyrosine, an asparagine and two 
threonines, three of these residues Thr^o®, Asn^^s^ Thr^i^ (GLUT3 residue 
numbers given) are predicted to lie on the polar face of the helix (Figures 6.1 
and 6.2). It was decided therefore to use a site directed mutagenesis approach to 
investigate this helix and to attempt to determine the residues important in 
binding site and channel formation. Previous studies have largely used GLUTl 
as a template for mutagenesis, therefore GLUT3 was chosen as a template in 
this mutagenesis study as there is a paucity of information available regarding 
this isoform. GLUT3 also has advantages over GLUT2 as a template for amino 
acid substitution: GLUT3 has a low value for deGlc zero-trans  entry into 
Xenoptis  oocytes, and therefore the kinetics of this isoform are easier to 
measure than the GLUT2 isoform which exhibits a very high Km value for this 
transport event. Cytochalasin B also inhibits uptake of deGlc by GLUT3 more 
efficiently than GLUT2. This will enable us to accurately investigate the effects 
of amino acid substitution on the endofacial binding site. Furthermore, 
immunoprécipitation of GLUT2 is not possible (Jordan & Holman, 1992). To 
quantitate the amount of this protein at the plasma membrane by comparative 
immunoblot procedures a standard protein sample of known concentration is 
required. A GLUT2 standard is not available: quantification of the protein 
concentration in such a standard would require equilibrium binding studies to 
be carried out using [^H] cytochalasin B in the presence and absence of D-
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glucose. The number of D-glucose sensitive cytochalasin B binding sites would 
be equivalent to the num ber of transporters in the sample, and protein 
concentration would be calculated from this by Scatchard analysis. This is not 
possible for GLUT2 as a consequence of the inability to immunoprecipitate it 
and the high value of GLUT2 for cytochalasin B. The Kd for cytochalasin B 
dissociation from GLUT2 is 1.7pm (Axelrod & Pilch, 1983), and the 
concentrations of cytochalasin B required to perform equilibrium binding 
studies on GLUT2 exceed the solubility limit of the ligand (~50pM).
6.3 Methods.
6.3.1 Alanine Scanning Mutagenesis.
It was decided to utilise an alanine scanning approach in the 
mutagenesis of helix 8. This approach involves the sequential replacement of 
each of the amino acid residues in the region of interest, in this case helix 8, 
alanine. Alanine is chosen because it is small in size and electro-neutral. Thus, 
mutating a particular residue to alanine effectively removes the side-chain 
properties of the original residue and leaves a "hole" in the helix. 
Additionally, no steric interference is introduced by alanine to confuse the 
results of the analysis, so that only the effect of removing the original residue 
of interest is measured. Since alanine is neutral, it is thought that it will not 
significantly disrupt either a polar or a non-polar environment. Glycine is 
smaller than alanine, and is also electo-neutral, however, it is thought that 
this residue could produce too much mobility in the a-helix.
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6.3.2 Construction and Subcloning of the Helix 8 Mutants.
Each individual amino acid residue in helix 8 of GLUTS was replaced by 
alanine. The construction of the mutants was carried out by Dr Michael J, 
Scatter (PhD Thesis, 1994, University of Glasgow). Two different site directed 
mutagenesis approaches were used: the first of which involved the use of 
Amersham's "RPN 1526 Oligonucleotide Directed Mutagenesis Kit". This kit is 
commercially available, and the m ethod used was exactly according to 
m anufacturers instructions. This m ethod was used to make eight of the 
nineteen mutants but was discarded in preference to the PGR based approach 
described in Figure 6.3, which proved to be significantly more efficient. This 
method is adapted from a method described by Katagiri et al (Katagiri et al.,
1992). The remaining eleven mutants were constructed using this approach. 
Similar problems were encountered with this procedure as those described in 
Chapter 5 in the construction of the second generation chimeras. These 
problems were mainly associated with the low fidelity of Taq polymerase, 
however, in this case they could be resolved with the dual approach of using 
proof-reading polymerases and by the restriction digest and subcloning of error 
free sequences into appropriate restricted sites of wild type GLUT3.
The mutant constructs were cloned into the pSPGT3 vector (Figure 2.3), 
and the sequence checked in both directions by automated sequencing (section 
2.7) for spurious mutations. (Further description of the mutagenesis and 
sub cloning procedures can be found in M.J.Seatter, PhD thesis, November 
1994, University of Glasgow.)
233
.i:
6.3.3 Expression of the Mutant Constructs in Xenopus Oocytes.
The m utant construct cDNAs were linearised with Xha I and used as 
templates for the in vitro transcription of cRNA (section 2.2). The cRNA was 
assessed for integrity and concentration by agarose gel analysis.
Due to the large number of oocytes needed to perform a K^ n estimation, 
only three or four mutants were individually injected into oocytes taken from 
the same oocyte batch, i.e. from the same toad. However, each estimation of 
Kjyi for m utant injected oocytes was accompanied at least once, by an 
estimation for wild type GLUTS injected oocytes.
6.4 Results.
All of the helix 8 mutants were found to be successfully expressed as 
indicated by their ability to transport deGlc. Relative numbers of m utant and 
wild type transporters at the plasma membrane were not determined (section 
4.6.3), and so it is not possible to say that the targeting efficiency of each mutant 
was similar to wild type. However, typical transport rates for the uptake of 
O.lmM deGlc were in the range of 2-9 pm oles/m in/oocyte. This was 
comparable to wild type, and was also much higher than the non-injected 
control rates which were typically 0.2-0.7 pmoles/min/oocyte.
An estimation of the value for each of the nineteen m utants for 
deGlc has been obtained. Figure 6.4 shows a Lineweaver-Burk plot of the 
uptake of deGlc by m utant Ile^oS-injected oocytes. Figure 6.5 shows the same 
plot of the uptake of deGlc by oocytes injected w ith m utant Asn^^^ 
Lineweaver-Burk plots for the other mutants are not shown as these are 
comparable to wild type GLUT3- as is the plot for mutant lle^os. However, Km 
values for all the mutants are presented in Table 6.2. Note that on average, 
50% of the "n" numbers in this study were obtained by Dr Michael J. Seatter.
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Figure 6.1
Comparison of Amino Acid Sequences in Putative Transmembrane Helix 8 of 
the Facilitative Glucose Transporter Family.
This diagram shows a comparison between helix 8 amino acid sequences 
of human GLUTs 1, 2, 3, 4 and 5. Residues which are completely conserved 
between these iso forms are shown in bold. A consensus sequence of GLUTs 1-4 
is also shown at the bottom of the diagram. Note that several polar amino 
acids are also conserved in this helix, including asparagine^^^ The positioning 
of these polar amino acids is shown in Figure 6.2.
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Figure 6.1
Comparison of Amino Acid Sequences in Putative Transmembrane Helix 8
of the Facilitative Glucose Transporter Family.
hCLUTl VYATIGSGIVNTAFTVVSLFV 
hGLUT2 VYATIGVGAVNMVFTAVSVFL 
hOLUTS lY A T IG A G W N T IF T V V S L F L  
hCLUT4 AYATIGAGW NTVFTLVSVLL 
hGLUTS QYVTAGTGAVNVVMTFCAVFV
GLUTl-4 x Y A T IG x G x V N x x x T x V S x x x
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Figure 6.2
Predicted a- Helical Structure of GLUTS Transmembrane Helix 8.
This is a helical wheel diagram which predicts the secondary structure 
of putative transmembrane helix 8 of GLUTS. The diagram looks down through 
the helix from the exofacial side of the membrane. The helix starts with Ile^o^ 
(numbered residue 1 on the wheel), and rotates dow nw ard in a clockwise 
direction to Asn^^s ^t the bottom (Leu^^é-jg the last residue shown on the wheel 
diagram, num bered residue 21). The diagram  highlights a num ber of polar 
residues which cluster on one side of the helix, on the other side, the residues are 
largely hydrophobic in nature.
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Figure 6.2
Predicted a- Helical Structure of GLUTS Transmembrane Helix 8.
M,I,LV
F.Y,W
G,A,P
K,H,R
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Figure 6.3.
Diagram Describing Recombinant PCR Approach.
This diagram  describes the PCR approach used to construct the helix 8 
mutants. The template used for the generation of primary products "a" and "b" 
was GLUTS cDNA. The internal primers used in these reactions were composed 
of GLUTS helix 8 sequence with the appropriate bases changed to encode for an 
alanine at the specific residue position of interest .
In the generation of primary product "a", the mutagenic, internal primer 
binds to the top (sense) strand of GLUTS, and G3 Start- the external primer, binds 
to the bottom (antisense) strand of GLUTS. Conversely, in the generation of 
primary product "b", the internal, mutagenic prim er binds to the bottom  
(antisense) strand of GLUTS, and the external primer- G3 End, binds to the top 
(sense) strand. Upon melting, reannealing and extension, primary products "a" 
and "b" are produced which have overlapping sequences, each encoding the 
mutation which was incorporated in the two mutagenic primers.
These primary products serve as templates in the secondary PCR reaction. 
After a few PCR rounds of melting, strand dissociation and re-annealing, the 
overlapping sequences are extended to produce full length constructs which 
encode the alanine substitution. These full length fragments are further amplified 
in subsequent rounds of PCR by the external primers G3 Start and G3 End.
The external primers contain Sal I restriction sites in their tail regions. This 
allows the PCR product to be cloned into Sal I restricted vector.
Details of oligonucleotides and PCR conditions can be found in: Michael J. 
Seatter, PhD Thesis, November 1994, University of Glasgow.
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Figure 6.3 Diagram Describing Recombinant PCR Approach.
GLUT3 template
^ point mutation in helix 8
---------- &  — ------K
internal primer
G3 start internal primer 
V3' ^  5' 3' ^  \  5'
point mutation in helix 8
primary PCR steps
primary product a primary product b
Sal  I site
A
overlapping
sequences
Sal
k j = ^
^ — I—  I
\  primary products a and b serve as templates in the secondary PCR.G2  Start .
^ ^
G3End
X  Secondary T PCR
A.
;  ;  VSa/1 site \  SaZ I site
point mutation
♦
Sa i l  restriction and subsequent ligation into vector.
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Figure 6.4.
Lineweaver-Burk Plot o£ the Uptake of DeGlc by Mutant Ile^os Injected Oocytes.
Each point is the mean transport rate determined from groups of 10 oocytes 
(see section 2.4). Rate of transport was determined by exposure of the oocytes to 
radiolabeled deGlc for 30 mins and the counts per minute determined as described 
(section 2.4). For each experiment endogenous oocyte transport was measured by a 
parallel incubation of non-injected "control" oocytes in trace radiolabeled deGlc. 
The values obtained for the control oocytes at each concentration were subtracted 
from the values obtained from  the m utant-injected oocytes to obtain the 
heterologous transport rate. Transport rates in control oocytes were typically 10% 
or less of the injected oocytes. Error bars are excluded for clarity, but the range of 
error was typically 10%. The data shown in this particular plot and in other plots 
presented in this chapter, is one of at least four separate experiments.
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Figure 6.4.
Lineweaver-Burk Plot of the Uptake of DeGlc by Mutant Ile^^s injected Oocytes.
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Figure 6.5.
Lineweaver-Burk Plot of the Uptake of DeGlc by Mutant Asn^is Injected Oocytes.
Each point is the mean transport rate determined from groups of 10 oocytes 
(section 2.4). Rate of transport was determined by exposure of the oocytes to 
radiolabeled deGlc for 30 mins and the counts per minute determined as described 
(section 2.4). (See also Figure legend 6.6). Transport rates in control oocytes were 
typically 10% or less of the injected oocytes. Error bars are excluded for clarity, but 
the range of error was typically 10%. The data shown in this particular plot and in 
other plots presented in this chapter, is one of at least four separate experiments.
243
Figure 6.5.
Lineweaver-Burk Plot of the Uptake of DeGlc by Mutant Asn^^s injected
Oocytes.
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Table 6.2.
Kinetic Parameters of Helix 8 Mutants in Oocytes.
This table shows the for deGlc for each of the helix 8 mutants when 
expressed in oocytes. The residue numbers given refer to GLUTS residues. All 
residues are substituted by alanine, therefore since residue^o^ |s alanine originally, 
it is not included in this study. All KmS for deGlc are similar to wild type GLUTS, 
with the exception of the Asn^^^ mutant, which has a approximately 4-fold 
higher than wild type GLUTS. Note that on average, 50% of these "n" numbers 
were generated by Dr. Michael J. Seatter.
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Table 6.2
Kinetic Parameters of the Helix 8 Mutants in Oocytes.
Residue
num ber
Original
designation deGlc Km (mM)
305 He 1.2+0.36
306 Tyr 2.1+0.6
308 Thr 1.5+0.6
309 lie 1.1+0.3
310 Gly 1.5+0.1
312 Gly 1.5+0.02
313 Val 1.16+0.07
314 Val 2.4+0.5
315 Asn 12.2+4.9
316 Thr 2.9+1.0
317 lie 1.53+0.3
318 Phe 1.7+0.3
319 Thr 2.7+0.4
320 Val 1.6+0.4
321 Val 2.4+0.8
322 Ser 1.4+0.5
323 Leu 1.9+0.6
324 Phe 2.6+0.3
325 Leu 1.3+0.5
wild type GLUTS 1.4+0.6
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6.5 Conclusions.
All nineteen m utants have been successfully expressed in Xenopus  
oocytes. Transport rates were similar to GLUTS wild type. Km values for deGlc 
transport for each of the helix 8 mutants have been determined (Table 6.2). The 
substitution of Asn^is with alanine in helix 8 of GLUTS produced a -3-fold 
increase in deGlc Km (Figure 6.5, Table 6.2). All other substitutions produced no 
effect on deGlc transport rate and Km-
6.6 Discussion.
From comparison of the helix 8 sequences in Figure 6.1, it can be seen 
that there are several residues which are highly conserved between the GLUT 
family members (there is also a high level of conservation between the species: 
human, rat, rabbit and mouse). Tyr^06  ^ Thr^^^, Gly^^^, Asn^is^ and
Thr^i^ are all conserved through the whole family (human GLUTS residue 
numbering). Ala^o^  ^ Ile^o ,^ VaU^i and Ser^22 are identical in GLUTs 1-4, but not 
in GLUT5. Since GLUT5 is a fructose transporter and not a glucose transporter, 
these residues may have some importance in this regard. Also, VaP^^ Thr^^^ 
and Phe3i8 are identical in GLUTl, GLUTS and GLUT4, but not in GLUT5 or in 
GLUT2, both of which are capable of fructose transport.
Figure 6.2 shows a helical wheel projection of helix 8. This diagram 
looks down through the helix from above, with Ile^os at the top of the helix 
winding down in a clockwise direction to Asn^^s at the bottom. Also shown in 
this diagram  is the positioning of the polar residues, the majority of which 
cluster on one side of the helix. The other side of the helix is composed mostly 
of hydrophobic residues. Three of the six helix 8 polar residues that are 
conserved throughout the family are predicted to lie on this polar face. These 
residues are Thr^^s^ Asn^i^ and Thr^^^. However, Tyr^^^ which is also capable
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of hydrogen bonding, and is conserved throughout the family, is predicted to 
lie opposite these residues, and so according to this model would be in a lipid 
environment. However, the helix may rotate upon conformational change to 
bring this residue into a polar environment.
Substitution of the equivalent residue of Asn^i^ GLUTl (Asn3^^-> lie, 
(Hashiramoto et al., 1992)) produced a 50% decrease in transport activity, which 
the authors of this study concluded was surprising considering the absolute 
conservation of this residue throughout the family. This decrease in transport 
activity was not due to disruption of the exofacial or endofacial binding sites as 
labelling with ATB-BMPA and cytochalasin B was comparable with wild type. 
The GLUT4 residue which is equivalent to Tyr^^^ in GLUT3 (Tyr3^8->Phe, 
(Wandel et at., 1994)), has been substituted without producing any effect on 
transport activity or on labelling with cytochalasin B and ATB-BMPA.
The results from the experiments presented in this chapter show that 
none of the nineteen substitutions of residues in helix 8 of GLUTS have a 
profound effect on functional activity, and therefore probably not on folding 
and targeting of the transporter to the plasma membrane in oocytes. At present 
there is no available procedure for obtaining pure oocyte plasma membrane 
fractions, and so it cannot be directly shown that the num ber of transporters 
that reach the plasma membrane is equivalent to wild type GLUTS (section 
4.6.S). However, the deGlc transport rate of mutant-injected oocytes was always 
at least 5-fold greater than non-injected or water injected oocytes. Therefore, it 
can be assumed that the substitutions have not produced any gross defect in 
the protein folding or targeting mechanism.
Measurement of deGlc uptake for each of these mutants has shown that 
no single amino acid in helix 8 of GLUTS is absolutely essential for transport 
activity. Additionally, the Km for deGlc is unaffected by substitution of eighteen 
of the nineteen residues in helix 8. The only substitution which produced any 
effect on the Km was that of Asn^^^. This residue is conserved throughout the
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GLUT family, and is predicted to be located on the polar face of helix 8. It seems 
possible that this residue may play a role in the exofacial binding site since the 
GLUTl site of photolabeling by the exofacial ligand ATB-BMPA has been 
m apped to a region betw een helix 7 and helix 8. However, although 
substitution of the equivalent residue in GLUTl produced a 50% decrease in 
transport activity, ATB-BMPA binding was comparable to wild type GLUTl. 
Therefore it may be more likely that Asn^^^ in GLUTS may participate in the 
transporter interactions with deGlc as it passes through the channel.
The change in Km that resulted from substitution of Asn^^s may 
represent a change in the affinity of the transporter for deGlc. However, this 
may also be due to a change in the turnover number of the protein. At present, 
it is not possible to determine this due to the difficulty in obtaining the pure 
oocyte plasma membranes fractions needed for the quantification of protein at 
the cell surface.
Nevertheless, binding studies using ligands such as cytochalasin B and 
ATB-BMPA will provide inform ation as to whether the substitution has 
resulted in perturbation of the endofacial and exofacial binding sites. It is also 
possible that these studies will highlight effects of the other substitutions on 
the exofacial and endofacial binding sites which are not necessarily 
accompanied by a loss of transport activity.
Measurement of the affinity of the Asn^is mutant for other substrates 
such as galactose will also indicate if this residue is more critical in the 
transport of sugars other than deGlc. Additionally the Ki values for the 
inhibition of deGlc by non-transported ligands such as maltose and 4,6-0- 
ethylidene-D-glucose will also indicate if there are any changes in the exofacial 
binding site.
In Chapter 4 we have proposed a model for the structural basis of 
substrate binding. We have speculated the C-4 position of D-giucose may bind 
to a region of sequence which lies between the end of helix 7 and the end of
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helix 10. Helix 8 lines the glucose transporter channel in both of the recently 
proposed helical packing models (Zeng et a i ,  1996), and the presence of several 
highly conserved polar residues suggests a role for this helix in hydrogen 
bonding to the sugar. The replacement of Asn^^^ with alanine is the only 
substitution in helix 8 which alters the Km for deGlc. However, it is unlikely 
that this residue is important for C-4 binding, since the substitution of Asn^^^ 
-the corresponding residue in GLUTl, does not affect exofacial or endofacial 
ligand binding. Also, it has been suggested that Tyr293 of GLUTl, which lies at 
the end of helix 7 may be involved in binding the sugar at the C-4 or the C-6 
positions (Mori et al., 1994). Nevertheless, it would be instructive to perform 
inhibition studies on this m utant using D-glucose analogues. The analogue 
approach allows us to investigate if the binding of the hydroxyls at any of the 
carbon positions have become less or more important in the binding of glucose 
to this mutant. It would be especially interesting to measure the affinity of this 
mutant for C-4 substituted hexoses, such as maltose and 4,6-O-ethylidene-D- 
glucose. A change in affinity of the mutant for these compounds compared to 
wild type GLUT3, may indicate a disruption of binding at the C-4 position of 
the sugar.
It is perhaps surprising that substitution of such highly conserved 
residues as those in helix 8 does not lead to greater structural and functional 
problems in the transporter. Indeed, of the many mutations that have been 
created throughout the transporter structure, remarkably few residues have 
been found to be of absolute importance. Clearly, there is a selective pressure 
m aintaining the absolute conservation of these residues in the transporter 
structure, but perhaps their role is more collective than singular. It may be that 
there are few single residues that are all important for protein folding for 
example, but several which act in concert to allow the protein to form folding 
intermediates and to maintain the final tertiary structure. The residues which 
have been found to be absolutely critical (i.e. GW^^, VaL^^, Tyr^^s^ and Pro^ss)
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may exist in locations where their precise geometry is required for function 
through hydrogen bonding or hydrophobic interaction (Mori et al., 1994, 
Mueckler, 1994a, Mueckler, 1994b, Tamori et al, 1994)
It is interesting in this regard to look at other transport proteins which 
have been subjected to site directed mutagenesis, such as the lactose (lac) 
permease of E.coli. The lac permease is a membrane transport protein that 
couples the transport of {3-galactosides with that of H+. The lac y gene which 
encodes this transporter has been cloned and sequenced, and based on 
spectroscopic analysis of the purified protein and hydropathy analysis of the 
amino acid sequence, a model for the secondary structure has been proposed 
which is extremely sim ilar to Muecklers model of GLUTl (Figure 1.2) 
(Mueckler, 1985). As with GLUTl the transporter is proposed to span the lipid 
bilayer twelve times with the N- and C-termini cytoplasmically disposed. Also 
similar to GLUTl is the predicted presence of a large cytoplasmic loop between 
helix 6 and helix 7 (Kaback, 1996).
The lac permease has been the subject of extensive mutagenesis studies, 
including the use of cysteine scanning mutagenesis, second site suppressor 
analysis and site-directed excimer fluorescence (reviewed in Kaback, 1996, 
Kaback et a l ,  1994). The cysteine scanning approach involves the use of a 
cysteineless permease (described in Kaback et a l ,  1994). Each amino acid in the 
entire protein is then individually substituted by cysteine. Cysteine residues 
can be labelled with radioactive, fluorescent or spin-labelled probes, or they can 
be chemically modified with thiol group-modifying reagents. Additionally, 
with this technique it is possible to investigate the proximity of any two 
fluorescent-labelled cysteines in the protein. Experiments such as these have 
been very successful in confirming various structural features of the lac 
permease. It has been shown for instance, that helix 7 is probably in close 
proximity to helix 10 and helix 11. Helix 8 is also predicted to lie near helix 10 
(Kaback, 1996).
-A
However, in spite of the extensive mutagenesis that has been performed 
on this protein (over 90% of the residues have been mutated), surprisingly few 
single residues have been found to be essential in the active transport 
mechanism. Those residues which have been identified as im portant are 
mostly involved in protein folding and m aintenance of the structure. 
Additionally, it has been shown from cysteine scanning mutagenesis studies 
that, w ith many of the residues in the lac perm ease, alkylation of the 
substituted cysteine (which replaces the original amino acid), produces slight 
alterations in the transport activity. It was observed that the mutants which 
display this slight reduction in transport activity upon alkylation appear to 
cluster together in the membrane, suggesting that the general shape and 
surface contours of the helices may be important in global transport function. 
It has also been suggested from such analyses that the large conformational 
change which occurs during transport catalysis involves widespread, multi­
determined conformational changes, and does not appear to be dependent on 
m any residue-specific side -cha in /substra te , and side-chain /side-chain  
interaction (Frillingos & Kaback, 1996, Kaback, 1996).
It could also be said of the facilitative glucose transporters that, despite 
the large number of mutational studies that have been performed, remarkably 
few residues have been found to be important. This situation may be similar 
between the GLUTs and the lac permease.
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CHAPTER 7.
Discussion.
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Glucose is the primary energy source for the brain, and can be readily 
taken up and utilised by all other mammalian cells to provide immediate 
metabolic energy, or alternatively, it can be converted to glycogen for storage in 
the liver and muscle. The mechanisms which facilitate this glucose disposal 
are therefore crucially im portant in m aintaining whole body glucose 
homeostasis. The tissue-specific expression of the m am m alian facilitative 
glucose transporters, and the structural and functional diversity of the 
isoforms of this family, are key components of this mechanism. Furthermore, 
since the transport of glucose into certain tissues is under both acute and 
chronic control by circulating hormones, it is thought that aberrant expression 
and / or dysfunction of some isoforms may play a role in diseased states. 
Peripheral insulin resistance for example, a condition which leads to non 
insu lin  dependent diabetes (NIDDM), is thought to be associated with 
depletion or inactivation of GLUT4 in skeletal muscle and fat. In NIDDM, 
expression of the GLUTS isoform in insulin responsive tissues is also impaired 
in the same way as GLUT4, and additionally, GLUT2, due to its presence in the 
liver and in the insulin secreting cells of the pancreas, is thought to play an 
important role in whole body glucose homeostasis.
Clearly therefore, in order to fully understand the basis of transport 
dysfunction, it is essential to understand the molecular mechanism by which 
these carriers mediate glucose transport in non-diseased states.
Investigation of the molecular basis of transport has largely focused on 
the GLUTl isoform. This is due to several factors which include the abundance 
of this protein in the erythrocyte membrane, the ready availability of 
erythrocytes, and the ease with which these cells can be manipulated. Kinetic, 
biochemical and biophysical studies of purified GLUTl, have enabled the 
construction of a detailed model for the topology and transport mechanism of 
this isoform. The protein is proposed to have twelve membrane spanning 
domains which cluster together in such a way as to form a water accessible
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pore through which glucose moves as it crosses the bilayer. During transport 
catalysis, the protein is thought to undergo a conformational change which 
results in the alternative exposition of an exofacial and an endofacial binding 
site. Glucose transport across the membrane begins by sugar binding to the 
exposed binding site. This is proceeded by a conformational change in the 
carrier which results in the appearance of glucose at the other side of the 
membrane. The binding sites at which glucose associate and dissociate from 
the transporter are structurally distinct and spatially separate. This proposed 
mechanism is known as the single site, alternating conformation model, and it 
is supported by most of the existing biochemical, biophysical and kinetic data.
Biochemical studies have mapped the exofacial and endofacial binding 
sites to specific regions in the transporter structure, and site directed 
mutagenesis studies have identified specific residues and stretches of sequence 
in the transporter which are im portant in the conform ational change 
mechanism.
The hydropathy plots of other isoforms of the glucose transporter family 
are virtually superimposable with that of GLUTl. Therefore the exofacial and 
the endofacial binding sites of these isoforms, the conformationally active 
regions, the general topology, tertiary structure and mechanism of action are 
thought to be analogous with GLUTl. However, the glucose transporters are 
expressed in a highly regulated, tissue-specific manner, indicating that they 
may be an important component of the glucose disposal system. Previously, 
expression of cloned transporter cDNAs or in vitro transcribed mRNA in the 
X en o p u s  oocyte system has shown that each isoform displays slightly different 
transport kinetics, preferences for alternative substrates, and sensitivity to 
transport inhibitors. Therefore, the regulated, tissue-specific expression of the 
transporter isoforms probably functions to meet the specific metabolic 
requirements of the various tissues in which they are present.
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Although the isoforms display similarities in general structure and 
mode of action, there clearly must be subtle structural differences which define 
isoform-specific behaviour. This structural basis of isoform-specific behaviour 
has largely been the subject of study in this thesis.
Previous work in this lab has utilised the X en o p u s  oocyte system to 
establish the kinetic characterisation and structural requirements for substrate 
binding to GLUT2 and GLUTS. This work has highlighted the disparity of these 
two isoforms, demonstrating for example, the fructose transport capacity of 
GLUT2, and the lack of fructose recognition by GLUTS. GLUTS was shown to 
transport both deGlc and galactose with a much higher affinity than GLUT2. 
These differences provided the basis for an assay in which a panel 
GLUT2/ GLUTS chimeric transporters were characterised for their fructose, 
deGlc and galactose transport activity. This results of this study, described in 
chapter 4, have shown that the structural inform ation which allows the 
GLUT2 isoform to accept fructose, resides entirely in helix 7. Whether other 
sequences in the transporter structure influence the kinetics  of fructose 
transport by this isoform is not clear from the existing data. Helix 7 was also 
identified as being important in the ability of GLUTS to transport deGlc and 
galactose with high affinity. This study is at present being taken further with 
ongoing work from this laboratory. On the basis of the observation that helix 7 
is essential for fructose recognition, new GLUT2 and GLUTS mutants have 
been constructed which have the QLS motif of helix 7 (of GLUTs 1, S and 4) 
swapped with the HVA motif of the GLUT2 helix 7. Initial analysis of these 
mutants suggest that it is the HVA motif of GLUT2 which is solely responsible 
for the ability of this isoform to accept fructose. Furthermore, the graft of the 
QLS motif onto a GLUT2 molecule results in high affinity deGlc transport.
The success of this study demonstrates that chimeric mutagenesis is an 
extremely useful approach which can be used to define regions of a protein 
im portant in specific functions. Once larger regions are m apped with this
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technique, it is then possible to closely search the amino acid content of these 
regions for specific motifs which may be relevant to the function of interest.
Previous characterisation of fructose transport by GLUT2 had shown 
that this isoform transports fructose in the furanose ring form, while glucose is 
transported in the pyranose ring form. In a separate study it was shown that 
the fructose transporter of the parasite Trypanosoma bruceii could transport 
both the furanose and the pyranose ring forms of fructose with approximately 
equal efficiency. Fructose, when in solution, exists predom inantly in the 
pyranose ring form, and since hum an GLUTS has been reported to be 
exclusively a fructose transporter, we have investigated which ring form of 
fructose is accepted by this isoform. The results of these experiments show that 
GLUTS, like GLUT2, transports the furanose ring form of fructose. Further 
experim ents using fructose analogues w hich have carbon hydroxyls 
substituted by non polar groups will provide information on the hydrogen 
bonding requirements of GLUTS. Previous investigations of GLUTS have been 
inconclusive in determ ining both the substrate specificity and kinetics of 
fructose transport by this isoform. Since the properties of human GLUTS have 
been documented only once in the literature, it was decided to examine the 
substrate selectivity and to m easure the for fructose transport of this 
isoform in the oocyte system. Our results from this work are in broad 
agreement with the previous study of human GLUTS in oocytes from Burant 
et al.
Recently, it has been shown that the affinity of the hum an sodium- 
linked glucose transporter SGLTl for glucose, changes in response to pH. This 
transporter is expressed in the gut in conjunction w ith GLUTS. The 
observation that human GLUTS is expressed in tissues which are subject to a 
range of pH values (both in the gut and elsewhere), and the ambiguity in 
reports that this isoform can transport glucose, led us to examine the effect of 
varying the pH of the extracellular transport medium on the ability of GLUTS
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to transport fructose and deGlc. The results of these experiments suggest that 
the affinity of human GLUTS for fructose, and the lack of ability to accept deGlc 
does not alter in response to pH.
Finally, we have examined the effects of amino acid substitution on 
each residue within helix 8 of GLUT3. Helix 8 was of interest to us because of 
its implied role in the exofacial binding site (section 1.6). GLUTS was chosen as 
a template for mutagenesis as most previous studies have focused on GLUTl. 
Our study would serve a dual role therefore, firstly it would investigate the 
structural importance of the amino acids of helix 8 to the GLUTS molecule, 
and secondly, it would serve as an isoform-comparative study to the existing 
GLUTl data. The experiments presented in this thesis have shown that none 
of the substitutions of helix 8 residues in GLUTS have a profound effect on the 
folding and targeting of the transporter. Also, despite the high conservation of 
a number of polar amino acids in this helix, only one of the substitutions 
produced any effect on the Km of GLUTS for the transport of deGlc. The 
substitution of Gln^i^ with Ala resulted in a 4-fold increase in the Km for 
transport of deGlc. This is analogous to the results of previous studies on the 
helix 8 of GLUTl.
In conclusion therefore, the chimeric approach has been extremely 
successful in identifying the domains involved in fructose recognition. Future 
work with the existing chimeras may involve the use of glucose analogues to 
study the interaction of indiv idual sugar hydroxyls w ith the chimeric 
transporters. The precise effects of swapping individual helices within GLUT2 
and GLUTS could not be determ ined in this study due to methodology 
problems. However, the enzymes which are commercially available for 
recom binant PGR are being quickly improved in terms of proof-reading 
capacity, and so it should soon be possible to construct error-free single domain 
swap mutants.
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Future studies of the existing chimeras and of single domain swap 
chimeras, would probably benefit from use of another expression system. The 
X en o p u s  oocyte system has proven to have extreme drawbacks. The seasonal 
variation of oocyte batches meant that reliable data could only be obtained 
during a very lim ited time period within the year. This restriction was 
com pounded by animal housing problems: Xenopus laevis are extremely 
sensitive to their environment, and this has a direct effect on the quality of the 
oocytes that are produced.
Expression of chimeras in another system such as CHO cells would also 
enable the m easurement of plasma membrane protein concentration, which 
would allow other kinetic parameters to be determined- such as V^ax and 
transporter turnover. More accurate and detailed kinetic studies would 
therefore be possible in another cell system.
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